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II. Abstract 
Heterochromatin covers a large fraction of the mammalian genome and defects in 
heterochromatin formation in mice result in severe developmental defects, genome 
instability, cancer and cell death (Dodge et al., 2004; Fodor et al., 2010; Hahn et al., 2010; 
Peters et al., 2001; Schotta et al., 2008). However, to which extent heterochromatin proteins 
are involved in transcriptional gene regulation in mammals and which heterochromatin 
proteins participate in this process is largely unknown. 
In this thesis I utilized the Intracisternal A-type Particle (IAP) retrotransposon of mice as a 
model system for heterochromatin formation. I identified a novel DNA sequence element of 
IAP retrotransposons that autonomously recruits heterochromatin formation and silences 
even strong constitutively active promoters in cis in mouse embryonic stem cells. I generated 
an EGFP-based silencing assay utilizing this IAP sequence and combined it with RNAi 
experiments to test genes for their involvement in heterochromatic gene silencing. Reporter 
gene silencing requires the H3K9 histone methyltransferase Setdb1 and the transcriptional 
corepressor protein Trim28, which are both known regulators of endogenous IAP 
retrotransposon silencing (Matsui et al., 2010; Rowe et al., 2010). Having established a 
reporter system that phenocopies endogenous IAP silencing, I sought to identify additional 
proteins involved in heterochromatin regulation by genome-wide RNAi-screening.  
I found that the SNF2-type ATPase Atrx and the histone H3.3 chaperone Daxx are required 
for rapid heterochromatic gene silencing. Notably, Atrx is also enriched at endogenous IAP 
elements. Cells that completely lack Atrx or Daxx show a severe delay of reporter silencing 
but are not completely deficient in heterochromatin formation. Consistently, endogenous IAP 
elements are not derepressed in Atrx or Daxx knockout ES cells. However, when 
heterochromatin status is challenged by depletion of Setdb1 or Trim28, Atrx knockout cells 
show a stronger derepression of endogenous IAP elements. This suggests that the 
Atrx/Daxx pathway suppresses heterochromatin plasticity at these elements. Consistently, 
recruitment of strong transcriptional activators to a heterochromatinized reporter gene only 
results in an activation of reporter expression when cells lack Atrx.   
Surprisingly, rescue experiments in Daxx knockout cells reveal that reporter silencing is 
independent of H3.3 association with Daxx. This is consistent with the finding that cells 
lacking H3.3 show no defect in reporter gene silencing.  
In summary, this thesis unravels a novel, H3.3-independent role of Atrx and Daxx in 
catalyzing heterochromatin formation.  
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III. Zusammenfassung 
Ein großer Teil des Säugetiergenoms ist in Heterochromatin verpackt. In Knockout-Studien 
mit Mäusen konnte gezeigt werden, dass Heterochromatin im Säugetier essentiell für das 
Überleben ist. So führen Defekte in der Etablierung oder Aufrechterhaltung von 
Heterochromatin zu Entwicklungsdefekten, Instabilität des Genoms, Krebs und Zelltod 
(Dodge et al., 2004; Fodor et al., 2010; Hahn et al., 2010; Peters et al., 2001; Schotta et al., 
2008).  Ob Proteine, die bei der Bildung von Heterochromatin beteiligt sind, auch eine direkte 
Auswirkung auf die Regulation der Genexpression in Säugetieren haben, ist aber 
weitgehend unbekannt. 
In dieser Doktorarbeit, habe ich zunächst eine DNA-Sequenz im Genom der Maus entdeckt, 
die in der Lage ist, die Bildung von Heterochromatin zu veranlassen, wenn man diese 
Sequenz neu ins Genom von embryonalen Mausstammzellen integriert. Die Sequenz 
stammt aus sogenannten IAP-Elementen, einer Unterfamilie von LTR-Retrotransposons die 
natürlicherweise hundertfach im Mausgenom vorkommt. Das identifizierte Sequenzelement 
kann nicht nur die Bildung von Heterochromatin veranlassen, sondern auch die 
Genexpression von benachbarten aktiven Genen in Mausstammzellen abschalten. Ich 
etablierte ein System bei dem das Sequenzelement ein grün-fluoreszierendes Reportergen 
(EGFP) ausschaltet, wenn es ins Genom von Mausstammzellen integriert wird. Durch 
Analyse von Zellen, in denen Heterochromatinkomponenten depletiert wurden, konnte 
gezeigt werden, dass die Histonmethyltransferase Setdb1 und das transkriptionelle 
Korepressorprotein Trim28 essentiell an der Abschaltung des EGFP-Reportergens durch das 
identifizierte Sequenzelement beteiligt sind. Für Trim28 und Setdb1 wurde bereits 
beschrieben, dass sie die Expression von endogenen IAP-Retrotransposon-Sequenzen in 
Mausstammzellen unterdrücken (Matsui et al., 2010; Rowe et al., 2010). Da das generierte 
EGFP-Reportersystem klare Eigenschaften widerspiegelt, die auch bei der Abschaltung von 
endogenen Retrotransposons eine Rolle spielen, wurde es benutzt um auch andere Gene zu 
finden, die bei der Stilllegung von Retrotransposons eine Rolle spielen. Dazu kombinierte ich 
die EGFP-Reportergenstudien mit einem RNA-Interferenz-Screen. Ich fand heraus, dass das 
EGFP-Reportergen nur noch sehr stark verlangsamt ausgeschaltet werden kann, wenn das 
Histon H3.3 Chaperon-Protein Daxx und die ATPase Atrx fehlen. Interessanterweise bindet 
das Atrx-Protein an endogene IAP-Retrotransposon-Sequenzen. Durch Re-Expression von 
Daxx in Daxx Knockout-Zellen konnte ich zeigen, dass die Bindung von Histon H3.3 durch 
Daxx nicht notwendig ist für die Funktion von Daxx bei der untersuchten Genabschaltung. 
Dieses Ergebnis ist mit der Beobachtung konsistent, dass Zellen in denen Histon H3.3 
depletiert wurde das EGFP-Reportergen immer noch genauso gut ausschalten können wie 
wild-typische Zellen. Obwohl diese Beobachtungen eine direkte Rolle von Atrx und Daxx bei 
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der Abschaltung von endogenen IAP-Retrotransposons nahelegen, sind endogene IAP-
Retrotransposon weder in Atrx-defizienten Zellen noch in Daxx-defizienten Zellen 
dereprimiert. Wird allerdings das Heterochromatin durch eine verminderte Expression von 
Trim28 oder Setdb1 beeinträchtigt, so reagieren Zellen denen Atrx fehlt mit einer stärkeren 
Derepression von IAP-Retrotransposons. Außerdem lassen sich Gene die von 
Heterochromatin umgeben sind, deutlich leichter wieder aktivieren, wenn Atrx in den Zellen 
ausgeschaltet wurde.  
Atrx und Daxx sind somit für die Repression von endogenen Retrotransposons nicht 
erforderlich, sorgen aber für eine geringe Plastizität des Heterochromatins und 
beschleunigen und stabilisieren somit dessen Entstehung an repetitiven Sequenzen im 
Genom. 
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1. Introduction 
1.1. Heterochromatin regulation  
1.1.1. DNA, chromatin and a definition of heterochromatin 
Nuclear DNA of eukaryotic cells is spooled around octameric protein complexes consisting of 
basic histone proteins. The formed structures are called nucleosomes and consist of roughly 
146 bp of DNA wrapped in 1.7 turns around a core of eight histone proteins. Two copies of 
each highly evolutionary conserved canonical histone protein H2A, H2B, H3 and H4 form the 
protein core of a nucleosome (Kornberg, 1974; Luger et al., 1997). In addition, specialized 
variants of different histones have evolved during evolution to exhibit specialized functions 
(Talbert and Henikoff, 2010). The association of DNA with histone proteins and non-histone 
proteins is called chromatin, named by Walther Flemming, who was among the first 
researchers describing cellular structures during cell division (Flemming, 1882).  
Since most somatic cells in an organism share the same DNA content, but every different 
cell type needs to express a different set of genes, gene expression has to be tightly 
regulated. The regulation of gene expression happens mainly on the level of transcription. 
Research in the last decades has unraveled that chromatin regulation is a key process that 
facilitates and maintains these transcriptional programs (Allis et al., 2007). Chromatin is 
constantly covalently and non-covalently modified by proteins and RNA to regulate 
transcription and other nuclear processes such as DNA replication or DNA repair. Many 
ways of chromatin regulation have been described including chemical modifications of 
cytosine DNA nucleotides, chemical modifications of histone proteins, sliding, exchange and 
replacement of histone proteins by chromatin remodeling enzymes and interactions of 
regulatory RNA with chromatin (Allis et al., 2007; Becker and Horz, 2002; Bernstein and Allis, 
2005; Jones, 2012; Kouzarides, 2007). For a more detailed introduction into general 
chromatin biology the reader is referred to reviews and books that can give a broader 
overview (Allis et al., 2007; Kouzarides, 2007). 
In the early 20th century, optically dense chromatin regions inside the cell nucleus have been 
discovered and termed heterochromatin and specialized genomic features of these 
chromatin regions have been proposed (Heitz, 1928). Even though this descriptive definition 
of heterochromatin holds true for most cells where repetitive, non-coding DNA sequences 
like centromeres and pericentric regions are constitutively heterochromatinized, already 
observations from the first half of the 20th century indicated that normally euchromatic regions 
can also be heterochromatinized under certain conditions (Brown, 1966). These findings 
prepared the ground for a modern definition of heterochromatin, which is based on the 
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functional state of the chromatin domain rather than its chromosomal localization, the 
underlying DNA sequence or the optical density.  
However, the parameters that determine the functional state of a chromatin domain are not 
defined precisely. Genome-wide analysis of histone modifications, binding of chromatin 
proteins, nuclease accessibility and genome transcription can define different types of 
chromatin domains (Consortium, 2004; Consortium et al., 2012; Filion et al., 2010; 
Kharchenko et al., 2011). When considering these datasets for a definition of 
heterochromatin, a heterochromatic domain is often defined as having the functional 
molecular features normally present at known constitutive heterochromatic regions like 
pericentric heterochromatin. Such molecular properties have already been used for a 
heterochromatin definition earlier (Huisinga et al., 2006). These would include: Trimethylation 
of lysine 9 in histone H3 (H3K9me3), Trimethylation of lysine 20 in histone H4 (H4K20me3), 
cytosine methylation of DNA, chromatin-association of Hp1 proteins and DNAseI 
inaccessibility (Huisinga et al., 2006).  
By now, a lot of experimental evidence underlines the fundamental importance of 
heterochromatin for basic cellular processes, mammalian development and consequently 
many human diseases (Dambacher et al., 2010; Hahn et al., 2010). However, the functional 
role and the regulation of heterochromatin are still incompletely understood.  
1.1.2. Regulation pathways at pericentric heterochromatin in mouse 
Most of our knowledge about heterochromatin in mammals comes from analyses of mouse 
pericentric heterochromatin that occludes highly repetitive major satellite DNA close to the 
centromeres. Pericentric heterochromatin is established in a sequential pathway (Figure 1.1). 
How heterochromatin-modifying enzymes are recruited to major satellite sequences in the 
first place is not understood, but binding of transcription factors Pax3 and Pax9 are involved 
in priming major satellite sequences for heterochromatin formation (Bulut-Karslioglu et al., 
2012). Next, different methyltransferases catalyze H3K9me1 at pericentric heterochromatin 
(Loyola et al., 2009; Pinheiro et al., 2012). Yet, it is not fully clear how these enzymes are 
recruited to major satellites and whether Prdm3, Prdm16 and Setdb1 are partially redundant 
in this process. Because Suv39h enzymes catalyze H3K9me3 at pericentric heterochromatin 
(Peters et al., 2001), and knockout of Suv39h results in an accumulation of H3K9me1 at 
pericentric heterochromatin (Peters et al., 2003), generation of H3K9me1 has to be an early 
and important step in heterochromatin formation. In addition, many H3K9 methyltransferases 
also directly interact, assuming that H3K9me1 could also be established by collaborative 
action of different enzymes (Fritsch et al., 2010). Furthermore, H3K9me1 and H3K9me2 are 
not limited to heterochromatic regions in general and are also abundant at other chromatin 
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regions making it complicated to unravel their specific deposition at heterochromatin (Lienert 
et al., 2011a). 
Upon generation of H3K9me3 by Suv39h enzymes Hp1 proteins can directly bind this 
modification via their chromodomains (Bannister et al., 2001; Lachner et al., 2001). Hp1 
proteins in turn recruit Suv4-20h enzymes that catalyze the formation of H4K20me3 and 
stabilize cohesin proteins at pericentric heterochromatin (Hahn et al., 2013; Schotta et al., 
2004; Schotta et al., 2008). Importantly, H3K9me3 is also responsible for recruitment of DNA 
methylation at heterochromatic regions (Lehnertz et al., 2003).  
In addition to this sequential establishment of heterochromatin marks and the recruitment of 
heterochromatic enzymes, a lot of other proteins have been found to bind either Hp1 or 
H3K9me3 (Dambacher, 2013; Hediger and Gasser, 2006; Kwon and Workman, 2011; 
Nozawa et al., 2010; Vermeulen et al., 2010). Consequently, many of these proteins have 
been shown to localize to pericentric heterochromatic foci in mouse cells (Fodor et al., 2010). 
The detailed mechanisms of how individual heterochromatic proteins act to ensure 
heterochromatin integrity are mostly unknown.  
  
Figure 1.1 A silencing pathway for pericentric heterochromatin   
Major satellite repeats are bound by Pax3 and Pax9 and facilitate  the recruitment of 
histone methyltransferases. Prdm3, Prdm16 or Setdb1 generate H3K9me1. Suv39h 
enzymes can take mono-methylated H3K9 as a substrate to generate H3K9me3. HP1 
binding to H3K9me3 recruits Hp1-interacting proteins like Suv4-20h enzymes that catalyze 
H4K20me3. DNA-methylating enzymes (Dnmts) are recruited by H3K9me3 (modified from 
(Dambacher et al., 2010; Schotta et al.,  2004)).  
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For Hp1 proteins and the H3K9me3 chromatin mark a spreading mechanism was postulated, 
that is driven by oligomerization of Hp1 on H3K9me3-modified chromatin fibers (Canzio et 
al., 2011; Hall et al., 2002; Hathaway et al., 2012; Verschure et al., 2005). Because Hp1 
proteins and the H3K9me3-modification can recruit H3K9 methyltransferases like Suv39h 
and Setdb1, this leads to the formation of additional H3K9me3-marks which again are bound 
by Hp1 proteins and further extend the heterochromatic domain. 
Even though pericentric heterochromatin seems to be a very dense and stable structure, and 
Suv39h2 and Suv4-20h2 enzymes stably associate with chromatin (Hahn et al., 2013), 
mobility of Hp1 proteins in the cell is high, showing that some heterochromatin components 
undergo a rapid turnover (Cheutin et al., 2003). In addition, there is even a higher mobility of 
heterochromatin proteins in pluripotent cells, indicating that heterochromatin plasticity is 
influenced in a cell type-specific manner (Meshorer et al., 2006). Therefore, heterochromatin 
plasticity and protein dynamics present another level of complexity of how heterochromatin is 
regulated and maintained.   
Recent biochemical and genetic studies have uncovered that heterochromatin pathways and 
proteins also play a role outside of pericentric heterochromatin, were they are involved in the 
suppression of gene expression, and the control of enhancer elements and transposons 
(Bulut-Karslioglu et al., 2012; Consortium, 2004; Consortium et al., 2012; Filion et al., 2010; 
Karimi et al., 2011; Kharchenko et al., 2011; Matsui et al., 2010; Nicetto et al., 2013; Rowe et 
al., 2013b; Rowe and Trono, 2011). A prominent example is the selective control of olfactory 
receptor expression in mammalian olfactory neurons (Magklara et al., 2011). In addition, 
defects in heterochromatin integrity have been linked to cancer and a variety of other human 
diseases (Ceol et al., 2011; Hahn et al., 2010; Kulis and Esteller, 2010; Ting et al., 2011; 
Yokoe et al., 2010; Zhu et al., 2011). Due to its essential role in genome regulation a deeper 
understanding of the molecular mechanisms at heterochromatin and the regulation of 
heterochromatin plasticity is required. Therefore, I focused on the functional analysis of 
heterochromatic gene silencing and wanted to uncover the associated molecular 
mechanisms. 
1.2. Retrotransposon silencing  
Apart from pericentric heterochromatin, heterochromatin modifications can also be found at 
many retrotransposon sequences (Consortium, 2004; Consortium et al., 2012; Filion et al., 
2010). In this thesis I focused on a subclass of LTR-retrotransposons as a model system to 
investigate heterochromatin formation at these particular sequences. Therefore, I will give an 
overview over our current knowledge about chromatin-dependent LTR-retrotransposon 
silencing in the following chapter.  
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Understanding the regulation of retrotransposons is important, because around 40 % to 60 % 
of the human and mouse genome consists of retrotransposons sequences which are 
implicated into many essential process (de Koning et al., 2011; Lander et al., 2001; Mouse 
Genome Sequencing et al., 2002). Retrotransposons are autonomous DNA sequences that 
colonized the genome via a copy and paste mechanism. Upon transcription the 
retrotransposon RNA gives rise to proteins that facilitate its reverse transcription into cDNA 
and stably integrate the cDNA into the cellular genome (Coffin et al., 1997). In mammals 
three different subclasses of retrotransposons exist: LINEs, SINEs and LTR-
retrotransposons.  
1.2.1. LTR-retrotransposons in mammals 
LTR retrotransposons make up around 10 % of the mammalian genome and are present in 
most animals and plants (Coffin et al., 1997). They received their name from carrying long-
terminal-repeat (LTR) sequences at both ends of the transposon sequence (Stocking and 
Kozak, 2008). In general, LTR retrotransposons encode a structural capsid protein (GAG), a 
reverse transcriptase (RT), an integrase (IN), an RNAse-helicase and a protease activity 
(Stocking and Kozak, 2008). Not all of these enzymatic activities are distributed among 
individual proteins but can be united in multifunctional proteins. LTR retrotransposons most 
likely originated by a fusion of a DNA-transposon, a non-LTR retrotransposons and host 
factors early in evolution (Malik and Eickbush, 2001). In mammals all LTR-retrotransposons 
belong to the endogenous retrovirus (ERV) superfamily, which leads to the fact that in 
mammals the term LTR-retrotransposon and the term endogenous retrovirus are mostly 
used synonymously (Stocking and Kozak, 2008). Endogenous retroviruses are closely 
related to modern exogenous retroviruses and therefore can be grouped according to their 
sequence similarity with exogenous viruses into three different classes (McCarthy and 
McDonald, 2004; Stocking and Kozak, 2008) (Figure 1.2A). 
Although the abundance of endogenous retroviruses within the mouse and the human 
genome are quite similar, many endogenous retroviruses are capable of active transposition 
in mice but not in humans, where only very few copies of the HERV-K family are still active 
(Belshaw et al., 2005; Medstrand and Mager, 1998). Conversely, around 10 % of de novo 
mutations in inbred mouse strains originate from transposition events of endogenous 
retroviruses (Maksakova et al., 2006). The most active endogenous retrovirus classes in 
mice are Intracisternal A-type Particle (IAP) transposons with an estimated number of around 
300 functional copies and MusD/ETn retrotransposons with ninefunctional copies 
(Dewannieux et al., 2004; Kuff and Lueders, 1988; Lueders and Kuff, 1977; Ribet et al., 
2004; Ribet et al., 2008). In addition, many mutated copies and subclasses of these 
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elements exist in the mouse genome, which in total contains around 350 MusD/ETn copies 
and around 1000 IAP 
 
Figure 1.2 Classification of mammalian endogenous retroviruses   
A) Endogenous retroviruses present in the mouse and human genome can be grouped 
according to their similarity with the genera of exogenous retroviruses (modified from 
(Rowe and Trono, 2011; Stocking and Kozak, 2008)). B) Dendrogram of the IAP 
superfamily that shows the evolutionary distance betwee n the subfamilies of IAP 
retrotransposons in the mouse genome. The analysis is based on the sequence homology 
of the amino acid sequence of the encoded RT gene. The IAPEz family (indicated in bold) 
is the most active subfamily which was also analyzed in mo re detail in this thesis. 
Annotations used by the Repeat Masker database have manually been added behind the 
automated Mus musculus retrotransposon (Mmr) annotation (modified from (McCarthy and 
McDonald, 2004)). C) Diagram showing the expression of individual endogenous 
retroviruses (ERVs) during mouse development in a simplified way (modified from (Rowe 
and Trono, 2011)). Some of the known ERV silencing factors are listed a t the specific time 
points of development. Factors that cooperate to maintain DNA methylation are listed in 
brackets.  
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copies grouped into various subclasses (Ribet et al., 2004; Stocking and Kozak, 2008) 
(Figure 1.2B). Even though retrotransposition activity of human endogenous retroviruses is 
almost lost in humans, it has been high 40 million years ago, which explains the high 
percentage of endogenous retroviral sequences in the human genome (Gifford and Tristem, 
2003). However, active autonomous retrotransposons in humans still exist today in terms of 
non-LTR Line L1 retrotransposons (Beck et al., 2010).  
Transposition events of endogenous retroviruses can influence the expression of nearby 
genes which has been linked to a lot of disease-causing phenotypes in humans and mice 
(Jern and Coffin, 2008; Kurth and Bannert, 2010; Rowe and Trono, 2011). However, 
mammals have also profited on endogenous retroviral elements in their evolution by adapting 
them as regulatory promoter sequences for endogenous gene regulation (van de Lagemaat 
et al., 2003). The expression of amylase in human saliva, for example, is a result of an 
insertion of an endogenous retrovirus (Ting et al., 1992). In addition, some essential 
mammalian genes even evolved directly from retrotransposon sequences, such as the 
placental syncytin proteins (Blaise et al., 2003; Blaise et al., 2005; Blond et al., 2000; 
Dupressoir et al., 2009). One of the most important impacts on human evolution might be 
that retrotransposon sequences are important recombination hotspots in mammalian 
meiosis. They are specifically targeted by Prdm9 to recruit the meiotic recombination away 
from genes that might otherwise be disrupted by meiotic recombination more frequently 
(Baudat et al., 2010; Berg et al., 2010; Brick et al., 2012; Grey et al., 2011; Parvanov et al., 
2010).  
However, independent of their ability to perform retrotransposition events, endogenous 
retrovirus sequences contain promoter and enhancer sequences and are expressed at 
different stages during mouse development (Rowe and Trono, 2011) (Figure 1.2C). 
Expression of retrotransposons at developmental stages has probably been evolutionary 
selected, because retrotransposon events are only transmitted to the germ line and 
consequently to future generations when occuring during the development of the organism or 
during the generation of its germ cells. In mouse, MaLR retrotransposon transcripts are 
specifically found in the oocyte (Peaston et al., 2004), while MERV-L retrotransposons can 
be detected at the 2-cell and are silenced at the blastocyst stage (Evsikov et al., 2004; 
Kigami et al., 2003; Maksakova et al., 2013; Peaston et al., 2004; Svoboda et al., 2004). IAP 
element transcripts are found in the oocyte, but peak in their expression at the blastocyst 
stage before they are efficiently silenced in later stages of development (Poznanski and 
Calarco, 1991; Svoboda et al., 2004).  
Mammals have developed numerous ways to repress the endogenous retrovirus life-cycle in 
order to maintain evolutionary fitness. The most important pathway is the suppression of 
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endogenous retrovirus transcription by chromatin regulation. As a consequence a complex 
system consisting of different silencing mechanisms has evolved in evolution that regulates 
thousands of endogenous retroviruses and endogenous retrovirus-derived regulatory 
elements (Gifford et al., 2013; Leung and Lorincz, 2012; Rowe and Trono, 2011). These 
silencing mechanisms are summarizes in the following paragraphs and have also been 
adapted for chromatin regulation outside of endogenous retroviral sequences. A lot of the 
summarized information about retrotransposon silencing presented here originates from 
three excellent reviews, that are highly recommended to the interested reader (Gifford et al., 
2013; Leung and Lorincz, 2012; Rowe and Trono, 2011). 
1.2.2. Silencing of endogenous retroviruses by DNA methylation  
DNA methylation in mammals involves the methylation of cytosine residues primarily at CpG 
dinucleotides by Dnmt1, Dnmt3a and Dnmt3b. Dnmt3a and Dnmt3b can de novo methylate 
DNA by collaborating with the non-enzymatic Dnmt3L protein, while Dnmt1 acts together with 
Np95 (Uhrf1) to maintain DNA methylation during DNA replication (Bird, 2002; Jones and 
Liang, 2009; Saitou et al., 2012). 
Even though Dnmt1 and Dnmt3b knockout mice die at embryonic day 8.5 and 14.5, 
preimplantation stages in these knockout mice are not compromised (Okano et al., 1999; 
Walsh et al., 1998). One explanation for this could be that the DNA is globally demethylated 
at this time point of development and starts to be newly methylated at the blastocyst stage 
(Saitou et al., 2012). 
Analyses of knockout mice revealed that loss of Dnmt3a and Dnmt3b only leads to a very 
mild reduction of DNA methylation at IAP elements of mouse ES cells, while loss of Dnmt1 
leads to almost a complete loss of global DNA methylation (Arand et al., 2012; Okano et al., 
1999). Dnmt1 knockout embryos show 100-fold upregulation of IAP retrotransposons at 
embryonic day 8.5 indicating that DNA-methylation by Dnmt1 is responsible for the 
repression of IAP elements at this embryonic stage (Walsh et al., 1998). Consistently, 
DNA-methylation inhibitor treatment leads to a strong derepression of IAP elements in MEF 
cells (Rowe et al., 2013a). In contrast to these observations knockout of Dnmt1, Dnmt3a, 
Dnmt3L or Dnmt3b in embryonic stem cells does not lead to defects in endogenous and 
exogenous retrovirus silencing suggesting that endogenous retrovirus silencing at 
preimplantation stages is independent of DNA methylation (Hutnick et al., 2010; Pannell et 
al., 2000; Quenneville et al., 2012). However, Dnmt3L is essential for IAP repression in the 
male germ line where it facilitates the de novo DNA methylation of IAP elements by Dnmt3a 
and 3b (Bourc'his and Bestor, 2004; Kato et al., 2007). Interestingly, depletion of Dnmt3 
family proteins in somatic cells has only a very mild effect on endogenous retrovirus silencing 
(Okano et al., 1999). This could be explained by the fact that de novo DNA methylation of 
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endogenous retrovirus elements is not required in preimplantation embryos because DNA 
methylation at endogenous retroviral elements is not completely lost during global DNA 
demethylation (Gaudet et al., 2004).  
Apart from Np95 and Dnmt3L other proteins are involved in maintaining and facilitating DNA 
methylation at endogenous retroviral sequences by Dnmt enzymes. The SNF2 chromatin-
remodeling factor Lsh1 (Hells) binds endogenous retroviral elements and is important for the 
maintenance of DNA-methylation and heterochromatic marks at these regions (Dennis et al., 
2001; Yan et al., 2003). Lsh1 knockout mice have a strong reduction of DNA methylation at 
endogenous retroviral elements and consequently show elevated expression of IAP 
retrotransposons at later stages of development (Huang et al., 2004). Similarly the Stella 
protein (also known as Pgc7, Dppa3) is critical to maintain DNA methylation at IAP elements 
and imprinting regions specifically at the maternal genome after fertilization (Nakamura et al., 
2007). Moreover, the H3K9 methyltransferase G9a is involved in the maintenance of DNA 
methylation at endogenous retroviruses and the establishment of DNA methylation at newly 
introduced MLV proviruses (Dong et al., 2008; Leung et al., 2011; Tachibana et al., 2008). 
However, the catalytic activity of G9a that facilitates methylation of H3K9 is dispensable for 
the maintenance of DNA methylation, and H3K9me3 marks at endogenous retroviruses are 
unaltered in G9a knockout ES cells indicating that G9a does not catalyze H3K9 methylation 
at these regions (Dong et al., 2008).  
In summary, DNA methylation seems to be the major pathway that restricts endogenous 
retrovirus expression in the germline and in postimplantation embryos. Factors like G9a, 
Stella and Lsh1 seem to cooperate with the DNA methylation machinery to regulate DNA 
methylation at specitic stages of development. Interestingly, it is suggested that DNA 
methylation was originally developed in evolution as a host defense mechanism to suppress 
retrotransposition (Yoder et al., 1997). However, in preimplantation embryos silencing of 
endogenous retroviruses is independent of DNA-methylation and mouse ES cells silence 
newly introduced IAP elements and MLV retroviruses (Pannell et al., 2000; Rowe et al., 
2010; Teich et al., 1977). This indicates that additional mechanisms of endogenous 
retrotransposon silencing occur at preimplantation stages.  
1.2.3. Repression of (endogenous) retroviruses by H3K9me3, Setdb1 and the 
corepressor Trim28  
The finding that DNA methylation is dispensable for endogenous retrovirus silencing in 
preimplantation embryos and embryonic stem cells suggests that other mechanisms ensure 
the repression of endogenous retroviruses during this time window (Figure 1.2C). In 
embryonic stem cells the heterochromatic modifications H3K9me3 and H4K20me3 are 
strongly enriched at many endogenous retroviruses including MusD/ETn and IAP elements 
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indicating that histone methylation is involved in that process (Mikkelsen et al., 2007). Even 
though Suv39h enzymes are responsible for catalyzing H3K9me3 at pericentric 
heterochromatin, H3K9me3 is reduced but not lost at endogenous retroviral sequences in 
Suv39h knockout cells (Bulut-Karslioglu et al., 2012).  
Instead, the histone methyltransferase Setdb1 (Eset) is the responsible enzyme for 
catalyzing H3K9 methylation at endogenous retroviruses (Matsui et al., 2010). Depletion of 
Setdb1 in mouse ES cells not only leads to a loss of H3K9me3 methylation but also results in 
a strong upregulation of many endogenous retroviruses classes (Karimi et al., 2011; Matsui 
et al., 2010). Interestingly, the loss of Suv4-20h enzymes and H4K20me3 does not result in a 
derepression of endogenous retrotransposons indicating that this chromatin mark is not 
strongly involved in transcriptional repression (Matsui et al., 2010). 
Similar to Setdb1 knockout cells, a severe derepression of endogenous retrotransposons 
was observed when the Setdb1-interacting protein Trim28 (Kap1) was depleted from mouse 
ES cells (Rowe et al., 2010). Depletion of Trim28 reduces H3K9me3 at endogenous 
retroviral elements indicating that Trim28 might act upstream or in concert with Setdb1 
(Rowe et al., 2013b). Interestingly, loss of Trim28 or Setdb1 in MEF cells does not lead to a 
depression of endogenous retrotransposons, indicating that both proteins are dispensable for 
retrotransposon silencing at later stages of development (Matsui et al., 2010; Rowe et al., 
2010). 
Therefore, the Trim28/Setdb1/H3K9me3 pathway is essential to repress endogenous 
retroviruses during phases of development when silencing is DNA methylation-independent. 
Strikingly, neuronal progenitor cells that lack Setdb1 are also modestly impaired in IAP 
silencing (Tan et al., 2012). Therefore, endogenous retroviruses might also be controlled by 
a Setdb1-dependent and DNA methylation-independent pathway in the neuronal lineage. 
Recently, active retrotransposition events of non-LTR retrotransposons have been observed 
in neurons of humans and Drosophila, indicating that a specific retrotransposon control in the 
brain is evolutionary conserved and might contribute to specific functions of neurons (Coufal 
et al., 2009; Garcia-Perez et al., 2010; Muotri et al., 2005; Perrat et al., 2013) .  
However, how the Trim28/Setdb1 complex targets endogenous retrotransposons is 
unknown. Because Trim28 is recruited by KRAB domain containing zinc finger proteins to the 
DNA it was suggested that sequence specific KRAB zinc finger proteins distinguish the 
different retrotransposon classes and recruit the Trim28/Setdb1 complex to its genomic 
targets (Rowe et al., 2010) (also see introduction section 1.3.1). This is consistent to the 
observation that there is a high coevolution between KRAB zinc finger proteins and 
retrotransposons (Thomas and Schneider, 2011). Interestingly, introducing a human 
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chromosomal fragment into transgenic mice, results in a derepression of human endogenous 
retrovirus sequences, indicating that mice might not have the recognition system to silence 
human endogenous retroviruses (Ward et al., 2013). Another piece of evidence for the 
hypothesis that endogenous retroviruses are targeted by sequence specific factors was the 
finding that exogenous M-MLV retroviruses are silenced by Zfp809, a mouse-specific KRAB 
zinc finger protein that recruits Trim28 to facilitate H3K9me3-dependent silencing of the 
M-MLV provirus (Wolf and Goff, 2007, 2009). Incidentally, M-MLV silencing is also 
modulated by Yy1 and Ebp1 although these proteins only enhance the silencing efficiency by 
Trim28 and are not strictly required for M-MLV silencing (Schlesinger et al., 2013; Wang et 
al., 2014a). 
Future experiments have to show if KRAB domain-containing zinc fingers recruit the 
Trim28/Setdb1 silencing complex to endogenous retroviruses. This would imply that 
endogenous retroviruses contain specific DNA binding sites for KRAB domain zinc finger 
proteins. 
Furthermore, how Setdb1- and Trim28-mediated silencing of endogenous retroviruses 
occurs mechanistically is unclear. In this thesis I identify a critical role of the proteins Atrx and 
Daxx in this process. Chapter 1.3 of this introduction gives a broader overview about the 
current knowledge of Trim28- and Setdb1-dependent silencing and Atrx and Daxx.  
1.2.4. Repression of endogenous retroviruses independent of DNA methylation and 
the Trim28/Setdb1/H3K9me3-pathway 
Expression of MERV-L retrotransposons has been linked to the two cell stage (Figure 1.2C), 
and is restricted by Lsd1, HDACs and G9a at the exit of totipotency (Macfarlan et al., 2011; 
Maksakova et al., 2013). Interestingly, MERV-L retrotransposon silencing in mouse ES cells 
is independent of Setdb1 and only slightly affected upon knockout of Trim28 underlining that 
they are silenced by an independent mechanism (Macfarlan et al., 2011; Maksakova et al., 
2013). Mechanistically, it was proposed that Lsd1 silences MERV-L elements by 
demethylating the active chromatin mark H3K4me3 on MERV-L promoters, while G9a is 
depositing a repressive H3K9me2 mark at these regions (Macfarlan et al., 2011; Maksakova 
et al., 2013). LTR fragments derived from MERV-L retrotransposons are also used as 
functional promoter sequences for several cellular genes expressed at the two-cell stage, 
indicating that mice have exploited the silencing mechanism for MERV-L retrotransposons to 
establish a time-point specific gene expression mechanism (Macfarlan et al., 2011; 
Macfarlan et al., 2012). 
In the germline of Drosophila a complex retrotransposon repression system that utilizes 
piRNAs has evolved. piRNAs are utilized by heterochromatin-associated RNAi proteins like 
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Piwi to detect and cleave retrotransposon RNAs (Ross et al., 2014). Heterochromatin 
formation and the establishment of H3K9me3 at repetitive regions is also dependent on RNA 
interference and small RNAs in plants and fission yeast, suggesting that these systems were 
very successful during evolution and might also exist in mammals (Castel and Martienssen, 
2013). Indeed, mice express Piwi-like proteins in their germ-line called Miwi, Mili and Miwi2. 
The depletion of these proteins leads to sterility and results in a slight upregulation of 
retrotransposon sequences and defects in de novo methylation of DNA (Rowe and Trono, 
2011). This indicates that small-RNA-dependent pathways might also be implicated in 
retrotransposon suppression in mammals. 
Furthermore, in somatic cells specific corepressor complexes might collaborate with 
DNA-methylation pathways to repress particular endogenous retrotransposons. Recently the 
Trim24/Trim33 corepressor complex has been found to suppress VL30-retrotransposons in 
the liver (Herquel et al., 2013). These retrotransposons get activated by retinoic acid 
receptors and failure of retrotransposon silencing results in ectopic activation of nearby 
genes and an inflammatory cell response in hepatocytes (Herquel et al., 2013).  
Failure of endogenous retrotransposon silencing has also been implicated in autoimmunity. 
In mice deficient for the exonuclease Trex1 endogenous retrotransposon transcripts 
accumulate in the cell and upon reverse transcription trigger a DNA induced interferon 
response that leads to autoantibody production (Stetson et al., 2008). Thus, cells that 
upregulate endogenous retroviruses under physiological conditions are harmful to the 
organism and are wiped out by the immune system due to the presentation of ERV antigens. 
A finding that supports this model is that antibody-deficient mice cannot remove cells that 
overexpress endogenous retroviruses (Young et al., 2012). In turn, a constant 
overexpression of endogenous retroviruses leads to recombination events that form 
functional retroviruses with oncogenic potential (Young et al., 2012).  
Interestingly, it was also postulated that expression of non-functional endogenous 
retroviruses in early mouse development protects mice form exogenous retroviruses (Best et 
al., 1996). The most striking example of this theory is given by the Fv1 protein that is derived 
from a MERV-L Gag protein and blocks the integration of exogenous MLV (Best et al., 1996).  
1.2.5. Concluding remarks about retrotransposon silencing pathways 
In summary, retrotransposons and the mechanism that repress their activity are important for 
pluripotency, gene regulation, genome stability, meiotic recombination, development and 
many fundamental processes in mammals. Investigation of mammalian retrotransposon 
biology provides important information how mammalian genomes are shaped and evolve 
during evolution and how gene activity is regulated during development.  
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In this thesis I have focused on the regulation of Intracisternal A-type-Particle (IAP) 
retrotransposons, a very active subclass of LTR retrotransposons in mice. This transposon 
class is specifically silenced by the Trim28/Setdb1/H3K9me3 pathway in mouse ES cells. 
Therefore, it is a suitable model system to analyze H3K9me3-dependent chromatin 
regulation and repression of gene-expression outside of highly repetitive pericentric 
heterochromatin. In addition, IAP retrotransposons are an interesting example for studying 
how endogenous retrotransposons are specifically recognized and targeted during early 
mouse development. 
1.3. Proteins involved in heterochromatic gene silencing in mouse 
In this thesis I screened for proteins involved in heterochromatic silencing induced by small 
sequence elements of IAP retrotransposons in mouse ES cells. I identified the SNF2-type 
ATPase Atrx, the Histone H3.3 chaperone Daxx, the corepressor protein Trim28 and the 
H3K9 methyltransferase Setdb1 to be important regulators of heterochromatic gene silencing 
at these sequences. Thus, I will introduce these proteins in more detail.  
1.3.1. KRAB zinc finger-dependent repression by the master regulator Trim28  
Zinc finger transcription factors harboring a Krüppel-associated box (KRAB) are tetrapod-
specific and are the largest family of zinc finger transcription factors encoded in the human 
and mouse genome (Corsinotti et al., 2013; Emerson and Thomas, 2009; Tadepally et al., 
2008; Thomas and Emerson, 2009). The KRAB domain is highly conserved among KRAB 
domain proteins and mediates strong transcriptional repression (Bellefroid et al., 1991; 
Margolin et al., 1994). Trim28 (also known as Kap1, Tif1β) is the only adapter protein known 
that binds KRAB domain proteins and it is the master regulator of KRAB domain-dependent 
silencing processes (Friedman et al., 1996; Kim et al., 1996; Le Douarin et al., 1996; 
Moosmann et al., 1996). Although Trim28 seems to be the only protein that binds KRAB 
domains, it is part of the Transcription-Intermediary-Factor protein family that also comprises 
the proteins Trim24, Trim33 and Trim66 (Iyengar and Farnham, 2011; Peng et al., 2002). 
Trim28 contains an N-terminal RING-B box-coiled-coil (RBCC) domain, also called tripartite-
motif (TRIM) that mediates binding and homotrimerization of three Trim28 proteins with a 
single KRAB domain (Peng et al., 2000a; Peng et al., 2000b) (Figure 1.3). In addition, Trim28 
harbors a HP1-box containing a canonical PxVxL motif that is responsible for direct binding 
of Trim28 to Hp1 proteins (Brasher et al., 2000; Lechner et al., 2000; Smothers and Henikoff, 
2000) (Figure1.3). At its C-terminus Trim28 has a PHD and bromodomain that does not bind 
acetylated lysine residues in vitro. Instead, the PHD domain has an intramolecular E3-Sumo 
ligase activity that sumoylates the neighboring bromodomain to facilitate Sumo-dependent 
interaction with Setdb1 and Chd3 (Ivanov et al., 2007; Schultz et al., 2002; Schultz et al., 
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2001; Zeng et al., 2008). Importantly, transcriptional silencing by Trim28 depends on its Hp1-
interaction motif, its auto-sumoylation-mediated interaction with Setdb1 and is associated 
with H3K9me3, which is catalyzed by Setdb1 (Ayyanathan et al., 2003; Sripathy et al., 2006; 
Wolf et al., 2008). 
As mentioned, Trim28 is recruited to chromatin through direct interactions with DNA-binding 
zinc finger proteins that contain a KRAB domain. In this regard Trim28 has been shown to be 
required for genomic imprinting via binding to Zfp57 (Li et al., 2008; Quenneville et al., 2011), 
silencing of retroviral M-MLV elements via recruitment by Zfp809 (Wolf and Goff, 2007, 
2009), morphogenesis of extraembryonic tissues via binding to Zfp568 (Shibata et al., 2011), 
and regulation of sex-specific liver-gene expression via binding to Rsl1 and Rsl2 (Krebs et 
al., 2009; Krebs et al., 2003). Additionally, the KRAB/Trim28 association has been implicated 
into neuronal differentiation, hematopoesis, mitophagy and maintenance of genome stability 
via suppression of endogenous retroviral elements (Barde et al., 2013; Jakobsson et al., 
2008; Rowe et al., 2010; Rowe et al., 2013b; Santoni de Sio et al., 2012a; Santoni de Sio et 
al., 2012b). Interestingly, Trim28 can be recruited via KRAB domain proteins that lack a DNA 
binding domain, but are associated with other DNA-binding proteins. This mechanism was 
proposed for the DNA-binding proteins SRY and VHL (Li et al., 2003; Peng et al., 2009). 
Aside of the KRAB domain associated genomic recruitment of Trim28, there are also 
examples for KRAB-independent recruitment of Trim28 to DNA by interaction with other 
transcription factors (Iyengar and Farnham, 2011; Iyengar et al., 2011). 
In addition to its role in transcriptional repression, Trim28 is also involved in DNA damage 
regulation. Here phosphorylation of Trim28 by DNA damage induced protein kinases is 
thought to prevent its sumoylation and consequently results in relief of transcriptional 
repression at the DNA damage site (Li et al., 2007; White et al., 2006).  
Being implicated in so many cellular and physiological processes, Trim28 is essential for 
early mouse development and pluripotency of embryonic stem cells (Cammas et al., 2000; 
Fazzio et al., 2008; Hu et al., 2009; Wolf and Goff, 2007). Even Trim28 deletion from the 
female germ line is sufficient to severely impair mouse development, maybe due to 
imprinting defects or impaired epigenetic inheritance of important chromatin marks 
(Messerschmidt et al., 2012). Apart from its function in germ cells and normal development, 
Trim28 is also implicated into gastric cancer (Silva et al., 2006; Yokoe et al., 2010). 
Although Trim28 function is well characterized using in vitro experiments where Trim28 is 
recruited by KRAB domain proteins (Groner et al., 2010; Groner et al., 2012; Quenneville et 
al., 2012; Rowe et al., 2013a; Sripathy et al., 2006), Trim28 DNA-binding in vivo is poorly 
understood because a lot of Trim28 binding sites do not colocalize with H3K9me3 or Setdb1 
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and are not located at genes that are deregulated upon Trim28 knockdown (Iyengar et al., 
2011; Rowe et al., 2013b). An explanation for this finding could be that Trim28 mainly 
regulates transcription via the repression of distal retrotransposon-based enhancers, rather 
than by direct promoter regulation (Rowe et al., 2013b).  
Since there is a high coevolution of KRAB zinc finger genes and retrotransposon sequences, 
the species-specific control of retrotransposons by Trim28 and KRAB zinc fingers links 
heterochromatic gene silencing to speciation and will be an interesting topic for future 
analyses (Thomas and Schneider, 2011). In addition, how Trim28-recruitment actually leads 
to a shutdown of transcription is still not fully understood. Hp1 and Setdb1 seem to be 
important players in this process. The role of Setdb1 is reviewed in the next chapter. 
 
Figure 1.3 The corepressor Trim28  
A) Scheme of mouse Trim28 containing an N-Terminal RBCC domain for binding KRAB 
domain proteins, an HP1-box for association with Hp1 proteins and a C-terminal PHD and 
Bromodomain. The PHD and Bromodomain is responsible for auto-sumoylation-dependent 
recruitment of Setdb1 and Chd3.  Sumoylated residues of Trim28 are indicated. Numbers 
below protein domain names indicate the amino acid position.  The protein is shown with 
the N-terminus on the left and the C-terminus on the right.  B) Illustration how the 
repressive Trim28 complex forms. A KRAB domain protein recruits Trim28 to its binding 
site, which in turn recruits Hp1 proteins, Chd3 and Setdb1. Please note that in vitro  
assays have shown, that zinc finger proteins frequently bind DNA as dimers and one 
KRAB domain recruits three Trim28 molecules , underlining that there is a high degree of  
amplification in the binding cascade (modified from (Iyengar and Farnham, 2011; Rowe 
and Trono, 2011)).  
1.3.2. The histone H3 lysine 9 methyltransferase Setdb1 (ESET) cooperates with 
Trim28 in heterochromatin formation and transcriptional repression 
Setdb1 (also known as ESET or KMT1E) was originally identified in two yeast two-hybrid 
screens for proteins associated with the transcription factor ERG and the corepressor protein 
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Trim28 (Schultz et al., 2002; Yang et al., 2002). Interaction between Setdb1 and Trim28 is 
mediated by a Sumo-interaction motif (SIM) at the N-terminus of Setdb1 that binds to the 
sumoylated PHD and bromodomain of Trim28 (Figure 1.4) (Ivanov et al., 2007). Immuno-
purified Setdb1 specifically monomethylates and dimethylates histone H3 lysine 9, but can 
also catalyze the formation of H3K9me3 when it is associated with its binding protein mAM 
(also known as Atf7ip or Mcaf1) (Schultz et al., 2002; Wang et al., 2003). Setdb1 is required 
for Trim28/KRAB-dependent repression and consequently also for repression of endogenous 
retroviruses by Trim28 (Matsui et al., 2010; Rowe et al., 2013a; Sripathy et al., 2006). 
Setdb1-mediated repression requires the catalytic activity of its SET domain (Matsui et al., 
2010). Genetic experiments where Hp1 proteins are tethered to specific sites in the genome 
also have shown that Setdb1 is important for Hp1-mediated transcriptional repression and is 
recruited in a Hp1-dependent manner (Hathaway et al., 2012; Verschure et al., 2005). 
Apart from its interaction with Trim28 and mAM, Setdb1 was found in a complex with the 
methyl-DNA binding protein MBD1 and the chromatin assembly factor CAF-1(p150) were it 
links H3K9-methylation to replication-dependent chromatin assembly (Sarraf and Stancheva, 
2004). The interactions between MBD1 and Setdb1 is presumably mediated via MBD1 
sumoylation and Sumo-dependent binding of Setdb1 (Lyst et al., 2006), or via the 
association of MBD1 with the Setdb1-interacting protein mAM (Ichimura et al., 2005). In 
addition, also the binding of MBD1 and mAM is dependent on MBD1 sumoylation suggesting 
that sumoylation plays an important role in recruiting the mAM/Setdb1 complex (Sekiyama et 
al., 2008; Uchimura et al., 2006). The chromatin assembly factor CAF-1(p150) also interacts 
with Hp1 proteins via a consensus PxVxL motif and its interaction with Setdb1 could be 
mediated via Hp1-proteins (Loyola et al., 2009).  
Setdb1 has also been found to associate with Pml-nuclear bodies in mouse cells, where it 
was thought to regulate Pml-nuclear body integrity and gene expression (Cho et al., 2011). 
Since Pml is also a sumoylated protein, it was again hypothesized, that Setdb1 is recruited in 
a Sumo-dependent manner to Pml-nuclear bodies (Cho et al., 2011). This is consistent with 
the finding, that sumoylation of a single transcription factor is sufficient to recruit Setdb1 and 
to repress transcription (Stielow et al., 2008).  
Similar to Trim28, Setdb1 is essential for early mouse development and pluripotency 
(Bilodeau et al., 2009; Dodge et al., 2004). An explanation for this finding is that Setdb1 
seems to repress the differentiation of cells of the inner-cell mass into the trophoblast lineage 
(Lohmann et al., 2010; Yuan et al., 2009). A more general explanation might be that like 
Trim28, Setdb1 is important to ensure stability of the transcriptional program in pluripotent 
cells. This is consistent with the finding that Setdb1 depletion leads to derepression of 
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endogenous retrotransposons, activation of silenced enhancers and the generation of cryptic 
transcripts (Karimi et al., 2011; Rowe et al., 2013b). 
Recent findings suggest that Setdb1 is as a potential oncogene in melanoma and lung 
tumors and facilitates cell transformation in vitro (Ceol et al., 2011; Macgregor et al., 2011; 
Rodriguez-Paredes et al., 2013; Watanabe et al., 2008). Besides its function in 
transcriptional regulation, Setdb1 interacts with the DNA-methylation pathway, which could 
explain some of the Setdb1-dependent effects in cancer cells (Li et al., 2006).  
In summary, Setdb1 is an essential H3K9 methyltransferase that is involved in 
developmental processes, crucial for the repressive activity of Trim28 and the maintenance 
of transcriptional programs.  
 
Figure 1.4 The histone H3 lysine 9 methyltransferase Setdb1   
The illustration shows the domain architecture of the Setdb1 protein. The positions of 
known interaction surfaces of the Setdb1 protein are indicated.  Numbers below protein 
domain names indicate the amino acid position. The protein is shown with the N-terminus 
on the left and the C-terminus on the right.  The Sumo-interaction motif (SIM) was mapped 
in detail by Tanaka and Saitoh (Tanaka and Saitoh, 2010). 
1.3.3. The chromatin-associated SNF2-type ATPase Atrx  
In this thesis I found an important function of the SNF2-type ATPase Atrx in heterochromatic 
gene regulation. Atrx was originally identified as the gene mutated in Alpha-Thalassemia X-
Linked Mental Retardation (ATRX) Syndrome, a genetic disease causing an altered facial 
morphogenesis, genital abnormalities, mental retardation and reduced expression of α-globin 
in red blood cells (alpha-thalassemia) (Gibbons, 2006; Gibbons et al., 1995). The Atrx gene 
gives rise to different splice isoforms which predominantly encode a full-length Atrx protein 
and a truncated Atrx protein which is usually expressed to a lesser extent (Garrick et al., 
2004; Garrick et al., 2006) (Figure 1.5).  
Disease causing mutations in the Atrx gene specifically cluster in the evolutionary highly 
conserved regions of the protein, which are the N-terminal ADD-domain and the seven C-
terminal helicase motifs forming a large SNF2-type ATPase domain (Gibbons et al., 2008). 
Most mutations occurring in ATRX-syndrome patients either reduce the ATPase activity of 
the helicase domain or impair the capability of the ADD domain to bind unmethylated H3K4 
together with di- or trimethylated H3K9 (Dhayalan et al., 2011; Eustermann et al., 2011; 
Iwase et al., 2011; Tang et al., 2004). Interestingly, the C-terminal helicase domain is missing 
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in the truncated protein isoforms of Atrx (Figure 1.5), assuming that the truncated isoforms 
might take over a specialized function. The function of the C-terminal SNF2-type helicase of 
Atrx is unknown. However, it has DNAse translocase activity, but shows only very weak 
nucleosome remodeling activity in vitro, which suggests that Atrx alone might not act as a 
classical nucleosome remodeler on chromatin (Xue et al., 2003).  
Atrx localizes to pericentric heterochromatin via interactions of its ADD-domain with 
pericentric H3K9me3 and via interactions of a consensus PxVxL motif with Hp1 (Dhayalan et 
al., 2011; Eustermann et al., 2011; Iwase et al., 2011; Kourmouli et al., 2005; McDowell et 
al., 1999). In addition, Atrx localization to pericentric heterochromatin is lost in neurons upon 
depletion of the DNA-methyl-binding protein MeCP2 (Nan et al., 2007) indicating a possible 
connection between Atrx and DNA-methylation. Consistently, cells from ATRX-syndrome 
patients or Atrx knockout mouse embryos show changes of DNA-methylation at rDNA 
repeats and some other parts of the genome (Garrick et al., 2006; Gibbons et al., 2000). In 
addition, the N-terminal ADD domain of Atrx is also strongly similar to the ADD domain 
present in Dnmt proteins underlining a structural relationship between Atrx and other proteins 
involved in gene repression (Dhayalan et al., 2011; Eustermann et al., 2011; Iwase et al., 
2011).  
Atrx forms a complex with Daxx, which also recruits Atrx to Pml-nuclear bodies in a 
phosphorylation-dependent manner (Ishov et al., 2004; Tang et al., 2004; Xue et al., 2003). 
Daxx is a histone H3.3 specific-chaperone that catalyzes the incorporation of H3.3/H4 
tetramers into repressive chromatin (Drane et al., 2010; Elsasser et al., 2012; Lewis et al., 
2010; Liu et al., 2012). Apart from their colocalization at Pml nuclear bodies, Atrx colocalizes 
with Daxx at pericentric heterochromatin and is thought to facilitate incorporation of H3.3 into 
pericentric heterochromatin (Drane et al., 2010). H3.3 incorporation at pericentric 
heterochromatin correlates with major satellite expression. However, the specific function of 
histone H3.3 incorporation at pericentric heterochromatin remains elusive.  
Heterochromatic chromatin modifications like H3K9me3, H4K20me3 and DNA methylation 
and many heterochromatin proteins are also present at telomeres, where they ensure 
telomere integrity (Benetti et al., 2007; Garcia-Cao et al., 2004; Gonzalo et al., 2006). Atrx is 
also found at telomeres where it colocalizes with the histone variant H3.3 (Wong et al., 
2010), and where Atrx might cooperate with Daxx to incorporate histone H3.3 into telomeres 
(Goldberg et al., 2010; Lewis et al., 2010). However, Atrx is not strictly required for the 
Daxx-dependent assembly of H3.3 containing nucleosomes in vitro, but is important to recruit 
Daxx to telomeres in mouse ES cells (Lewis et al., 2010). Even though it has not been 
directly shown that Daxx incorporates histone H3.3 at telomeres, H3.3 incorporation is 
reduced at telomeres in Daxx or Atrx depleted cells, suggesting that the Atrx/Daxx complex 
1. Introduction  31 
 
plays an important role of in this process (Goldberg et al., 2010; Lewis et al., 2010). 
Interestingly, inhibition of H3.3 incorporation at telomeres by depletion of Atrx only results in 
a very mild derepression of telomeric TERRA transcripts (Goldberg et al., 2010). Therefore, it 
is unclear, if the major molecular function of Atrx at telomeres is only the incorporation of 
histone H3.3. 
Genome-wide binding profiles of Atrx indicate an enrichment of Atrx at tandem repeats, 
telomeres, pericentric regions and G-rich sequences (Law et al., 2010). Very importantly, 
H3.3 incorporation is not changed at Atrx target loci when Atrx is depleted indicating that the 
main function of Atrx outside telomeres is not to incorporate H3.3 (Law et al., 2010). Instead, 
it was postulated that secondary structures of the DNA generated by tandem repeat and G-
rich sequences are resolved by Atrx (Law et al., 2010). These inhibitory DNA structures 
might interfere with transcription when Atrx is depleted (Law et al., 2010). Consistently, the 
length of tandem repeats at the α-globin locus correlates with the reduction of α-globin 
expression in ATRX-syndrome patients (Law et al., 2010). Functional analysis at the α-globin 
locus upon Atrx depletion indicates an elevated binding of the repressive histone variant 
macroH2A, suggesting an activating function of Atrx at the α-globin locus by inhibiting macro-
H2A incorporation (Ratnakumar et al., 2012). However, how macro-H2A influences nearby 
transcription and whether Atrx directly influences macro-H2A incorporation is unknown. 
Functional analyses of ATRX-syndrome mutations indicate that they are hypomorphic and 
result in a residual protein function (Gibbons et al., 2008). This is consistent with the finding 
that Atrx knockout mouse embryos die before embryonic day 9.5 in development (Garrick et 
al., 2006). Furthermore, Atrx has been implicated into loading of the chromatin insulator 
CTCF and the methyl-binding protein MeCP2 at imprinted genes, suggesting that 
misregulation of imprinted genes could be a cause for the mental retardation phenotype 
observed in ATRX-syndrome (Kernohan et al., 2010).  
Atrx and Daxx are commonly mutated in pancreatic neuroendocrine tumors, glioblastoma 
and pediatric neuroendocrine tumors, suggesting that both genes act as strong tumor 
suppressors (Cheung et al., 2012; Heaphy et al., 2011; Jiao et al., 2012; Jiao et al., 2011; 
Molenaar et al., 2012; Schwartzentruber et al., 2012). Interestingly a lot of these cancers 
activate an alternative lengthening of telomeres (ALT) pathway to ensure telomere 
elongation in the absence of telomerase expression and ALT activation correlates with 
mutations in Atrx and Daxx (Lovejoy et al., 2012). Associated mutations in the genes 
encoding histone H3.3 in pediatric glioblastoma have also been suggested to be involved in 
Atrx- and Daxx-dependent processes in these tumors (Elsasser et al., 2011). Recently it has 
been shown that these H3.3 mutations directly affect gene expression by globally inhibiting 
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histone H3K27-methylation, suggesting that H3.3 mutations might not be directly implicated 
into the ALT phenotype and Atrx-dependent processes (Lewis et al., 2013). 
Despite the indications that Atrx might be a tumor-suppressor, ATRX-syndrome patients do 
not have an increased risk for malignancies. This suggests that either residual Atrx activity is 
sufficient for its tumor suppressor function or Atrx loss is not a driver for tumor development. 
Atrx loss has also been correlated with genomic instability and chromatid cohesion defects, 
which might also contribute to tumor development (De La Fuente et al., 2004; Ritchie et al., 
2008). However, other groups have not observed major genetic instability in Atrx depleted 
cells (Garrick et al., 2006; Wong et al., 2010). 
In summary, Atrx is an essential chromatin regulator in development and tumor suppression 
with still enigmatic functions. In this thesis I found Atrx to be involved in mammalian 
retrotransposon repression and established a quantitative assay to measure Atrx function 
during heterochromatic gene silencing. 
 
Figure 1.5 Atrx protein domain structure   
The scheme shows the domain architecture of the Atrx protein.  The two most prominent 
splice isoforms are shown. The positions of known interaction surfaces are indicated.  
Numbers below protein domain names indicate the amino acid position (modified from 
(Garrick et al., 2006; Ratnakumar and Bernstein, 2013)). 
1.3.4. The role of Daxx in transcriptional repression and histone H3.3 incorporation  
Apart from identifying Atrx as an important factor in retrotransposon silencing I also found 
that the Atrx-associated protein Daxx is involved in heterochromatic repression of 
retrotransposons. 
Daxx was originally discovered as a protein that connects Fas receptor signaling at the 
plasma membrane to activation of the JNK signaling pathway (Yang et al., 1997). However, 
these initial findings were mainly based on yeast two-hybrid experiments and further reports 
showed that Daxx has a nuclear localization and Daxx-dependent activation of JNK signaling 
might be due to transcriptional effects (Lindsay et al., 2009; Torii et al., 1999). In the nucleus, 
Daxx is found finely dispersed in the nucleoplasm, but accumulates at specific subnuclear 
domains. 
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The most prominent nuclear structures where Daxx accumulates are Pml nuclear bodies to 
which Daxx is recruited by binding sumoylated Pml protein with its C-terminal Sumo-
interaction motif (Ishov et al., 1999; Li et al., 2000a; Lin et al., 2003; Zhong et al., 2000) 
(Figure 1.6A). Pml nuclear bodies (also called nuclear dots) are dynamic matrix-associated 
structures consisting of large protein complexes that are either naturally present in the cell or 
can form under a variety of cellular stresses (Gamell et al., 2014). In addition, Daxx can itself 
recruit Atrx to Pml nuclear bodies or colocalize with Atrx at pericentric heterochromatin (Ishov 
et al., 2004; Tang et al., 2004; Xue et al., 2003). Daxx is also recruited to the nucleolus by 
Msp58 (Lin and Shih, 2002). Besides its localization to these distinct nuclear structures, Daxx 
is also extensively recruited to the DNA by many transcription factors to repress transcription, 
where it is mostly recruited in a Sumo-dependent manner (Chang et al., 2005; Croxton et al., 
2006; Hollenbach et al., 1999; Kim et al., 2003; Kuo et al., 2005; Lehembre et al., 2001; Li et 
al., 2000b; Lin et al., 2004; Lin et al., 2006; Lin et al., 2003; Obradovic et al., 2004; Park et 
al., 2007; Shih et al., 2007; Zhao et al., 2004). 
Interestingly, the activity of Daxx as a transcriptional corepressor is dependent on the 
concentration of the Pml protein. Upon overexpression of Pml, Daxx is predominantly 
recruited to Pml nuclear bodies by binding sumoylated Pml with its C-terminal SIM. This 
reduces the recruitment of Daxx to sumoylated transcription factors and consequently 
Daxx-mediated transcriptional repression (Lehembre et al., 2001; Lin et al., 2006; Lin et al., 
2003). When cells are depleted of Pml, Daxx is strongly enriched at heterochromatic regions 
together with Atrx (Ishov et al., 1999). Importantly, also the recruitment of Daxx to 
heterochromatin is dependent on its Sumo-interaction motif (Lin et al., 2006), indicating that 
Sumo-SIM interactions are the predominant ways of recruiting Daxx to its genomic targets. 
Consequently, recruitment of Daxx to sumoylated Pml can globally regulate transcriptional 
repression by Daxx or its association to sumoylated heterochromatin (Ishov et al., 1999; Lin 
et al., 2006; Shih et al., 2007).  
How Daxx mediates transcriptional repression is not precisely understood. In addition to its 
interaction partners mentioned above, Daxx has been found to associate with HDAC1, 
HDAC2, the Dnmt1-associated protein (DNAP1) and the Dek oncoprotein (Hollenbach et al., 
2002; Li et al., 2000a; Muromoto et al., 2004). It can be hypothesized, that Daxx-mediated 
transcriptional repression could be due to the recruitment of additional heterochromatic 
proteins that are associated with Daxx. A prominent candidate for this could be Setdb1, 
which also colocalizes with Daxx at PML-bodies and pericentric heterochromatin and can be 
recruited by sumoylated transcription factors (Cho et al., 2011; Stielow et al., 2008). 
In addition to repressing endogenous gene expression, Daxx, Pml and Atrx have been found 
to repress viral replication of herpesviruses, adenoviruses, papillomaviruses and retroviruses 
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(Schreiner and Wodrich, 2013). How the Pml, Daxx and Atrx pathway mechanistically 
restricts viruses replication is hardly understood, but probably involves transcriptional 
repression of the viral genome. Interestingly, virion proteins that inactivate Daxx do not share 
any structural similarity, but can efficiently bind endogenous Daxx, suggesting that also these 
protein interactions might be facilitated by posttranslational modifications like sumoylation 
(Schreiner and Wodrich, 2013).  
Apart from its function as a transcriptional regulator, Daxx is a histone H3.3 chaperone that 
incorporates H3.3/H4 tetramers at heterochromatic regions (Drane et al., 2010; Elsasser et 
al., 2012; Goldberg et al., 2010; Lewis et al., 2010; Liu et al., 2012). Apart from centromeric 
histone H3, mammalian cells express three highly similar core histone proteins in somatic 
cells, H3.1, H3.2 and H3.3 (Hake and Allis, 2006). Histone H3.1 and H3.2 only differ in one 
amino acid and are incorporated into chromatin in a replication-coupled manner (Burgess 
and Zhang, 2013). In contrast, H3.3 differs in four to five amino acids from the other variants 
and is incorporated into chromatin in a replication-independent manner (Ahmad and 
Henikoff, 2002). Despite only minor differences in their amino acid composition, H3.3 is 
incorporated by a distinct set of histone chaperones, which leads to an enrichment of H3.3 at 
specific region in the genome (Burgess and Zhang, 2013; Goldberg et al., 2010). At active 
and repressed genes the histone chaperone Hira incorporates H3.3 (Adam et al., 2013; 
Banaszynski et al., 2013; Goldberg et al., 2010). Hira-dependent incorporation is specifically 
important to recruit the repressive H3K27me3 chromatin mark at some developmentally 
regulated promoters and to recover a functional transcriptional state upon DNA damage 
(Adam et al., 2013; Banaszynski et al., 2013). However, Hira does not catalyze H3.3 
incorporation at heterochromatic regions and at some transcription factor binding sites 
(Goldberg et al., 2010). Instead, H3.3 incorporation at telomeres and pericentric regions has 
been shown to rely on Daxx (Drane et al., 2010; Goldberg et al., 2010; Lewis et al., 2010), 
and in vitro assays confirm that Daxx binds H3.3/H4 tetramers with great specificity (Elsasser 
et al., 2012; Liu et al., 2012). Yet, the function of H3.3 incorporation at heterochromatic 
regions is unclear. It was suggested that H3.3 incorporation results in transcription of 
heterochromatic repeats (Drane et al., 2010). Interestingly, expression of heterochromatic 
repeats is important for heterochromatin formation in yeast (Grewal and Jia, 2007), but H3.3 
has so far not been implicated into heterochromatin formation. Another possibility is that 
H3.3/Daxx complexes form a nuclear reservoir of H3.3, and H3.3 incorporation into 
heterochromatin is a secondary effect of the accumulation of H3.3/Daxx complexes at these 
regions. In addition, the Drosophila homolog of the Daxx-associated protein Dek also shows 
H3.3 chaperon activity (Sawatsubashi et al., 2010), suggesting that the mechanism of 
Daxx-mediated H3.3 deposition could be even more complex. Upon Atrx or Daxx depletion, 
H3.3 incorporation at telomeres is reduced, leading to a slight upregulation of telomeric 
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TERRA transcripts (Goldberg et al., 2010). It is unclear, if H3.3 incorporation has an 
important function in telomere maintenance.  
Consistent with its important cellular functions Daxx knockout mice die at embryonic day 9.5 
of development (Michaelson et al., 1999). Extensive apoptosis and cell death precedes the 
death of Daxx-deficient embryos suggesting that either Daxx suppresses apoptotic pathways 
in vivo or Daxx deficiency leads to the accumulation of cellular defects (Michaelson et al., 
1999). Interestingly, the time point of embryonic lethality coincides with that of Atrx-deficient 
embryos implying that the observed association of Atrx and Daxx in vitro might also reflect a 
functional cooperativity in vivo (Garrick et al., 2006). In addition, to its function in normal 
development, Daxx seems to be an important tumor suppressor gene (already reviewed in 
the introduction chapter about Atrx).  
In summary, the histone H3.3 chaperone Daxx is an essential protein in development that is 
targeted to most of its genomic targets by sumoylation where it represses transcription. 
However, the relationship between its catalytic activity to incorporate H3.3 and its ability to 
repress transcription are not understood.  
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Figure 1.6 Daxx protein functions and interactions   
A) The scheme shows the domain architecture of the Daxx protein. The pos itions of 
known interaction surfaces are indicated.  Numbers below protein domain names indicate 
the amino acid. The protein is shown with the N-terminus on the left.  Daxx is also 
sumoylated, but this is neither important for its repressive activity nor its  localization 
(Lin et al., 2006). B) The illustration gives an overview over the most prominent nuclear 
localizations and functions of Daxx. Daxx is recruited to Pml nuclear bodies via binding to 
sumoylated Pml, which could be a reservoir of nuclear Daxx. Similarly,  Daxx is recruited 
by sumoylated transcription factors to repress transcription.  In addition, it can also be 
found at heterochromatin, where it colocalizes with Atrx. Please note that Daxx 
recruitment to heterochromatin is also dependent on its Sumo -interaction motif. However, 
which sumoylated protein is bound by Daxx at heterochromatin is not known. At 
heterochromatin Daxx has been shown to be a H3.3/H4 chaperone, while in euchromatic 
regions H3.3 is incorporated by the histone chaperone Hira  (modified from (Shih et al.,  
2007)). 
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1.4. Aim of the thesis  
Most of the heterochromatin proteins in mouse have been investigated due their orthology 
with heterochromatin factors identified in Drosophila by genetic reporter screens for position-
effect-variegation (Fodor et al., 2010). In addition, genetic screens for heterochromatin 
proteins have also been performed in mouse in low throughput (Ashe et al., 2008; Blewitt et 
al., 2006; Chong et al., 2007).  
Although mammalian species share a high number of orthologous genes with other model 
organisms, the higher complexities of the mammalian genome and mammalian gene 
regulation request a deeper functional understanding of heterochromatin regulation in 
mammals. Consequently, proteomic studies revealed important insights and characteristics 
of mammalian heterochromatin (Bartke et al., 2010; Nozawa et al., 2010; Vermeulen et al., 
2010). However, proteomic studies provide no information about the functionality of these 
heterochromatin players and their importance in heterochromatic gene silencing. Moreover, 
transient and short-term interactions of proteins often remain undetected by proteomic 
analysis.  
Therefore, we wanted to establish a genetic screening platform for heterochromatic gene 
silencing in mammals that is fast, easy and reliable.  
The first aim of my thesis was the establishment of a robust cellular heterochromatin reporter 
system. I first focused on genetic regions that are modified by heterochromatic marks and 
that are regulated by heterochromatin proteins.  
Secondly, having established such a screening system, the additional aim was to identify 
molecular mechanisms and genes involved in mammalian heterochromatin formation using 
unbiased RNAi experiments. 
After identification of primary hits from the screen, these hits should be validated by genetic 
and biochemical experiments to learn more about the underlying mechanisms.  
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2. Results 
2.1. Investigation of a heterochromatic reporter gene locus. The 
pseudoautosomal exons of the midline1 gene are derepressed in Suv39h 
double knockout and Suv4-20h double knockout mouse embryonic stem cells 
Since the aim of this study was to establish a heterochromatic screening system for the 
functional identification of heterochromatic proteins, the initial idea was to use endogenous 
gene loci that are regulated by heterochromatic pathways as a heterochromatin reporter 
locus.  
A large expression dataset of different mouse ES cell lines during embryoid body 
differentiation was previously generated in our lab by Dr. Matthias Hahn. This dataset was 
analyzed to find derepressed genes in cell lines mutated for the histone methyltransferases 
Suv39h1 and Suv39h2 or Suv4-20h1 and Suv4-20h2, which act together in a consecutive 
pathway in heterochromatin formation (introduction chapter 1.1.2) (Schotta et al., 2004; 
Schotta et al., 2008). The only gene that was consistently derepressed through all stages of 
embryoid body differentiation in Suv4-20h double knockout and Suv39h double knockout 
mES cells was midline1 (data not shown).  
Semi-quantitative RT-PCR was performed from RNA isolated from mES cells deficient for 
Suv39h or Suv4-20h enzymes to validate that midline1 is deregulated in these cells 
(Figure 2.1A). Strong amplification of midline1 cDNA only in mES cells deficient for Suv39h 
or Suv4-20h suggested that midline1 transcription is normally repressed by Suv39h and 
Suv4-20h enzymes (Figure 2.1A). 
The midline1 gene lies on the X-chromosome but flanks the pseudoautosomal boundary in 
mice. This means the 5’ end of the midline1 gene lies exclusively on the X-chromosome 
(exons 1-4), while its 3’ exons lie on the pseudoautosomal region (PAR) which is present on 
both, the X-chromosome and the Y- chromosome (Figure 2.1B). Published ChIP-sequencing 
profiles of the heterochromatic marks H4K20me3 and H3K9me3 indicate an enrichment of 
these histone marks on the pseudoautosomal part of the gene (Mikkelsen et al., 2007) 
(Figure 2.1B). Because these repressive histone marks are only present on the 
pseudoautosomal part of the midline1 gene, I performed exon-specific RT-qPCR to 
investigate whether the observed derepression of the midline1 gene in Suv39h and 
Suv4-20h mutant cells originates from the pseudoautosomal or the X-chromosome-specific 
part of the gene. Interestingly, the derepression of the midline1 gene is exclusively limited to 
its pseudoautosomal exons (Figure 2.1B). In summary, this data suggests that Suv39h and 
Suv4-20h regulate specific midline1 transcripts from the pseudoautosomal region in mice.  
2. Results  39 
 
 
Figure 2.1 The pseudoautosomal exons of the midline1  gene are derepressed in Suv39h  
and Suv4-20h double knockout mES cells  
A) The midline1  transcript is ectopically expressed in Suv39h  and Suv4-20h dko mES cells 
as shown by semi-quantitative reverse transcriptase PCR. The PCR amplification of the 
midline1  transcript is dependent on the addition of reverse transcriptase during reverse 
transcription. The M18bp1  transcript serves as an internal positive control.  B) The 
midline1  gene flanks the pseudoautosomal boundary in mice . The 5’ end of the midline1 
gene lies exclusively on the X-chromosome (exons 1-4), while its 3’ exons are situated on 
the pseudoautosomal region which is present on both, the X-chromosome and the 
Y-chromosome. Publicly available ChIP profiles point to an enrichment of H3K9me3 and 
H4K20me3 on the pseudoautosomal region  (Mikkelsen et al., 2007). Exon-specific RT-
qPCR shows that the derepression of midline1  in Suv39h  and Suv4-20h dko mES cells is 
limited to the pseudoautosomal exons of the gene. Number o f different cell lines 
analyzed: wild type n=2, Suv39h dko n=2, Suv4-20h dko n=1. Error bars indicate the 
standard deviation.   
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2.2. The pseudoautosomal midline1 transcript potentially originates from the 
Y-chromosome, is orientated in sense direction and originates from a complex 
genetic environment 
Because the derepression of the midline1 gene in Suv39h and Suv4-20h knockout cells is 
limited to its pseudoautosomal part, it was unclear, whether these midline1 transcripts 
originated from the X- or the Y-chromosome. Northern blot analysis of female and male mES 
cells revealed that the midline1 gene is specifically expressed in male cells deficient for 
Suv39h or Suv4-20h (Figure 2.2A). This suggests that these transcripts arise from the 
Y-chromosome. In addition, the derepressed midline1 transcript seems to be of a specific 
size on the Northern blot, indicating that it originates from a specific transcriptional start site. 
To check for any directionality of the transcript, direction-dependent RT-PCR was performed. 
Because amplification of the derepressed midline1 transcript could only be detected when an 
antisense primer was used for reverse transcription, the derepressed midline1 transcript is 
originated in sense direction (Figure 2.2B). This represents the same directionality as the full-
length X-chromosomal midline1 transcript.  
Having identified a specific midline1 transcript that is probably arising from the 
Y-chromosome, I wanted to make use of it as a heterochromatic reporter locus for further 
genetic screening approaches. However, there is still no reliable source of sequence 
information of this part of the mouse Y-chromosome. In addition, several papers suggested 
that the mouse pseudoautosomal region is short, highly polymorphic and a source of many 
de novo mutations (Kipling et al., 1996a; Kipling et al., 1996b; Palmer et al., 1997; Perry et 
al., 2001). Since using the Y-chromosomal midline1 locus as a reporter locus would involve 
gene-targeting in that particular region in mES cells, I tested the heterogeneity and copy 
number of the deregulated midline1 exons in different cell types (Figure 2.2C). In contrast to 
the copy number of autosomal gene loci, the copy number of the derepressed midline1 
exons was highly polymorphic and different in every cell line. In summary, the 
pseudoautosomal midline1 transcript might originate from a highly polymorphic locus on the 
Y-chromosome, a region which is difficult to modify by standard gene-targeting approaches. 
In addition, there is only poor sequence information available. These findings encouraged me 
to develop an alternative genetic screening approach. 
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Figure 2.2 The pseudoautosomal midline1  transcript  potentially arises from the 
Y-chromosome, is orientated in sense direction and originates from a complex genetic 
surrounding.   
A) Male Suv39h  and Suv4-20h dko, but not female Suv4-20  dko cells show a robust 
upregulation of pseudoautosomal midline1  transcripts in northern blot analysis. The 
position of the northern probes upstream or downstream of the pseudoautosomal 
boundary is indicated in the cartoon. M18bp1 and the X-chromosomal probes serve as 
loading controls. B) Only the antisense Primer used for reverse transcription gives rise to 
an RT-PCR product, revealing that the derepressed midline1  transcript is oriented in 
sense direction. The M18bp1  transcript serves as a positive control.  C) Genomic DNA of 
different mutant cell lines was isolated and allele copy number was analyzed using qPCR. 
The number of autosomal alleles is identical between different mutant cell lines, while the 
number of pseudoautosomal midline1  exons varies among different cell lines. The barplot 
represents two biological replicates. The average number of autosomal loci was 
determined by analyzing three independent autosomal loci.  The number of 
pseudoautosomal midline1  exons was determined using two independent primer pairs. 
Error bars indicate the standard deviation.  
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2.3. A candidate luciferase reporter screen for heterochromatic gene regulators 
identifies Setdb1, Trim28, Prdm6 and Hp1 proteins as transcriptional 
repressors 
Apart from midline1 no other strongly deregulated gene could be identified in our expression 
dataset generated from Suv39h and Suv4-20h knockout mES cells. Because depletion of 
Suv39h and Suv4-20h did not result in consistent transcriptional misregulations of specific 
genes, I wondered whether other heterochromatin-associated proteins directly influence 
gene expression. Gal4-fusion proteins of various heterochromatin-associated proteins were 
cloned and tested on their potential to silence a luciferase reporter gene. A candidate list of 
heterochromatin-associated proteins was taken from a mass-spectrometry-based screen for 
proteins associated with H3K9me3-peptides (Dambacher, 2013). In addition, other proteins 
were chosen, which were implicated into trimethylation of H3K9 (Falandry et al., 2010; 
Schultz et al., 2002).  
 
Figure 2.3 Setdb1, Trim28, Prdm6 and Hp1 Gal4-fusion proteins silence a luciferase  
reporter gene  
A) A candidate screen checking the repression capabilities of H3K9me3-associated 
chromatin proteins. Candidate genes were fused to the Gal4 -DNA binding domain and co-
transfected with a constitutively active firefly luciferase  vector containing five UAS 
binding sites for the Gal4 protein. A renilla luciferase control vector was co-transfected to 
normalize for unspecific effects on transcription and gene expression. B) Gal4 -fusions of 
Hp1 proteins (Cbx1, Cbx3 and Cbx5), Setdb1, Trim28 and Prdm6 repress the firefly  
luciferase reporter vector. A representative experiment performed in triplicates is shown. 
The transactivator Vp16 is used as a negative control. Error bars re present the standard 
deviation.  
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A mouse phosphoglycerate kinase (mPGK) promoter was cloned between five Gal4-binding 
sites (5xUAS) and the firefly luciferase gene to ensure a high basic level of transcription of 
the firefly luciferase reporter gene (Figure 2.3A). A renilla luciferase reference plasmid was 
used as an internal control for normalization of global and unspecific transcriptional effects. 
Setdb1, Trim28, Prdm6 and Hp1 proteins (Cbx1, Cbx3 and Cbx5) were identified to repress 
the mouse PGK promoter (Figure 2.3B). In contrast, no strong repression was observed by 
targeting Suv39h and Suv4-20h enzymes to the firefly luciferase gene promoter.  
In summary, proteins involved in heterochromatic gene silencing can be identified by using 
reporter gene assays and Setdb1, Trim28, Hp1 proteins and Prdm6 are sufficient to induce 
gene silencing. These proteins are suitable positive controls for establishing a novel 
screening platform for heterochromatic gene silencing.  
2.4. EGFP is a suitable reporter gene for heterochromatic gene silencing  
Heterochromatin repression assays using luciferase as a reporter gene can detect 
transrepressive effects (Figure 2.3). However, measurement of luciferase activity always 
occurs after lysis of a cell pool and the reporter expression of individual cells cannot be 
detected. Because I wanted to combine a heterochromatic reporter assay with pooled 
shRNA-screening, a reporter assay was required that allows the isolation of functional 
shRNA sequences from single cells that bypass heterochromatic silencing. Thus, a reporter 
gene was needed that can be analyzed in a single cell-based manner. Enhanced green 
fluorescent protein (EGFP) was cloned behind a strong CMV promoter and Gal4-binding 
sites to test, whether EGFP-detection using fluorescence-activated cell sorting (FACS) could 
be used to detect reporter gene repression (Figure 2.4A). Gal4-fusion proteins of Cbx1, 
Suv39h1, Suv4-20h1 and M18bp1 were transiently co-transfected with the 8xUAS-CMV-
EGFP reporter vector into HeLa cells and EGFP expression was monitored after two days. 
Similar to the data obtained by the luciferase assay in Figure 2.3 only Cbx1 could strongly 
reduce reporter gene expression (Figure 2.4B). Please note that an internal control gene 
similar to the renilla luciferase plasmid could not be used, due to a lack of an excitation-laser 
for other fluorescent proteins in FACS. However, since the EGFP-based silencing assay 
phenocopied the outcome of the internally controlled luciferase assay, I concluded that 
EGFP expression is usable as a read-out for single-cell-based repression assays. 
Because transient transfection experiments of the EGFP reporter results in a high variability 
of EGFP expression, it is difficult to evaluate whether a single cell that expresses EGFP only 
on a low level has just taken up a low amount of plasmid or whether reporter gene silencing 
has occurred. Therefore, a very homogenous EGFP reporter expression was required. In 
addition the EGFP reporter should be incorporated into the genome of the cell, to ensure that 
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also chromatin-dependent events can be detected, when combining the assay with shRNA-
based screening. MEFs and HeLa cells were transfected with the 8xUAS-CMV-EGFP 
reporter vectors to generate stable cell lines and single cell derived clones were generated 
using a FACS sorter. Even though transfection of the 8xUAS-CMV-EGFP reporter resulted in 
the generation of some EGFP-positive cell lines, a homogenous EGFP expression could not 
be obtained with this construct (Figure 2.4C). Because of the inhomogeneous expression of 
the CMV reporter constructs the CMVpromoter of the reporter vector was replaced with the 
mPGK promoter. This modification resulted in several clonal reporter cell lines that 
homogenously expressed EGFP. However, when transfecting these cells with Gal4-Cbx1 or 
Gal4-Vp16 no repression or further activation of EGFP expression could be seen 
(Figure 2.4C). In summary, EGFP is a suitable reporter gene for heterochromatic gene 
silencing, but the generation of reporter cell lines that are responsive to heterochromatic 
silencing was not successful.  
 
Figure 2.4 EGFP is a suitable reporter gene for investigating heterochromatic repression 
activities  
A) The principle of the luciferase experiment of Figure 2.3 was translated into a single-
cell-based assay by replacing the luciferase cassette with EGFP. B) Proof -of-principle 
experiment showing that Gal4-Cbx1 represses the 8xUAS-CMV-EGFP transgene. HeLa 
cells were transiently transfected with different Gal4 -fusion proteins and the 8xUAS-CMV-
EGFP reporter plasmid. Two days after transfection the number of EGFP-positive cells 
was measured using FACS. C) Generation and testing of stable EGFP reporter cell lines. 
Two independent EGFP reporter plasmids carrying either the CMV or the PGK prom oter 
were transfected into MEF and HeLa cells and selected using Zeocin™ as a selection 
marker. After several days post transfection individual EGFP-positive cells were sorted 
into a 96-Well plate giving rise to clonal cell l ines. The 8xUAS-CMV-EGFP transgene is 
silenced after several days and EGFP expression is lost within these clones. In contrast 
the PGK-EGFP transgene mainly results in clonal cell lines with homogenous EGFP 
expression. However, transfection of these cells with Gal4 -Cbx1 leads to no repression of 
EGFP signals.  
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2.5. Generation and optimization of a second generation lentiviral packaging 
system pseudotyped with ecotropic envelope protein of M-MLV 
Incorporating reporter cassettes into the cellular genome and into a chromatinized genomic 
environment is difficult and time consuming using standard plasmid transfection technologies 
(Figure 2.4C). For generating a reliable method to deliver reporter genes into cells, lentiviral 
transduction was optimized for using it under biosafety level 1 condition. This was necessary, 
because modifications of a lentiviral vector used under biosafety level 2 would in each case 
require a notification to governmental authorities. This organizational bottleneck was avoided 
by restricting the lentiviral system to exclusively transduce mouse and rat cells resulting in a 
biosafety level 1 transduction system. Restriction of lentivirus to rodent cells has been 
performed earlier (Schambach et al., 2006). However, a more reproducible and more 
efficient second generation lentiviral packaging system has not been established.  
For restricting lentiviral transduction to mouse or rat cells, the commonly used VSVg 
envelope protein was replaced by the ecotropic envelope protein of the Moloney-Murine 
Leukemia Virus (M-MLV) (Figure 2.5A). This envelope protein uses the mouse-specific 
cationic amino acid transporter Slc7a1 (mCAT1) as an entry receptor (Albritton et al., 1989). 
Second generation lentiviral packaging works via co-transfection of a plasmid encoding the 
required proteins of HIV-1 (gag, pol, tet, rev), a plasmid encoding an envelope protein 
determining viral tropism and a lentiviral transfer vector into HEK293T cells (Naldini et al., 
1996; Zufferey et al., 1997) (Figure 2.5A). The lentiviral transfer vector will give rise to an 
RNA, which after transduction and reverse transcription inside the host cell, will integrate at 
active sites of the genome (Schroder et al., 2002). After testing different plasmid backbones 
for the ecotropic envelope plasmid, the highest lentiviral titers were obtained when the 
plasmid carrying the ecotropic envelope gene was lacking an SV-40 origin of replication and 
contained a CMV promoter including an intron of the β-globin gene (Figure 2.5A and data not 
shown). 
After optimizing transfection efficiency and transfection method (Figure 2.5B), the ratio of the 
three packaging vectors used for co-transfection of HEK293T cells was optimized with an 
EGFP containing transfer vector using MEF cells (Figure 2.5C). Optimal titers were achieved 
by using equal amounts of packaging vectors (Figure 2.5C). Next, transduction efficiencies of 
differently treated viral particles were determined. While storage of the viral supernatants at 
4°C or freezing hardy influences the virus titer, applying g-forces of 1000 x g during 
transduction of target cells increased the number of functional transduction particles 
(Figure 2.5D). Careful optimization of ecotropic pseudotyped lentivirus provided a reliable 
tool for using reporter vectors that stably and quantitatively integrate into the genome of 
mouse cells.  
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Figure 2.5 Generation and optimization of a second generation lentiviral packaging 
system pseudotyped with ecotropic envelope protein of M-MLV  
A) The packaging system is based on a co-transfection of three plasmids into HEK293T 
cells that will produce viral transduction particles. The packaging vector provides the 
four required proteins of the HIV-1 virus (gag,pol,tet,rev) and was described earlier 
(Zufferey et al., 1997). These four proteins work with most commercially available 
lentiviral transfer vectors. The use of the ecotropic M-MLV envelope protein replaces the 
traditionally used VSVg protein and leads to the generation of  ecotropically pseudotyped 
virus, which can only transduce mouse or rat cells.  B) Optimization of transfection 
efficiency in HEK293T cells. HEK293T cells were transfected with an EGFP transfer vector 
and the ratio of EGFP-positive cells was measured in FACS. Calcium phosphate also 
outperforms the other transfection methods in terms of cell viability (data not shown). C) 
Optimization of plasmid ratios during lentiviral packaging to increase viral titers. 
Different ratios of the three packaging plasmids are u sed for viral packaging while 
maintaining the total amount of plasmid DNA constant. In contrast to many VSVg -based 
packaging systems, the viral supernatant has the highest number of infectious particles 
when equal ratios of the plasmids are used.  D) Differently treated viral supernatants 
packaged from an EGFP transfer vector were titrated on MEF and T37 HeLa cells to 
determine effects on virus titer.  Storage of the virus at 4°C and freezing can slightly 
impair virus titer (n=2). Spinning the cells at 1000  x g for  one hour during viral 
transduction strongly increases the relative virus titer (n=6). Error bars indicate the 
standard deviation.  
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2.6. Transrepressor binding sites cloned into lentiviral EGFP expression 
vectors are tools for monitoring transcriptional silencing kinetics  
Because reporter gene assays can be used for measuring the silencing activities of 
heterochromatin proteins (Figure 2.3) and because EGFP can be used as a reporter gene to 
monitor single-cell reporter expression (Figure 2.4), the next aim was to establish a silencing 
assay based on EGFP expression in individual cells. Because standard transfection 
technologies did not obtain stable EGFP reporter cell lines which can be silenced by 
heterochromatin proteins (Figure 2.4), a lentiviral reporter system was established. Similar 
lentiviral assays have previously been described for analyzing silencing activities of the 
M-MLV LTR promoter or the detection of repressive DNA sequences in transposable 
elements (Haas et al., 2003; Rowe et al., 2010). For reducing the complexity of the system, 
repressor binding sites of an endogenous repressor protein were directly cloned upstream of 
an EGFP reporter cassette inside a lentiviral vector. This “one-component” approach did not 
require the transduction of additional transgenic repressor proteins like Gal4-fusions 
constructs (Figure 2.6A).  
I chose three binding sites of the mouse-specific KRAB-box protein Zfp809. A binding site of 
Zfp809 is present downstream of the LTR region of the M-MLV provirus and is a well 
described repressor binding-site in mouse cells (Barklis et al., 1986; Feuer et al., 1989; Loh 
et al., 1987; Petersen et al., 1991; Wolf and Goff, 2009; Yamauchi et al., 1995). In addition, 
Zfp809-dependent silencing has been shown to be dependent on H3K9me3, Trim28 and 
Hp1 proteins, suggesting that it reflects a form of heterochromatic gene silencing (Wolf et al., 
2008; Wolf and Goff, 2007). 
Twelve hours after transduction of the lentiviral reporter vector, weak EGFP expression can 
be observed inside a MEF cell population (Figure 2.6B). When the Zfp809 binding sites are 
present upstream of the EGFP expression cassette, EGFP expression is strongly repressed 
in the majority of the cells (Figure 2.6B, right panel). However, in the absence of a repressor 
binding site EGFP expression increased over time (Figure 2.6B, middle panel).  
In summary, combining lentiviral transduction technology with a repressive silencing 
sequence resulted in the establishment of an EGFP-based silencing assay that allows 
detection of reporter silencing in single cells.  
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Figure 2.6 Establishment of a quantitative EGFP-based silencing assay  
A) A reporter cassette consisting of an EGFP-T2A-neoR reporter gene driven by a 
constitutively active EF1-alpha promoter was inserted into a lentiviral vector backbone.  
Different test sequences can be inserted into a cloning site upstream of the reporter 
cassette to monitor their influence on reporter gene expression using FACS. A lentiviral 
system was chosen, because the reporter stably integrates into the genome of the 
transduced cell.  B) FACS plots showing a representative experiment how a sequence 
element silences reporter gene expression. Three consecutive binding sites for the KRAB  
zinc finger protein 809 where cloned upstream of the reporter cassette. Zfp809 is a known 
repressor in MEF cells (Barklis et al.,  1986; Feuer et al., 1989; Loh et al. , 1987; Petersen et 
al., 1991; Wolf and Goff, 2009; Yamauchi et al., 1995), and Zfp809 binding leads to a 
repression of EGFP expression shortly after transduction. The FITC-channel detecting 
green fluorescence is plotted on the x -axis and the PE-channel detecting yellow-
fluorescence is plotted on the y-axis. This arrangement allows a good discrimination 
between weak EGFP-fluorescence and autofluorescence.  
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2.7. HeLa cells stably expressing Slc7a1 (mCAT-1) are susceptible to ecotropic 
M-MLV pseudotyped lentivirus transduction and can control for mouse- and 
cell-type-specific silencing activities 
Having established a lentiviral system to analyze repressive silencing sequences using 
EGFP reporters, a quantitative comparison of lentiviral titers carrying silencing or control 
sequences is needed (Figure 2.6). This is because the number of functional particles 
resulting in genomic integrations has to be known to quantify the strength of repression of 
different sequence elements inside a lentiviral reporter. This can only be achieved, when the 
virus titers of different constructs can be accurately measured. One way of comparing the 
virus titer of different reporter viruses is testing them on a cell line where no silencing occurs. 
Such a cell line, which does not contain repressors acting on mouse-specific repressor 
sequences (like Zfp809), was generated by making a human HeLa cell line susceptible to 
ecotropic lentiviral transduction (Figure 2.7A).  
This was done by stably expressing the Slc7a1 (mCAT-1) gene in HeLa cells. A similar 
approach was used for characterizing Slc7a1 as the ecotropic entry receptor in the first place 
(Albritton et al., 1989). The HeLa cell line that was generated was named T37. By titrating 
different vectors on T37 cells, mouse-specific silencing pathways did not influence the 
expression strength of the EGFP transgene in different vectors. In this way the number of 
functional viral particles could be quantified and compared between different reporter viruses 
(Figure 2.7B). This allowed a relative quantification of silencing capabilities between different 
reporter viruses. 
 
Figure 2.7 Generation of HeLa cells susceptible to transduction with ecotropic lentivirus
  
A) Expression of the mouse Slc7a1 protein makes HeLa cells susceptible to transduction 
with lentivirus pseudotyped with M-MLV ecotropic envelope protein. B) Proof of concept  
experiment showing that the generated Hela cell line (T37) is easily transduced with a 
lentivirus encoding an EGFP transgene cassette. The concentration of functional lentiviral 
particles can be determined by titrating different amounts of viral supernata nt on the 
cells.  
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During titrations the number of EGFP-positive cells was tried to be kept below 15 %, to 
ensure that the number of EGFP-positive cells linearly correlates with the virus titer. In 
summary, the establishment of a human control cell line for normalizing ecotropic virus titers 
can control for mouse and cell-type specific silencing activities of DNA elements.  
2.8. The GAG-region of the mouse IAP-Ez retrotransposon subclass contains a 
mouse embryonic stem cell specific silencing sequence 
Cloning transrepressor binding sites into lentiviral EGFP reporter vectors is a powerful 
system not only to characterize events at known transrepressor binding sites, but also to 
identify new sequence elements that recruit reporter silencing. This is a way of genetic 
screening for the DNA-elements that recruit silencing factors. A similar assay has been 
performed by others to check for silencing recruiting sequences at the UTR region of IAP 
retrotransposons (Rowe et al., 2010). I tried to verify the data obtained on IAP 
retrotransposons to check whether my generated vector system can detect the presence of 
transrepressor binding sites. Fragments of IAP-Ez retrotransposons were cloned from mouse 
DNA into the lentiviral EGFP reporter vector as shown in Figure 2.8A. Lentivirus was 
packaged, titrated and the number of EGFP-positive MEF and mES cells was determined by 
FACS (Figure 2.8A). Consistent with published data, a mild transrepressive activity could be 
measured for the UTR-region of IAP elements, when normalized on the empty EGFP control 
vector and the virus titer in T37 HeLa cells (Rowe et al., 2010) (Figure 2.8C). Surprisingly, 
the GAG sequence element of the IAP-Ez retrotransposon leads to almost a full repression 
of the EGFP reporter in mouse ES cells (Figure 2.8B and C). This repression was specific for 
mouse ES cells, since it could not be observed in MEF cells (Figure 2.8B right panel).  
In summary, the established lentiviral reporter system can detect transrepressor binding sites 
in cloned genomic DNA fragments. The GAG-sequence element of IAP retrotransposons 
contains a novel and strong silencing element that recruits reporter gene silencing in mES 
cells. MEF cells probably do not contain the recognition machinery to silence the GAG 
sequence.  
Figure 2.8 The GAG region of IAP-Ez retrotransposons contains a strong heterochromatic 
silencing element  
A) General description of the workflow for identifyin g heterochromatin recruiting 
sequence elements. Four fragments (LTR, UTR, GAG, POL) of IAP -Ez retrotransposons 
were cloned from mouse genomic DNA upstream of the EGFP reporter cassette. Titers of 
the ecotropically pseudotyped lentiviruses were determined b y titration on T37 HeLa cells 
and EGFP-FACS. After transduction of MEF and mES cells the number of EGFP-positive 
cells was determined using FACS. B) FACS plots of a representative dataset  showing that 
the GAG silencing element represses EGFP reporter gene expression in mES cells but not 
in MEF cells. C) Quantification of the individual reporter gene silencing capabilities of the 
different IAP-Ez sequence elements.  The GAG sequence element strongly silences the 
EGFP reporter gene in mES cells. The relative percentage of EGFP-positive cells was 
calculated by normalizing the percentage of EGFP-positive cells to the percentage of 
EGFP-positive cells transduced with an empty reporter vector carrying only EGFP but  
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having an identical virus titer. The plot represents three individual experiments of each 
reporter vector. Error bars indicate the standard deviation. The raw data contain  some 
data points acquired by experiments by Katharina Schmidt who I supervised durin g her 
medical PhD project (Schmidt, 2014). 
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2.9. The minimal silencing element inside the IAP-GAG sequence is 160 bp long 
and requires the histone methyltransferases Setdb1 for its repressive activity. 
Please note that the detailed mapping data in this passage and the experiments in different 
knockout mES cells were obtained and performed by Katharina Schmidt, who I supervised 
during her medical PhD thesis in our lab. Detailed descriptions of these experiments can be 
found in her doctoral thesis, once it is finished (Schmidt, 2014).  
The GAG-sequence element of IAP retrotransposons I identified in Figure 2.8 is roughly 2 kb 
long. For identification of the core silencing element inside this region, a large number of 
different subfragments were cloned into the lentiviral reporter vector and their silencing 
properties in mouse ES cells and MEF cells were determined as described in Figure 2.8. A 
small subset of the analyzed fragments is shown in Figure 2.9A. First, a larger fragment of 
400 bp (GAG2) was identified that contained the majority of the transrepressive silencing 
activity (Figure 2.9B). Finally this GAG2 element could be narrowed down to a minimal 
silencing element of 160 bp, named GAG2.22 (Schmidt, 2014) (Figure 2.9). I also cloned the 
GAG2.22 sequence in front of a different promoter to test whether GAG2.22 silencing 
behavior differs when the EGFP transgene is driven by mPGK promoter rather than the 
human EF1α promoter (Figure 2.9B). No obvious difference in silencing properties could be 
observed (Figure 2.9B). However, since the EF1α promoter-driven EGFP transgene 
generates a higher fluorescence of the cells, all following experiments were performed using 
EF1α promoter driven EGFP reporters.  
Next, we asked whether the repressive activity of the GAG2.22 sequence element on the 
EGFP reporter cassette was dependent on the recruitment of known heterochromatin 
proteins. Therefore, different mouse embryonic stem cell lines deficient for heterochromatin 
proteins were analyzed for their ability to silence the EGFP reporter dependent on the 
GAG2.22 sequence (Figure 2.9C). Mouse ES cells deficient for Dnmt1, Dnmt3a and Dnmt3b, 
Suv39h enzymes, and Suv4-20h enzymes silence the GAG2.22 reporter just like wild type 
cells (Figure 2.9C). 
Yet, mES cells deficient for the histone methyltransferases Setdb1 could no longer silence 
the lentiviral GAG2.22-EGFP reporter cassette (Figure 2.9C). 
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Figure 2.9 The minimal silencing element inside the IAP-GAG sequence is 160 bp long, 
can silence different promoters and requires the histone methyltransferases Setdb1 for 
silencing. 
A) The cartoon indicates the position of the IAP sequence elements that are responsible 
for the core silencing activity of the IAP-GAG element. B) The sequence elements in A) 
were cloned in front of the EGFP expression cassette either driven by the  hEF1α promoter 
or the mPGK promoter into lentiviral reporter vectors. Mouse ES cells and MEF cells were 
transduced with the according lentivirus. The percentage of EGFP expressing cells was 
measured in FACS two days after viral transduction. The experiment shows that the GAG2 
and GAG2.22 silencing element is sufficient to robustly repress expression of the EGFP  
transgene-cassette in mES cells but not MEF cells. The GAG2.22 sequence can silence the 
mouse PGK promoter as well as the human EF1α promoter. The barplot is generated from 
three independent experiments. Error bars indicate the standard deviation.  C) Setdb1 but 
not Suv39h, Suv4-20h, Dnmt1 or Dnmt3ab is required for silencing of the GAG2.22 
sequence. Mouse embryonic stem cell lines with indicated genomic backgrounds were 
transduced with a lentiviral EGFP reporter vector carrying the GAG2.22 silencing element. 
In the case of Setdb1, mouse ES cells were used that carry a floxed Setdb1  allele and 
knockout was applied two days before reporter transduction using a lentivirus enconding 
the Cre recombinase. The percentage of EGFP expressing cells was measured in FACS 
two days after reporter transduction. The relative percentage of EGFP-positive cells was 
calculated as described in B). The barplot is generated from three independent 
experiments. Error bars indicate the standard deviation.  Raw data of B) and C) originate 
from Katharina Schmidt (Schmidt, 2014). 
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Please note that Setdb1 is required for pluripotency of mES cells and cells don’t survive in 
the absence of Setdb1 (Bilodeau et al., 2009; Dodge et al., 2004).  
Therefore, mES cells were used which contained floxed Setdb1 gene loci. For analyzing 
Setdb1 depleted mES cells, cells were transduced with a lentivirus encoding the Cre 
recombinase two days before GAG2.22-EGFP reporter transduction. 
In summary, GAG2.22 a very potent silencing element of 160 bp was identified inside of IAP 
retrotransposons. In addition, GAG2.22 silences EGFP reporter gene expression in mouse 
ES cells in a Setdb1-dependent manner. 
2.10. The GAG2.22 sequence recruits Histone 3 Lysine 9 trimethylation when 
integrated into chromatin of mES cells 
GAG2.22, a 160 bp sequence of mouse IAP retrotransposons, silences strong constitutive 
reporter genes (Figure 2.9). Silencing occurs in mES cells and requires the histone 
methyltransferase Setdb1 (Figure 2.9).  
Endogenous IAP retrotransposons are modified with H3K9me3 (Mikkelsen et al., 2007). 
However, whether the short GAG2.22 sequence element is really a nucleation site of IAP 
retrotransposon silencing and is sufficient to recruit H3K9me3 independently of the 
surrounding IAP sequence, is unknown. Therefore, a single copy of the GAG2.22 sequence 
was integrated into the genome of mES cells using a recombinase-mediated cassette 
exchange system (Baubec et al., 2013; Lienert et al., 2011b) (Figure 2.10A). For this 
purpose, the GAG2.22 sequence was directly cloned in a plasmid downstream of an EGFP-
T2A-ZeoR reporter gene under the control of an inactive Tet-inducible promoter (TRE). The 
full cassette was flanked with inverted loxP sites to enable a cassette exchange with a floxed 
and stably integrated locus harboring a HygroR-HSV-TK marker gene (Figure 2.10). After 
co-transfection of the transfer plasmid with a plasmid encoding the Cre recombinase 
successfully recombined clones were devoid of the HygroR-HSV-TK gene and sensitive to 
ganciclovir selection.  
Chromatin immunoprecipitation experiments revealed that the integrated GAG2.22 cassette 
was strongly enriched for H3K9me3 (Figure 2.10B). H3K9me3 also spread across the entire 
reporter locus. 
In summary, the GAG2.22 sequence element of IAP retrotransposons autonomously recruits 
H3K9me3 to nearby chromatin.   
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Figure 2.10 The GAG2.22 sequence recruits Histone 3 Lysine 9 trimethylation in mouse ES 
cells 
A) A recombinant cassette containing the GAG2.22 sequen ce is inserted into HA36 mouse 
ES cells using recombinase-mediated cassette exchange (RMCE)(Baubec et al., 2013; 
Lienert et al., 2011b). First, a plasmid flanked by inverted loxP sites is co-transfected into 
HA36 mouse ES cells together with a plasmid encoding the Cre recombinase. The cell line 
contains a positive and negative selection marker (HygR -HSV-TK) flanked by inverted loxP 
sites that is removed after successful RMCE allowing selection of recombined cell clones 
using ganciclovir. Numbered black bars indicate the position of qPCR amplicons used for 
ChIP-qPCR in figure B. B) Chromatin immunoprecipitation experiment. H3K9me3 is 
recruited to a positive control region (Polrmt),  to IAP elements (IAP global) and to the 
GAG2.22 sequence. H3K9me3 spreads over the entire reporter locus.  Tia1 serves as a 
negative control. The barplot represents the average of two biological replicates. Error 
bars indicate the standard error of the mean.  
2.11. The IAP-GAG silencing sequences are silenced in a Trim28-dependent 
manner 
Setdb1 has been found to be essential for silencing of the GAG silencing element of IAP 
retrotransposons in reporter assays (Figure 2.9C). This is consistent with the finding that 
Setdb1 knockout mES cells show a strong upregulation of endogenous retroviral elements 
including IAP retrotransposons (Matsui et al., 2010). Apart from Setdb1 also Trim28 has 
been implicated into silencing of retrotransposons in mES cells (Rowe et al., 2010). 
Therefore, I wondered, whether Trim28 is also required for the recognition and silencing of 
EGFP reporter genes in a GAG2.22-dependent-manner. I depleted Trim28 from wild type 
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mES cells using lentiviral short-hairpin RNAs (shRNAs). Trim28 depletion by four 
independent shRNAs led to an impairment of GAG2.22-EGFP reporter silencing 
(Figure 2.11A). One of the Trim28 shRNAs was tested in three different mouse embryonic 
stem cell lines to rule out cell line-specific effects. In addition, I tested, whether the longer 
400 bp parental GAG2-sequence fragment that contains the GAG2.22 sequence is also 
silenced in a Trim28–dependent manner. Indeed, Trim28 knockdown led to impaired 
silencing of the GAG2-EGFP reporter in three different cell lines (Figure 2.11B). Because I 
only analyzed Trim28 knockdown cells and did not investigate Trim28 knockout cells, I could 
not judge whether the effect of Setdb1 depletion on reporter silencing was severer than the 
effect of Trim28 depletion. Notably, the reduction of Trim28 mRNA by the shRNA used in 
Figure 2.11B was on average only around 60 % (Figure 2.11C). 
 
  
Figure 2.11 Combining the EGFP-based GAG-silencing assay with shRNA knockdowns 
reveals that the IAP-GAG sequence is silenced in a Trim28-dependent manner. 
 
A) Mouse ES cells were transduced with lentiviral shRNAs against Trim28  or a scrambled 
control sequence. Cells were grown for  two days and selected with 2 µg/ml puromycin for 
additional two days. Afterwards cells were transduced again with lentiviral EGFP 
reporters and the silencing potential of the GAG2.22 sequence was  measured after 
additional two days as described in Figure 2.9. The barplot shows an average of  four 
independent shRNAs targeting Trim28. Error bars represent the standard deviation.  
B) Different wildtype cell lines silence the GAG2 sequence in a Trim28-dependent manner. 
Wild type mouse embryonic stem cell  lines were used and tested for their silencing 
potential of the GAG2 sequence after knockdown with one Trim28 shRNA. The figure 
represents an average of three experiments using different wild type cells lines. Error 
bars represent the standard deviation. C) The average amount of Trim28 knockdown 
generated by the Trim28 shRNA used in Figure 2.11B is around 60 %. The expression was 
measured by quantitative RT-PCR and normalized to a scrambled shRNA control.  The 
barplot represents four experiments. Error bars represent the standard deviation.  
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In summary, the GAG2.22 or the GAG2 sequence of the mouse IAP retrotransposon 
silenced EGFP reporter genes in a Trim28-dependent manner. Combining shRNA depletions 
of potential candidate genes with lentiviral EGFP reporter assays can identify genes that are 
involved in GAG-mediated transcriptional repression.  
2.12. Optimization of two genome-wide shRNA screening assays for factors 
involved in reporter gene-silencing 
Sh-RNA-mediated depletion of Trim28 led to impaired repression of the GAG2.22-EGFP 
reporter (Figure 2.11). Therefore, unbiased RNA-interference (RNAi) screening experiments 
could potentially identify novel factors involved in reporter gene silencing of this sequence. 
An easy way of testing a large set of shRNA sequences is using pooled lentiviral shRNA 
libraries (Figure 2.12) (Moffat et al., 2006; Ngo et al., 2006; Silva et al., 2008). These libraries 
consist of a mix of thousands of different viral particles of which each encodes a different 
shRNA sequence targeted against a different mRNA transcript. After transduction of a cell 
line with a pooled shRNA library at a low multiplicity of infection every individual cell takes up 
only one shRNA and downregulates the respective mRNA. This heterogenic cell pool can be 
used to isolate individual cells that bypass the silencing of a lentiviral EGFP silencing 
reporter. If an shRNA in an individual cell downregulates a factor that is required for EGFP 
reporter gene silencing, EGFP expression will be maintained in this cell. Because lentiviral 
shRNA sequences stably integrate into the genome of the transduced cells, shRNA 
sequences leading to a bypass of silencing can be identified by PCR after sorting EGFP-
positive cells using a FACS sorter. An EGFP reporter not bearing a silencing sequence can 
be used as a negative control and to normalize for unequal representations of shRNA 
sequences in the shRNA pool (Figure 2.12). 
Except Trim28 and Setdb1 other factors involved in IAP retrotransposon silencing initiation 
are unknown. Since the GAG2-EGFP reporter silencing assay mirrors many aspects of 
endogenous IAP silencing in mouse ES cells like Setdb1- and Trim28-dependency 
(Figure 2.11B, Figure 2.9B and C), a genome-wide screening protocol was optimized on the 
GAG2-EGFP repression assay (Figure 2.12B). The required amount of pooled shRNA virus, 
the optimal puromycin concentration, virus titers of the lentiviral EGFP reporters, the choice 
whether the GAG, GAG2 or GAG2.22 elements should be used for screening and the 
optimal time points for all steps were empirically optimized for a good signal to noise ratio 
between control shRNAs and shRNAs targeting Trim28 (data not shown). The final protocol 
of the genome-wide shRNA screen is shown in Figure 2.12B.  
Because IAP-GAG-mediated silencing only occurs in mES cells (Figure 2.8), the shRNA 
screen had to be performed in these cells. Mouse ES cells are rather sensitive cells that 
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respond to a variety of stimuli with cell death. Precautionary, a similar screening approach 
was also established in more robust MEF cells to control, if my screening approach in 
general results in the identification of functional hits. For this second screening experiment 
the Zfp809-EGFP reporter silencing assay was chosen, which also works in MEF cells 
(Figure 2.6). Zfp809-dependent silencing constructs were already established (Figure 2.6). 
Moreover, Zfp809-dependent silencing is also dependent on the corepressor protein Trim28, 
H3K9me3 and Hp1 proteins (Wolf et al., 2008; Wolf and Goff, 2007, 2009). Screening 
parameters for the Zfp809 control screen were determined accordingly using shRNAs 
against Zfp809 and Trim28 (data not shown and Figure 2.12A). 
 
Figure 2.12 Optimized and final conditions of the two independent genome-wide shRNA 
screening approaches  
A) The screening protocol was optimized for the identification of genes involved in 
heterochromatic silencing by Zfp809 and Trim28 in MEF cells. Another motivation for this 
screen was to test the feasibil ity of the shRNA screening combined with lentiviral 
reporters in a robust differentiated cell line. MEF cells were transduced with a genome-
wide pool of mixed lentivirus-encoded shRNAs. A low multiplicity of infection (MOI) was 
used to ensure only one shRNA integrated in each cell. After selection of transduced cells 
with an optimized puromycin concentration for  three days, the cell pool was split and 
either transduced with an EGFP reporter virus containing one or no Zfp809 binding site. 
The EGFP reporter containing the Zfp809 binding site was silenced unless particular 
shRNAs led to a bypass of silencing. Cells that bypassed silencing were EGFP-positive 
and were sorted using a FACS sorter. The shRNA sequences integrated in these cells 
were identified by deep-sequencing of PCR products from shRNA sequences. The EGFP 
reporter without a Zfp809 binding site was used as a negative control and to normalize for 
unequal representations in the shRNA pool. B) Optimized conditions for the GAG2/mES 
screen are shown for identifying genes involved in IAP silencing in mouse ES cells. The 
screen was carried out with the GAG2 sequence as described in A) except for the 
indicated changes in the protocol.  
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In summary, two pooled genome-wide shRNA screens were set up. The first screen aimed 
for the identification of factors that together with Setdb1 and Trim28 silence the GAG region 
of IAP retrotransposons. The second screen was done to prove the feasibility of pooled 
shRNA screening on EGFP reporter assays and to find additional factors required for 
Zfp809-dependent and Trim28-dependent silencing in MEF cells.  
2.13. Genome-wide screening for Zfp809 and IAP-GAG-dependent silencing 
identifies many potential genes involved in heterochromatic gene silencing 
Two genome-wide shRNA screening experiments have been carried out as described in 
Figure 2.12. EGFP-positive cells that bypass silencing were isolated using a FACS sorter 
and genomic DNA was isolated. In parallel cells transduced with an EGFP reporter without a 
silencing sequence were also harvested to normalize for unequal representations of shRNAs 
in the initial virus pool.  
The shRNA sequences integrated in the genome of the cells were isolated via PCR and the 
sequences were identified using next-generation sequencing. Sequence reads were aligned 
to the respective shRNA sequences in the TRC library documentation (Moffat et al., 2006). 
ShRNAs that were not identified by sequencing or shRNAs identified with less than 20 reads 
in the EGFP-only control sample were removed from the analysis. The number of total reads 
between different samples was normalized and reads enriched more than three times were 
designated as hits (Figure 2.13A). 
In total 1144 genes scored as hits in the Zfp809/MEF control screen. Please note that Trim28 
was among the two strongest hits scoring with three independent shRNAs (Figure 2.13B). 
2379 genes scored as hits in the GAG silencing screen with DNA topoisomerase 2-beta as 
the strongest hit.  
The number of scoring genes is relatively high, probably reflecting the fact that FACS sorting 
displayed a bottleneck in the workflow. Since only 200.000 EGFP-positive cells could be 
obtained that bypassed silencing of the Zfp809 reporter and only 30.000 EGFP-positive cells 
could be obtained that bypass silencing of the GAG2 reporter, a high shRNA library 
representation during next generation sequencing could not be obtained. However, since 
Trim28 was identified as the strongest hit in the control screen, both lists will likely contain a 
large number of bona fide genes involved in heterochromatic silencing. The full lists of hits 
from both genetic screens can be found in the appendix.  
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Figure 2.13 Genome-wide screening for Zfp809 and IAP-GAG-dependent silencing 
identifies many potential genes involved in reporter silencing  
A) Workflow of how the shRNA-seq reads of the two different samples of each screen were 
processed after alignment to the shRNA library to identify hits of the primary screen. Next 
generation library preparation and sequencing was carried out at Partners HealthCare 
Center for Personalized Genetic Medicine (PCPGM) Cambridge, MA, USA. Alignment of 
reads to the shRNA library has been performed by Prof. Dr. Gunnar Schotta.  B) The table 
shows the most prominent hits of the two screens and the number of genes iden tified. In 
the Zfp809/MEF screen Trim28  is the strongest hit.  
2.14. A secondary genetic-screen identifies Atrx as a regulator of GAG-
sequence silencing of IAP retrotransposon sequences 
Genome-wide screening for Zfp809-dependent silencing in MEFs identified the corepressor 
Trim28 as the strongest hit, which is a known and validated regulator for Zfp809-mediated 
repression (Wolf and Goff, 2007, 2009). This underlines that the method for genome-wide 
shRNA screening on reporter genes identifies functional regulators of silencing.  
However, since a lot of the regulation on IAP retrotransposons is still unknown, I focused on 
the validation of the GAG-EGFP shRNA screen (Figure 2.13B). In addition, our genome-wide 
screening approach identified a long list of potential genes involved in IAP silencing. 
Therefore, secondary screening of individual shRNA sequences was required.  
A small candidate library of 75 lentiviral shRNA vectors was cloned directly from isolated 
DNA of the primary screen to validate individual shRNAs that bypass reporter gene silencing 
(Figure 2.14A). These lentiviral shRNA vectors were packaged into lentivirus and mES cells 
were transduced. After selection of knockdown cells with puromycin, the GAG2-EGFP 
reporter or an EGFP control lentivirus was transduced and GAG2-dependent silencing was 
determined using FACS as described in Figure 2.9.  
Silencing potential of the individual shRNAs was compared to an shRNA targeting Trim28 as 
a positive control and to an shRNA targeting a scrambled control sequence. The best 
performing shRNAs in the screen were sequenced using Sanger sequencing. An shRNA 
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targeting Atrx was found to have the strongest effect in the secondary screen (Figure 2.14A). 
The effect of the shRNA on Atrx mRNA level was determined by RT-qPCR showing that Atrx 
mRNA levels were indeed reduced upon shRNA transduction (Figure 2.14B). 
In summary, a secondary screen of the primary GAG2-mES shRNA screen verified shRNAs 
that significantly reduce GAG2-EGFP reporter gene silencing. The highest scoring shRNA of 
the secondary screen targets the Atrx gene.  
 
Figure 2.14 A secondary screen identifies Atrx as a regulator of IAP/GAG silencing   
A) 75 shRNA vectors were directly cloned from DNA of EGFP-positive cells of the primary 
screen and analyzed in a secondary screen. Mouse ES cells were transduced with the 75 
shRNA viruses in 96-Wells and selected with puromycin after  two days. After additional 
two days the cells were transduced with either GAG2 -EGFP reporter virus or an EGFP-only 
control virus. The different knockdown cells were analyzed for their silencing potential of 
the GAG2-EGFP reporter after additional two days. The relative percentage of EGFP-
positive cells for every knockdown cell line was normalized to the relative percentage of 
the EGFP-only control. Control shRNAs where included in the experiment as an internal 
reference (shRNA against a scrambled sequence shown in blue, shRNA ag ainst Trim28 
shown in yellow).  The best performing shRNA-vectors were sequenced using standard 
Sanger sequencing. The targeted genes of these shRNAs are listed above the barplot. B) 
The identified shRNA against Atrx downregulates Atrx mRNA. Cells were tran sduced with 
shAtrx or an shRNA targeting a scrambled sequence. After selection of transduced cells 
with puromycin, RNA was isolated and reverse transcriptase -qPCR was performed. The 
barplot represents three individual experiments. Error bars indicate the s tandard 
deviation.  
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2.15. Atrx knockout cells show strongly retarded silencing kinetics of the 
GAG2.22-EGFP reporter  
ShRNA-screening revealed that an shRNA targeting Atrx strongly impairs silencing of the 
GAG-EGFP reporter (Figure 2.14). Atrx is a known chromatin-associated SNF2-type ATPase 
that contains an N-terminal ADD-domain which binds to methylated H3K9 and which is 
implicated into the human X-lined alpha-thalassemia mental retardation syndrome 
(Eustermann et al., 2011; Gibbons et al., 2000; Gibbons et al., 1995; Iwase et al., 2011; 
Picketts et al., 1996) (Introduction 1.3.3). Therefore, a direct role of Atrx into Setdb1- and 
Trim28-dependent silencing of IAP retrotransposons was suggested. However, RNAi 
experiments often result in a substantial number of off-target effects and acquired hits require 
careful validation (Jackson et al., 2003). Thus, the connection between Atrx and 
retrotransposon-silencing was validated by analyzing mES cells deficient for Atrx.  
CRISPR/Cas9 technology was used to disrupt the Atrx locus with RNA-guided-nucleases 
(RGN) (Figure 2.15A). Male mES cells were co-transfected with a plasmid containing a 
puromycin-resistance and the pX330 plasmid encoding a codon-optimized Cas9 enzyme and 
a small guide RNA (sgRNA or crRNA) targeting the N-Terminal region of the Atrx ORF (Cong 
et al., 2013; Mali et al., 2013) (Figure 2.15A). After selection of transfected cells using a short 
puromycin treatment, individual cell clones were analyzed for mutations at the Atrx locus. 
Four cell clones having frame-shift mutations were identified using Sanger sequencing of 
PCR products and verified by western blotting (Figure 2.15A and C).  
Next, Atrx-deficient cell lines were analyzed for their ability to silence the GAG2.22-EGFP 
reporter cassette as described in Figure 2.9. All four Atrx-deficient cell lines are not 
completely defective in silencing, but show strongly retarded silencing kinetics 
(Figure 2.15B). However, this is consistent with the finding that knockdown of Atrx using a 
lentiviral shRNA leads to impaired silencing of the GAG2-EGFP reporter gene. To rule out 
CRISPR-dependent off-target effects, an independent mouse ES cell line was targeted with 
different sgRNAs against Atrx giving the same results (data not shown).  
In summary, Atrx-deficient cells were generated via RNA-guided nucleases. Knockout of Atrx 
results in impaired silencing of the GAG2.22-EGFP reporter gene. 
2. Results  63 
 
 
Figure 2.15 Atrx  knockout cells show strongly retarded silencing kinetics of the GAG2.22 -
EGFP reporter  
A) Generation of Atrx  knockout cells via transient transfection of CRISPR/Cas9 plasmids. 
The used crRNA and the targeted position of the Atrx  locus are shown. Single mouse 
embryonic stem cell colonies were expanded after CRISPR/Cas9 transfection and analyzed 
for mutations in the Atrx  open reading frame. The Atrx  locus also lies on the 
X-chromosome in mice, and male cells only contain one Atrx  allele. The Sanger 
sequencing result of four independent clones reveal ed non-sense mutations in these 
cells. B) Atrx  knockout cells were transduced with the GAG2.22 -EGFP reporter as 
described in Figure 2.9 and the silencing of the reporter was monitored at the indica ted 
time points using FACS. The plot represents three experiments of four independent Atrx  
knockout cell clones and two Atrx  expressing control cell  lines. Error bars represent the 
standard deviation. The plot in B) contains data points acquired by Katharina Schmidt 
(Schmidt, 2014). C) Western blot verifying that the generated Atrx  knockout cells lost Atrx 
protein expression.  
2.16. Atrx and H3K9me3 are enriched at endogenous IAP elements in mouse 
ES cells and are recruited to novel integrations of the GAG2.22 sequence 
Depletion of Atrx via RNAi or RNA-mediated nucleases leads to defects in silencing of a 
lentiviral EGFP reporter using the GAG2.22 sequence element of IAP retrotransposons 
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(Figure 2.14 and Figure 2.15). Therefore, it was suggested that Atrx also plays a role at 
endogenous IAP elements in mES cells. Published datasets of Atrx ChiP-sequencing 
experiments in mES cells and ChIP-sequencing reads for H3K9me3 that were generated 
with mES cells in our lab were aligned to the mouse genome ((Law et al., 2010) and 
unpublished data). Full-length IAP element copies in the genome were identified and aligned 
at the GAG2.22 sequence. The relative number of ChIP-sequencing reads over these full 
length IAP elements shows a strong enrichment of Atrx at these sites (Figure 2.16A). 
Similarly, H3K9me3 is also found at IAP sequences in mES cells, as it has been reported 
before (Karimi et al., 2011; Mikkelsen et al., 2007). Interestingly, Atrx binding peaks directly 
next to the GAG2.22 sequence while H3K9me3 is more widely distributed over the IAP 
sequence and flanking genomic regions (Figure 2.16A). Similar data were obtained when 
Atrx enrichment on IAP elements was measured using ChIP-qPCR (Figure 2.16B). 
Enrichment of H3K9me3 on IAP elements and positive control regions is not changed in Atrx 
knockout mES cells, indicating that Atrx depletion has not an immediate impact on H3K9me3 
in mES cells and seems to be downstream of H3K9 trimethylation (Figure 2.16C).  
I analyzed Atrx binding in cells engineered to carry a single copy integration of an EGFP-
GAG2.22 sequence via recombinase-mediated cassette exchange (RMCE) to see whether 
the GAG2.22 sequence can autonomously recruit Atrx (Figure 2.10 and 2.16D). Atrx is 
bound to the GAG2.22 sequence but does not spread over the reporter locus (Figure 2.16D).  
In summary, Atrx protein and H3K9me3 are present at endogenous IAP retrotransposons in 
mES cells. Atrx deficiency does not lead to a detectable reduction of H3K9me3 in these cells. 
However, the GAG2.22 sequence autonomously recruits Atrx to nearby chromatin. 
 
Figure 2.16 Atrx and H3K9me3 are enriched at endogenous IAP elements and are recruited 
to novel integrations of the GAG2.22 sequence   
A) Full-length IAP copies were aligned at the GAG2.22 site and the relative number of 
ChiP-Seq reads for H3K9me3 and Atrx was plotted on the Y-axis. The GAG2.22 sequence 
is highlighted in dark ocher inside the GAG sequence. Atrx ChIP -seq data have been 
published by others (Law et al., 2010), H3K9me3 ChIP-seq data originate from unpublished 
datasets generated in our lab. Data analysis was p erformed by Prof. Gunnar Schotta. Atrx 
not only localizes to IAP elements in vivo  but also Atrx enrichment peaks next to the 
GAG2.22 sequence. B) Atrx chromatin immunoprecipiation. Atrx is bound to positive 
control regions (Polrmt) and to IAP elements, but  not to a negative control region (Tia1). 
The barplot indicates an average of two independent ChIP experiments. Atrx  knockout 
cells were used as a negative control to control for antibody specificity.  Error bars 
indicate the standard deviation.  C) H3K9me3 chromatin immunoprecipitation in wild type 
and Atrx  knockout cells. Atrx  knockout cells maintain prominent levels of H3K9me3 at a 
positive control region (Polrmt)  and at IAP elements. Tia1 serves as a negative control.  
The barplot represents an average of two experiments of wild type cells and three 
experiments of different Atrx  knockout cell clones. Error bars indicate the standard 
deviation. D) Atrx ChIP in cells engineered to carry a single copy integration of an EGFP -
GAG2.22 transgene via RMCE (see Figure 2.10). The newly integrated  GAG2.22 sequence 
recruits Atrx. However, Atrx does not spread to neighboring chromatin. ChIP -Data have 
been normalized to background binding to the beads. The barplot shows  an average of 
two experiments. Error bars indicate the standard deviation.   
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2.17. Atrx knockout cells have normal DNA methylation on IAP retrotransposon 
sequences and a normal cell cycle distribution 
Atrx knockout cells show an impaired silencing on GAG2.22-EGFP and Atrx binds to 
endogenous IAP elements in vivo (Figure 2.15B and Figure 2.16A and B). Yet, H3K9me3 in 
Atrx knockout cells appears to be unaltered (Figure 2.16C). Since endogenous IAP elements 
are heavily methylated by DNA methylation and Atrx has been reported to influence DNA 
methylation at repetitive elements (Gibbons et al., 2000; Walsh et al., 1998), DNA 
methylation analysis was performed in Atrx knockout cells to identify potential changes upon 
Atrx depletion. Genomic DNA of wild type and Atrx knockout cells was bisulfite-converted to 
identify changes of DNA methylation. Individual sequences were analyzed by Sanger 
sequencing (Figure 2.17A). No significant difference in the level of DNA methylation on 
endogenous IAP elements could be detected between wild type and Atrx knockout mES cells 
(Figure 2.17B).  
Atrx depletion has been implicated into chromosome cohesion and congression defects and 
defects of the meiotic spindle (De La Fuente et al., 2004; Ritchie et al., 2008). In addition, 
Atrx has been involved in telomere integrity (Heaphy et al., 2011; Lovejoy et al., 2012; Wong 
et al., 2010). Therefore, I wondered whether aneuploidy or differences in the cell cycle 
distribution occur upon Atrx knockout. However, no change in DNA content or cell cycle 
distribution was detected in Atrx knockout cells (Figure 2.17C).  
In summary, Atrx knockout cells show no perturbed DNA-methylation or cell cycle 
distribution.  
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Figure 2.17 Atrx  knockout cells have normal DNA methylation on IAP retrotransposon 
sequences and a normal cell -cyle distribution.   
A) DNA methylation status of Atrx  knockout cells at IAP Gag regions and at the Oct -4 
promoter. DNA was isolated from cell lines , bisulfite-converted and PCR products of the 
respective regions were subcloned for Sanger sequencing. The cytosine-methylation state 
was analyzed via BiQ Analyzer (Bock et al., 2005). B) Quantification of the DNA 
methylation data. C) Atrx  knockout mouse embryonic stem cell lines show a normal cell  
cycle distribution in PI-FACS. 
2.18. Daxx knockout cells phenocopy the impaired silencing kinetics of Atrx 
knockout cells 
Atrx is a known interacting protein of the histone H3.3 chaperone Daxx and several 
publications suggest a functional interaction of these proteins during deposition of histone 
H3.3 (Drane et al., 2010; Elsasser et al., 2012; Goldberg et al., 2010; Lewis et al., 2010; 
Wong et al., 2010). I generated Daxx knockout mES cells to see, whether Atrx and Daxx also 
functionally interact during the repression of IAP retrotransposons. Wild type mES cells were 
transfected with CRISPR/Cas9 plasmids targeting the Daxx ORF (Figure 2.18A), and cell 
lines that were deficient for Daxx protein were obtained (Figure 2.18B). Daxx knockout cells 
were analyzed for their ability to silence the GAG2.22-EGFP carrying the strong silencing 
sequence of IAP retrotransposons (Figure 2.9, Figure 2.18C). Similar to Atrx knockout mES 
cells, Daxx knockout cells show strongly retarded silencing kinetics. Interestingly, the 
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strength of remaining silencing activitiy of the GAG2.22-EGFP reporter is highly comparable 
between Atrx and Daxx knockout cells. Importantly, knockout of Daxx does not lead to a loss 
of Atrx expression (Figure 2.18D). Please note that also Trim28 expression was not changed 
in Atrx and Daxx knockout cells (Figure 2.18D). 
In summary, Daxx knockout cells phenocopy the impaired silencing kinetics of Atrx knockout 
cells. Because depletion of Daxx does not alter the expression of Trim28 or Atrx, the Daxx 
protein seems to be involved in the process. 
 
Figure 2.18 Daxx  knockout cells phenocopy the impaired silencing kinetics  of Atrx 
knockout cells   
A) Mouse ES cells were transiently transfected with CRISPR/Cas9 plasmids targeting the 
Daxx  ORF. In total four cell clones were isolated harboring frameshift mutations on both 
Daxx  alleles. B) A representative western blot showing the loss of Daxx protein in two of 
the generated Daxx  knockout cell lines. α -tubulin was used as a loading control. C) Daxx  
knockout cells were transduced with the GAG2.22 -EGFP reporter as described in 
Figure 2.9. and the silencing of the reporter was monitored at the indicated time points 
using FACS. The plot represents three experiments of four independent Daxx  knockout 
cell clones and the parental wild type cell line. Error bars represent the standard 
deviation. D) Western Blot for testing expression levels of Atrx and Trim28 in different 
genetic backgrounds. Trim28 is not strongly deregulated when Atrx or Daxx is depleted 
from the cells. Daxx  knockout cells show normal Atrx levels. α-tubulin served as a loading 
control.  
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2.19. H3.3 interaction mutants of Daxx and wild type Daxx protein rescue the 
silencing defect of Daxx knockout cells 
Daxx knockout cells and Atrx knockout cells show impaired silencing of the GAG2.22-EGFP 
reporter, which is a model system of IAP retrotransposon silencing (Figure 2.15, 
Figure 2.18). However, how one of the proteins on the molecular level participates in this 
process is unclear. Daxx has been shown to act as a histone chaperone for H3.3/H4 
tetramer (Elsasser et al., 2012; Liu et al., 2012). In particular, arginine 257 of Daxx has been 
shown to be essential for binding of Daxx to the H3.3/H4 tetramer and glutamate 231 was 
identified to ensure that Daxx has selectivity for H3.3 rather than H3.1 (Elsasser et al., 2012). 
In addition, the C-terminus of Daxx has been shown to contain a Sumo-interaction motif that 
is essential for Daxx to act as a corepressor (Chang et al., 2005; Chang et al., 2011; Kuo et 
al., 2005; Lin et al., 2004; Lin et al., 2006). Therefore, I wondered, whether the histone 
chaperone activity of Daxx or its Sumo-interaction motif is important for its repressive 
function on the GAG2.22-EGFP reporter assay. 
Thus, wild type Daxx cDNA and mutant Daxx cDNA were reintroduced into Daxx knockout 
cells to analyze, if the Daxx proteins harboring different mutations would rescue the reporter 
gene silencing defect (Figure 2.19A). After generation of stable cell lines, the GAG2.22-
EGFP reporter was transduced and the silencing capabilities were measured after two days. 
Daxx knockout cells only transduced with an empty vector performed like Daxx knockout 
cells as shown in Figure 2.18 and showed a defect in GAG2.22-EGFP reporter gene 
silencing (Figure 2.19B). However, reintroduction of wild type Daxx cDNA and Daxx mutants 
carrying mutations E231A and R257A partially rescued the silencing phenotype in these 
cells, but reintroduction of Daxx lacking the Sumo-interaction motif (SIM) at its C-Terminus 
(amino acids 732 to 739) did not (Figure 2.19B). This indicates that H3.3 binding by Daxx or 
its binding specificity for H3.3 are not required for the repressive function of Daxx. In addition, 
the Sumo-interaction motif (SIM) seems to be required for the silencing activity of Daxx. 
Importantly, all Daxx proteins were overexpressed to a similar extent, ruling out the 
possibility that the SIM-mutant of Daxx was simply not expressed (Figure 2.19C). 
In summary, Daxx mutants carrying mutations that affect H3.3 binding or H3.3 binding 
specificity can rescue IAP-GAG reporter silencing to the same extend as the wild type 
protein. However, Daxx carrying a deletion at its C-terminal Sumo-interaction motif did not 
rescue reporter gene silencing.  
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Figure 2.19 Wild type Daxx protein and H3.3 interaction mutants of Daxx rescue the 
silencing defect of Daxx  knockout cells   
A) Daxx  knockout cells were stably transduced with Daxx, a Daxx mutant that has 
impaired selectivity between H3.3 and H3.1 (E231A), a Daxx mutant that has been shown 
to lose interaction with H3.3 (R257A) and a Daxx mutant lacking the C -Terminus carrying a 
phosphorylation and Sumo-interaction site (Elsasser et al., 2012; Lin et al., 2006). B) 
Rescue cells were transduced with the GAG2.22 -EGFP reporter as described in Figure 2.9 
and the silencing of the reporter was monitored two days after transduction using FACS. 
All Daxx constructs except the C-Terminal truncation mutant were able to rescue the 
silencing defect. The barplot represents an average of three experiments performed for 
the E231A and the R257A rescue cells and six experiments of the other cell lines. Error 
bars indicate the standard deviation.  C) Daxx expression levels in the stable rescue cell  
lines indicating a strong overexpression of the transgene. α -tubulin was used as a 
loading control.  
2.20. Association of Daxx with H3.3 is dependent on arginine 257 and the Daxx 
C-terminus 
Daxx mutants carrying mutations in arginine 257 or glutamate 231 can rescue the silencing 
defect of Daxx knockout cells in reporter gene assays (Figure 2.19). This indicates that 
binding to H3.3 or binding specificity for H3.3 are both dispensable for the repressive function 
of Daxx. However, the finding that these two mutations affect histone H3.3 binding and 
binding specificity to H3.3 originates from analysis of human Daxx and crystallization 
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experiments of N-terminal Daxx truncations (Elsasser et al., 2012). Therefore, co-
immunoprecipitations were carried out to verify, whether the generated mutations of the 
mouse Daxx protein really affect H3.3 binding.  
 
Figure 2.20 Association of Daxx with H3.3 is dependent on arginine 257 and the Daxx C -
terminus  
A) 3xFLAG/HA tagged wild type Daxx and Daxx mutants were stably transduced into wild 
type mES cells and nuclear extracts were used for FLAG-IP. B) Western blot showing the 
expression levels of the overexpressed proteins. The silver staining serves as a loa ding 
control. C) High amounts of Daxx protein can be immunoprecipitated by FLAG -IP. H3.3 
only co-precipitates with wild type Daxx and the glutamate 231 to alanine mutant. H3.3 
can also be seen as faint bands in the silver staining of the IP.  
I generated wild type cell lines that overexpressed wild type 3xFLAG/HA-tagged Daxx or 
different Daxx mutants (Figure 2.20A). FLAG-CoIPs with these different Daxx overexpression 
cell lines were performed and histone H3.3 binding was analyzed via western blotting and 
silver staining. Even though Daxx mutants were slightly differently expressed in the individual 
cell lines (Figure 2.20B), similar amounts could be bound to FLAG-agarose beads, as 
estimated from the amount of bound Daxx protein via silver staining (Figure 2.20C). 
However, only wild type Daxx and Daxx E231A showed binding to histone H3.3 
(Figure 2.20C). Please note that the binding of histone H3.3 is slightly reduced in the Daxx 
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E231A mutant. This is consistent with a loss of binding selectivity for histone H3.3 over 
histone H3.1 in this mutant (Elsasser et al., 2012). Interestingly, the C-terminal truncation of 
Daxx lacking the Sumo-interaction motif, is also defective in histone H3.3-binding 
(Figure 2.20C). 
In summary, the histone H3.3-binding mutant of Daxx (R257A) and Daxx lacking the C-
terminal Sumo-interaction motif fail to bind to histone H3.3 in vitro. The Daxx mutant that has 
been shown to affect H3.3-binding selectivity of Daxx (E231A) shows slightly reduced H3.3-
binding.  
2.21. H3.3 depleted cells show no change in GAG2.22 reporter gene silencing 
Daxx mutants which do not bind to histone H3.3 or which are not selective for H3.3-binding 
rescued the reporter gene silencing defect of Daxx knockout cells (Figure 2.20, Figure 2.19). 
This suggests that histone H3.3-binding by Daxx is not required for Daxx to act as a co-
repressor on IAP-GAG-EGFP reporter genes. However, the molecular function of Daxx has 
recently been described as being a histone H3.3 chaperone and impaired binding of H3.3 in 
vitro does not imply that H3.3 is not an important factor for the repressive activity of Daxx in 
vivo.  
Histone H3.3 deficient mES cells were generated to investigate whether incorporation of 
histone H3.3 has indeed no influence on IAP-GAG reporter gene silencing. The histone H3.3 
protein is encoded by two independent autosomal loci in mice, H3f3a and H3f3b. 
Furthermore the mouse genome contains a large number of promoter-less retrotransposed 
copies of the histone H3f3a gene, that in many cases carry point mutations.  
Depletion of H3.3 from mES cells was carried out in two consecutive steps. 
Figure 2.21 H3.3 depleted cells show no change in GAG2.22 reporter gene silen cing 
A) Generation of H3.3 depleted cells. In mice H3.3 is encoded by two genes H3f3a  and 
H3f3b . In addition the mouse genome encodes additional retrotransposed copies of H3f3a 
that lack promoter sequences and frequently carry point mutations. H3f3b  was deleted in 
the cells by transfection of a CRISPR/Cas9 plasmid targeting the 5’ region of the H3f3b  
open reading frame to generate frameshift mutations on both alleles. Mutated cell clones 
were identified by showing a strong reduction of H3f3b  mRNA-level using RT-qPCR most 
likely due to frameshift mutations resulting in non-sense-mediated mRNA decay (data not 
shown). H3f3b  knockout cell clones were then either transfected with two CRISPR/Cas9 
plasmids removing the first coding exon of the gene or transd uced with an shRNA 
targeting H3f3a .  B) H3.3 protein levels are massively reduced upon mutating H3f3b  and 
H3f3a  using CRISPR/Cas9 genome editing. Alpha-tubulin serves as a loading control.  C) 
H3f3a/b  double knockout and H3f3b  single knockout cells show no defect in silencing the 
GAG2.22-EGFP reporter gene. The silencing assay was carried out as described in 
Figure 2.9. The number of different cell lines used for the analysis is indicated below the 
barplot. Error bars indicate the standard deviation. D) Weste rn blot showing H3.3 
depletion upon lentiviral knockdown of H3f3a  in H3f3b  knockout cells. α -tubulin serves as 
a loading control. E) The barplot shows the same experiment as described in C) except for 
using H3f3b  knockout cells after H3f3a  knockdown. Again, no strong derepression of the 
IAP-GAG2.22-EGFP reporter could be observed in H3.3 depleted cells . 
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First, the H3f3b locus was mutated via RNA-guided nucleases (Figure 2.21A). Cell clones 
carrying mutations on both H3f3b alleles were identified by a strong reduction of H3f3b 
mRNA, most likely occurring through non-sense-mediated RNA decay (data not shown). 
Next, H3f3b knockout cell lines were used to either mutate the H3f3a gene locus or to 
knockdown H3f3a transcripts via lentiviral shRNAs (Figure 2.21A). Mutating the H3f3a ORF 
using RNA-guided nucleases was not possible, due to a high number of homologues 
retrotransposed copies of H3f3a in the mouse genome. Therefore, the first coding exon of 
H3f3a was completely removed by two RNA-guided nucleases targeting the flanking introns 
of this exon. Depletion of H3.3 protein in H3f3b knockout cells either by RNA-guided 
nucleases or by RNAi was monitored using western blot (Figure 2.21B and D). However, a 
very small signal of H3.3 protein was still detectable in these cells, probably due to weak 
expression of retrotransposed H3f3a copies, insufficient specificity of the H3.3 antibody or 
incomplete knockdown (Figure 2.21B and D). Importantly, even though H3.3 protein level 
was largely reduced in these cells, no change on reporter gene silencing of the GAG2.22-
EGFP reporter could be observed (Figure 2.21C and E).  
In summary, depletion of histone H3.3 protein from mES cells has no influence on silencing 
the GAG2.22-EGFP reporter cassettes that mimics IAP retrotransposon silencing. This 
finding is consistent with the observation that Daxx mutants deficient in H3.3-binding can still 
rescue the silencing defect of Daxx knockout cells (Figure 2.19).  
2.22. Atrx is important for efficient Trim28- and Setdb1-dependent silencing at 
endogenous IAP elements 
Trim28 and Setdb1 depletion leads to a strong derepression of endogenous retroviral 
elements including IAP retrotransposons (Matsui et al., 2010; Rowe et al., 2010). Silencing of 
IAP retrotransposons originates to a great extent from the GAG2.22 sequence element 
(Figure 2.8, Figure 2.10). A generated lentiviral reporter system based on reporter gene 
silencing of this IAP-GAG sequence element phenocopies important properties of 
endogenous IAP silencing, including Setdb1- and Trim28-dependency and restriction of the 
silencing to embryonic stem cells. In addition, I found Atrx and Daxx to catalyze the silencing 
of the GAG2.22-EGFP reporter within a short time-frame (Figure 2.14, Figure 2.18). 
However, it is unknown, whether Atrx or Daxx deficiency also leads to derepression of 
endogenous IAP elements.  
Therefore, endogenous IAP expression of Atrx and Daxx knockout cells was analyzed via 
RT-qPCR. IAP expression was not found to be deregulated in these cells, indicating that Atrx 
and Daxx are dispensable for the maintenance of silencing of these elements (Figure 2.22A). 
However, GAG2.22 reporter experiments in vitro suggested that the main function of Atrx 
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and Daxx is to catalyze the silencing process (Figure 2.15 and Figure 2.18). This argues that 
they are not absolutely required for the silencing process but are important for a high 
silencing efficiency. Thus, I sought to analyze transcript levels of IAP retrotransposons upon 
knockdown of Trim28 to test whether an impaired silencing efficiency at IAP 
retrotransposons can be observed when Atrx is depleted. 
Atrx knockout mES cells show a higher derepression of endogenous IAP retrotransposons 
than wild type cells when Trim28 is depleted (Figure 2.22B). This suggests that Atrx might 
indeed catalyze heterochromatic gene silencing. Similarly, treating the cells with 5-
azacytidine, a compound that is known to inhibit DNA methylation and to increase DNA 
damage at DNA-methylated regions (Christman, 2002), leads to a stronger upregulation of 
endogenous IAP transcripts in Atrx depleted cells (Figure2.22C). 
 
This suggests that endogenous IAP elements are more sensitive to inhibition of 
DNA-methylation by DNA damage-inducing agents in Atrx knockout cells. Interestingly, also 
silencing of the GAG-EGFP reporter is further impaired in Atrx knockout cells, when Trim28 
or Setdb1 are depleted (Figure 2.22D). This indicates that the rate-limiting concentration of 
Setdb1 and Trim28 required for efficient reporter gene repression is higher in Atrx knockout 
cells.  
In summary, Atrx seems to increase the efficiency of Trim28- and Setdb1-dependent 
silencing at endogenous IAP elements and exogenous reporters. This implies that Atrx 
depletion leads to higher plasticity of heterochromatin. 
2.23. Atrx depletion leads to a higher heterochromatin plasticity when 
heterochromatin is challenged by activating factors  
If Atrx increases the efficiency of Trim28- and Setdb1-dependent heterochromatic silencing, 
Trim28- and Setdb1-dependent heterochromatin will have a higher plasticity in the absence 
of Atrx. Higher heterochromatin plasticity might result in an easier destabilization of 
heterochromatin, if strong activating factors or transcription challenge the heterochromatic 
state. 
I induced strong transcription over the heterochromatinized reporter locus generated in 
Figure 2.10 to test whether Atrx is required when strong activating factors and transcription 
challenge the heterochromatic state (Figure 2.23A). For this, a reverse tet-transactivator was 
stably introduced into the cells carrying an EGFP-GAG2.22 locus under the control of an 
inactive tet-response element (Figure 2.10). Transcription at this reporter locus was induced  
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Figure 2.22 Atrx  is important for efficient Trim28- and Setdb1-dependent silencing at 
endogenous IAP elements   
A) Endogenous IAP expression levels are not changed in Daxx  or Atrx  knockout cells. 
RNA of wild type, Daxx  and Atrx  knockout mouse ES cells was reverse transcribed and 
IAP expression was analyzed using qRT-PCR. The barplot represents the average of three 
to eight biological replicates (wild type n=6, Atrx ko n=8, Daxx ko n=3). Error bars 
represent the standard deviation. B) Trim28  depletion leads to a stronger upregulation of 
endogenous IAP transcripts in Atrx  knockout cells. Wild type and Atrx  knockout mES cells 
were transduced with shRNAs against Trim28  and endogenous IAP transcripts were 
analyzed as described in A). The barplot represents three experiments using three 
different shRNAs against Trim28. Error bars indicate the standard error of the mean.  C) 
Atrx  knockout cells show higher upregulation of endogenous IAP elements upon 
treatment with 5-azacytidine. Cells were treated for 24 h with 7µM 5 -azacytidine or DMSO 
as a control. Endogenous IAP expression was measured using RT-qPCR. Upregulation of 
endogenous IAP transcripts upon 5-azacytidine treatment was compared to DMSO treated 
cells. Error bars indicate the standard error of the mean. Wild type samples n=4, Atrx  
knockout samples n=8 Unpaired two-sided t-test p-value = 0,017 D) Trim28  and Setdb1  
depletion leads to an increased silencing defect in Atrx  knockout cells. Wild typed and 
Atrx  knockout mES cells were transduced with shRNAs against Trim28 , Setdb1  and a 
scrambled control sequence.  Four days after shRNA transduction the cells were 
transduced with the GAG2.22-EGFP reporter virus. Silencing potential of the GAG2.22 
sequence was analyzed in FACS as described in Figure 2.9. The plot corresponds to three 
independent experiments. Error bars represent the s tandard deviation. The experiment in 
D) has been carried out by Katharina Schmidt (Schmidt, 2014). 
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by adding 1 µg/ml doxycyclin and activation of the reporter gene was monitored by EGFP 
expression. In addition, cells were treated with shRNAs targeting Atrx or a non-silencing 
scrambled control shRNA. Only few control knockdown cells (< 5 %) could reactivate the 
reporter gene upon doxycyclin addition, probably due to its heterochromatinization 
(Figure 2.23B and Figure 2.10B). However, a much higher number of cells could reactivate 
the reporter locus in Atrx knockdown cells (Figure 2.23B). 
In summary, a heterochromatinized reporter locus can be easier reactivated by 
transactivating factors when Atrx is depleted from the cells. This suggests that, Atrx is 
important to ensure low heterochromatin plasticity.  
 
Figure 2.23 Atrx depletion leads to a higher heterochromatin plasti city when 
heterochromatin is challenged by activating factors   
A) HA36 mouse ES cells carrying a stable integration of an inducible EGFP -GAG2.22 
cassette were stably transduced with a doxycyclin -dependent reverse tet-transactivator 
that allows the induction of transcription over the EGFP-GAG2.22 cassette (also see 
Figure 2.10). B) Atrx depleted cells show a much stronger reactivation of the 
heterochromatinized EGFP-GAG2.22 cassette. Cells were either transduced with an shRNA 
targeting Atrx or an shRNA targeting a scrambled control sequence. Four days after 
shRNA transduction, the transcription over the EGFP-GAG2.22 transgene was induced 
using 1 µg/ml doxycycline and the EGFP expression of the cells was monitored using 
FACS. The plot represents an average of three experiments (for day six n=2). Error bars 
represent the standard deviation.  
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2.24. Trim28 is associated with Atrx and other known heterochromatin proteins 
Trim28 and Setdb1 are required for silencing of IAP retrotransposons and the GAG2.22-
EGFP reporter gene ((Matsui et al., 2010; Rowe et al., 2010), Figure 2.9, Figure 2.11). In this 
thesis it was found, that depletion of Atrx and Daxx decelerates heterochromatic silencing of 
a GAG2.22-EGFP reporter gene that mirrors many aspects of endogenous IAP silencing 
(Figure 2.14, Figure 2.18). In addition, Atrx ensures low heterochromatin plasticity at 
endogenous IAP retrotransposon sequences and reporter loci (Figure 2.22, Figure 2.23). 
Yet, how Atrx or Daxx cooperate with Trim28 or Setdb1 on protein level to ensure rapid 
heterochromatic silencing is unknown and it is very likely that additional proteins are involved 
in this process. Since Trim28 is probably a factor that acts in the initiation of heterochromatic 
silencing, I wondered which proteins interact with Trim28. Hence, Trim28-interacting proteins 
might be involved in the silencing process of IAP retrotransposons. Moreover, Trim28 
associates with KRAB zinc finger proteins, a large family of mammalian transcription factors, 
which are capable of directly recruiting Trim28 to genomic regions (Bellefroid et al., 1991; 
Friedman et al., 1996; Kim et al., 1996; Moosmann et al., 1996; Schultz et al., 2001). 
Consequently, a KRAB Zinc finger protein or other Trim28-associated proteins might be 
involved in recognition of the GAG2.22 sequence of IAP retrotransposons. Therefore, I 
screened for proteins associated with Trim28 using co-immunoprecipitation experiments 
followed by mass-spectrometry analysis.  
First, mouse cell lines were generated which overexpress 3xFLAG/HA-tagged Trim28 or the 
N-terminal RBCC domain of Trim28 (Figure 2.24A). This was done, to achieve a higher 
amount of immunoprecipitated material for mass-spectrometry. 
Figure 2.24 Trim28 is associated with Atrx and other known heterochromatin proteins  
A) Experimental design of the Trim28 pull-down experiment. Mouse ES cells and mouse 
embryonic fibroblasts where stably t ransduced with lentiviral vectors encoding either 
triple FLAG/HA-tagged Trim28 or a truncation of Trim28 encoding the N -terminal RBCC 
domain (aa1-480). Stable cell lines where harvested for FLAG -co-immunoprecipitation and 
Trim28-associated proteins were identified using liquid chromatography coupled tandem -
mass spectrometry (LC-MS/MS). B) Silver staining of SDS-PAGE gel showing eluted 
proteins after FLAG-immunoprecipitation. The prominent bands at 55 and 20 kDa 
correspond to the FLAG-antibody chains. The wild type sample in the first lane contains 
no FLAG-tagged protein and serves as a negative control for proteins nonspecifically 
associated to the FLAG-beads. The RBCC domain (aa1-480) of Trim28 co-precipitates the 
endogenous full-length Trim28 protein (second lane). Trim28 protein is strongly stained at 
110 kDa (indicated on the right of the gel). C) Heatmap showing the 50 proteins most 
prominently associated with Trim28. The number of peptides were identified using 
Scaffold3™. Proteins were sorted by the di fference of the average number of identified 
peptides among all three IPs compared to the wild type control IP.  The Uniprot-ID of the 
strongest hit “TIF1B_MOUSE” corresponds to Trim28 protein and that Atrx is i dentified as 
a Trim28-interacting protein. The complete l ist of Trim28-interacting proteins can be 
found in the appendix. The mass-spectrometry after in-gel digestion and the peptide 
search using Scaffold3™ were performed by Dr. Ignasi Forné. D) Hits from the genetic 
GAG2/mES IAP silencing screen were analyzed for Trim28-associated proteins. In total 44 
proteins were found of which 35 are not mitochondrial or ribosomal proteins.  
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Proteins associated with 3xFLAG/HA-Trim28 were eluted from FLAG-beads after IP with 
SDS loading buffer and separated on an SDS page for silver staining (Figure 2.24B). Please 
note that endogenous Trim28 full-length protein seems to co-precipitate with the FLAG-
tagged N-terminal Trim28-RBCC domain (Figure 2.24B).This is consistent with previous 
reports that show Trim28 oligomerization (Peng et al., 2000a; Peng et al., 2000b; Peng et al., 
2002). The full lane of separated proteins was cut into eight gel pieces. Proteins inside the 
gel-fragments were treated with DTT, cysteine residues were alkylated using iodoacetamide 
and proteins were in-gel digested using trypsin before mass-spectrometry. Peptides were 
identified using Scaffold3™ software. 
A lot of known Trim28-binding proteins were consistently found to be associated in the 
immunoprecipitation experiments (Figure 2.24C), including Atrx, Hp1 proteins and KRAB 
domain containing proteins like Zfp57 (Quenneville et al., 2011; Ryan et al., 1999) 
(Figure 2.24). Most of them were associated in MEF and mouse ES cells (Figure 2.24C). The 
full list can be found in the Appendix.  
Identification of Trim28-associated proteins could confirm known Trim28-interaction partners 
and could identify novel proteins that might be functionally involved in Trim28-dependent 
silencing. Which of these proteins is functionally involved in Trim28-dependent silencing is 
unclear and might be a basis for future experiments. Candidate proteins could be hits that 
were identified in the genetic screening experiments and which are physically associated 
with Trim28 protein (Figure 2.24D). However, since the number of (false positive) hits 
identified in the genetic screen is presumably quite high and mass-spectrometry experiments 
usually suffer from a high number of false negative hits, additional experiments and 
secondary screens might further increase the confidence of the identified hits.  
2.25. DNA pull-down experiment for GAG2.22-binding proteins using SILAC 
Please note that the DNA pull-down experiments and the SILAC mass-spectrometry 
screening in this chapter have been performed by Dr. Falk Butter, who collaborated with me 
in this project.  
GAG2.22, a 160 bp fragment of the GAG region of IAP retrotransposons silences EGFP 
reporter genes in mES cells (Figure 2.8, Figure 2.9). Reporter assays using the GAG2.22 
sequence element could phenocopy properties of endogenous IAP retrotransposon silencing 
including Trim28- and Setdb1-dependency (Figure 2.9, Figure 2.11). Moreover, GAG2.22 
reporter assays have been useful to identify novel players involved in IAP retrotransposon 
silencing like Daxx and Atrx (Figure 2.14, Figure 2.18). However, the way the GAG2.22 
sequence is only recognized and silenced in mES cells is still elusive. Trim28-associated 
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proteins have been analyzed to identify factors that might be functionally important for 
silencing (Figure 2.24). Yet, this proteomic screen does not give any specific information 
which is the recognition factor for the GAG2.22 sequence.  
A DNA pull-down assay was performed using the GAG2.22 sequence and control sequences 
to identify DNA-binding proteins that can specifically bind to the GAG2.22 sequence. Mouse 
ES cells grown in medium containing arginine and lysine either labeled with light or heavy 
isotopes were used to generate nuclear extracts. “Heavy” nuclear extracts were used for a 
DNA pull-down experiment using the GAG2.22 sequence and “light” nuclear extracts were 
used for a DNA pull-down experiment using the control sequence (Butter et al., 2010) 
(Figure 2.25A). Eluted proteins were pooled, trypsinized and the mass-ratios of the identified 
peptides were used to identify proteins specifically binding to one of the sequences 
(Figure 2.25A). The experiment was also performed by swapping “heavy” and “light” nuclear 
extract to increase the statistical reliability. 
First, feasibility of the approach was tested in a control experiment to verify the known 
binding of the protein Zfp809 to its DNA-binding site. A point mutated Zfp809-binding site 
was used as a negative control sequence. Specific binding of Zfp809 and its associated 
protein Trim28 to the Zfp809-binding site could be detected (Figure 2.25B). This indicated 
that the experimental approach was sensitive and specific enough to unravel Protein-DNA-
interactions at heterochromatic target sequences.  
Next, proteins specifically binding to the GAG2.22 sequence flanked by additional 60 bp 
were identified using a 220 bp fragment of the Spectinomycin-resistance gene as a control 
sequence (Figure 2.25C). Since the number of differently binding proteins was high, a 
second approach was performed, searching for proteins binding to GAG2.22 but not to a 
point mutant sequence (Figure 2.25D). The point mutant sequence was identified by 
Katharina Schmidt (Schmidt, 2014). 
The first approach identified numerous proteins binding to GAG2.22 that are ubiquitously 
expressed or not restricted to mES cells (Figure 2.25C). Since GAG2.22 silencing is limited 
to mES cells, it was not very likely that these proteins are the cell type-specific recognition 
factors for the GAG2.22 sequence. However, the mouse specific KRAB zinc finger protein 
Zfp71-rs1 was also found to bind to the GAG2.22 sequence (Figure 2.25C). In a second 
screening approach were a GAG2.22 point mutant sequence was used as a control, the 
ubiquitous protein Ubtf was the only specifically enriched protein (Figure 2.25D). I generated 
knockdown cell lines for Ubtf and Zfp71-rs1, to verify whether these proteins have a 
functional role in silencing the GAG2.22 sequence element. Silencing of a GAG2.22-EGFP 
reporter gene was not impaired upon knockdown of either Ubtf or Zfp71-rs1 (Figure 2.25E). 
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In summary, DNA pull-downs can work as a powerful tool for identification of DNA-binding 
proteins. However, DNA-binding proteins that specifically recognize the GAG2.22 sequence 
element of IAP retrotransposons in mES cells could not be identified.  
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Figure 2.25 DNA pull-down experiment for GAG2.22-binding proteins using SILAC  
A) Nuclear extracts isolated from mES cells labeled with either heavy or light isotopes are 
incubated with biotinylated DNA fragment immobilized on streptavidin beads. The bound 
proteins are pooled after elution and specific binding to one of the DNA sequences is 
detected by a change in the mass-ratio in mass-spectrometry. As a control the experiment 
is repeated with heavy and light nuclear extract swapped. B) A proof-of-principle 
experiment using a Zfp809-binding site and a control sequence where the binding site was 
mutated identifies Zfp809 and its binding partner Trim28. Enrichment is plotted as heavy 
to light ratio of identified peptides on the x -axis and the y-axis. In the reverse experiment 
the light and the heavy extract were swapped leading to reciprocal values of enrichment 
C) A slightly bigger GAG2.22 sequence (218 bp) was compared to a sequence fragment of 
the spectinomycin resistance gene of equal size  in a first DNA pull -down experiment. Only 
factors in the top left corner are specifically enriched at the GAG2.22 sequence showing a 
heavy to light ratio >1 in the forward experiment and a heavy to light ratio <1 in the 
reverse experiment.  D) The plot shows the result of the second experiment using the 
GAG2.22 sequence (160 bp) and a point mutant sequence as a control.  E) Zfp71 -rs1 was 
identified as a potential protein from experiment 1 for being a mouse-specific protein 
containing a KRAB domain that facilitates binding to Trim28. Ubtf was the only hit in 
experiment 2. Knockdown of either Zfp71-rs1 or Ubtf resulted in no significant changes of 
reporter gene silencing. Knockdown efficiencies on RNA level are indicated and were 
either measured via qRT-PCR or taken from the prevalidated TRC clone collection at 
Sigma Aldrich. The knockdown experiment for Zfp71 -rs1 was performed two times and for 
Ubtf only once. Error bars indicate the standard deviation. SILAC pull-down experiments 
and data analysis was performed by Dr. Falk Butter.   
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3. Discussion 
3.1. The pseudoautosomal exons of midline1 gene are derepressed in male 
Suv39h and Suv4-20h knockout cells  
In this thesis I tried to identify genes that are regulated by heterochromatin proteins to use 
them as reporter systems for monitoring heterochromatin status. I first focused on gene 
expression datasets generated from Suv39h and Suv4-20h knockout cells, because these 
enzymes act together in a consecutive pathway in pericentric heterochromatin formation 
(Schotta et al., 2004; Schotta et al., 2008).  
The X-chromosomal midline1 gene flanks the pseudoautosomal boundary in mouse (Palmer 
et al., 1997), and I found that its pseudoautosomal exons are consistently derepressed in 
Suv39h and Suv4-20h knockout cells (Figure 2.1). These pseudoautosomal midline1 
transcripts only arise in male Suv39h and Suv4-20h knockout cells and are oriented in the 
same direction as the full-length midline1 transcript (Figure 2.2). This suggests that these 
transcripts might originate from the Y-chromosomal pseudoautosomal region.  
Aggravatingly, I could confirm previous studies that indicate a high heterogeneity and 
polymorphic structure of the mouse pseudoautosomal region (Figure 2.2) (Kipling et al., 
1996a; Kipling et al., 1996b; Palmer et al., 1997). This is due to the fact, that the 
pseudoautosomal region in mice is comparably short and crossing over events during male 
meiotic prophase I exclusively take place in this chromosomal region (Perry et al., 2001). 
Even though, the pseudoautosomal exons of midline1 are present in multiple copies in the 
genomes of different cell lines, the strong derepression of these pseudoautosomal exons in 
Suv39h and Suv4-20h knockout cells does not correlate with the copy number of 
pseudoautosomal midline1 exons (Figure 2.2). This indicates that Suv39h and Suv4-20h 
enzymes might indeed have a functional role in repressing transcripts from the 
pseudoautosomal region. In addition, ChIP sequencing studies revealed that the 
pseudoautosomal region is enriched for H3K9me3 and H4K20me3 in mouse ES cells 
(Figure 2.1) (Mikkelsen et al., 2007). Thus, the observed derepression of the 
pseudoautosomal midline1 transcripts might be a consequence of an impaired 
heterochromatin structure of the Y-chromosome. The pseudoautosomal midline1 transcripts 
might originate from spurious promoter sequences of the Y-chromosome that are normally 
silenced by Suv39h and Suv4-20h enzymes. The mouse Y-chromosome is also highly 
repetitive and enriched for H3K9-methylation, suggesting that H3K9me3 could be involved in 
repressing Y-chromosomal transcription (Peters et al., 2002). 
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Moreover, the pseudoautosomal region is evolutionary selected to facilitate recombination 
during male meiosis and its repetitive nature might require a dense heterochromatin structure 
to avoid recombination events in somatic cells. Interestingly, already in the early 20th century 
it was found that centromeric or pericentromeric DNA regions repress recombination events, 
and it was proposed that heterochromatin plays a role in repression of recombination 
(Beadle, 1932; Mahtani and Willard, 1998; Mather, 1939). Quantitative analysis of 
recombination events in Drosophila also indicate that impairment of the heterochromatin 
status directly increases the rate of recombination events at heterochromatic regions 
(Westphal and Reuter, 2002).  
Apart from midline1 no other genes were strongly and consistently deregulated in Suv39h 
and Suv4-20h knockout cells. This indicates that Suv39h and Suv4-20h might only play a 
minor role in gene regulation even though they have important roles in pericentric and 
telomeric chromatin (introduction 1.1.2). Consistently, Suv39h knockout cells show only 
slightly reduced levels of H3K9me3 outside of heterochromatin (Bulut-Karslioglu et al., 2012). 
However, Suv4-20h enzymes are involved in non-coding RNA-mediated repression of 
ribosomal DNA repeats and retrotransposon sequences (personal communication Prof. 
Ingrid Grummt – article in press), underlining that a direct role of Suv4-20h enzymes in 
transcriptional regulation cannot be ruled out.  
Due to constant recombination events in male meiosis the pseudoautosomal region is 
extremely diverse between different mammalian species, which suggests that sequence-
dependent features are not important for the general function of the pseudoautosomal region 
(Helena Mangs and Morris, 2007). In contrast to the short pseudoautosomal region in mice, 
human sex-chromosomes, for example, contain two pseudoautosomal regions, which 
encode almost 20 genes (Helena Mangs and Morris, 2007). How chromatin regulation is 
involved in the function of the pseudoautosomal region and consequently mammalian 
speciation will be an interesting topic in future research.  
3.2. Setdb1, Trim28, Prdm6 and Hp1 proteins are transcriptional repressors 
To identify heterochromatin proteins that can directly influence gene expression, I cloned a 
candidate-library of heterochromatin-associated proteins into a Gal4/UAS reporter system. I 
found that Hp1 proteins (Cbx1, Cbx3 and Cbx5), Setdb1, Trim28 and Prdm6 can strongly 
repress transcription from the constitutively active mouse PGK promoter (Figure 2.3). 
Setdb1, Trim28 and Hp1 proteins are known to collaborate in transcriptional silencing and to 
recruit each other when tethered at reporter gene loci (1.3.1. and 1.3.2.) (Ayyanathan et al., 
2003; Hathaway et al., 2012; Schultz et al., 2002; Sripathy et al., 2006). 
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Prdm6 has not been implicated into Setdb1- or Trim28-dependent processes, but has been 
described to be a tissue-specific repressor that is required for mouse development, for the 
development and function of the vascular system and for neurogenesis (Davis et al., 2006; 
Gewies et al., 2013; Kinameri et al., 2008; Wu et al., 2008). Prdm6 also has a SET-domain, 
which has been described to have no detectable methyltransferase activity (Davis et al., 
2006). However, others have found that immunopurified Prdm6 shows H4K20-methylation 
activity in vitro (Wu et al., 2008). Interestingly, Prdm6 has also been found to associate with 
Hp1 proteins (Davis et al., 2006), which could explain its ability to repress reporter gene 
transcription (Figure 2.3). In addition, Hp1 has been found to bind to Suv4-20h H4K20-
methyltransferases (Schotta et al., 2004), which would suggest that the observed H4K20me-
activity of immunoprecipitated Prdm6 by Wu et al. is indirectly mediated by co-precipitating 
Suv4-20h enzymes (Wu et al., 2008). 
However, I could not identify a strong silencing effect for other Hp1-associated proteins like 
Suv4-20h or Suv39h enzymes in luciferase assays (Figure 2.3). This was surprising, 
because Su(var)3-9, the Drosophila homologue of Suv39h, is a potent repressor in luciferase 
assays (Boeke et al., 2010). However, the repressive activity of Su(var)3-9 seems to be 
largely dependent on the co-recruitment of histone deacetylases rather than the SET-domain 
activity of Su(var)3-9 (Boeke et al., 2010). Possibly, not all heterochromatin proteins are 
capable of silencing the PGK promoter. Promoter-specific effects might therefore mask the 
transcriptional silencing potential of individual H3K9me3-associated proteins.  
3.3. Establishment of an ecotropic, lentiviral EGFP-based silencing assay 
utilizing a binding site for Zfp809. 
In this study, I established an EGFP-based silencing reporter assay which is stably 
integrated into the genome using ecotropic lentiviruses (Figure 2.4, 2.5 and 2.6). Similar 
systems have been generated earlier to monitor EGFP silencing by cis-acting DNA elements 
(Haas et al., 2003; Rowe et al., 2010). Stably integrated EGFP transgenes have also widely 
been used in chromatin research to study reporter silencing with single cell resolution (Akhtar 
et al., 2013; Ashe et al., 2008; Daxinger et al., 2013; Hathaway et al., 2012). 
I picked EGFP as a reporter gene due to the brightness of fluorescence of the EGFP protein 
and its technical compatibility with available FACS devices, even though it is a poor choice 
for a silencing reporter due to its long half-live of 26 h (Corish and Tyler-Smith, 1999). 
However, in my assays the lentiviral EGFP transgene is silenced before full expression of the 
EGFP transgene is reached, which prevents an accumulation of large amounts of stable 
EGFP protein inside the cells (Figure 2.6). An improvement of the EGFP reporter system 
could be the use of fast-degrading EGFP-derivatives even though the lowered half-life of 
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these variants is accompanied with a fundamental decrease of detectable fluorescence 
(Corish and Tyler-Smith, 1999). Alternatively, td-tomato reporter genes have successfully 
been used by others to monitor fast fluctuations of reporter gene expression (Macfarlan et 
al., 2012).  
In experiments were I triggered transcriptional silencing by using three Zfp809-binding sites, I 
found that silencing of the lentiviral reporter occurred within 12 to 24 h (Figure 2.6). Yet, it is 
unclear, whether the lentiviral EGFP reporter containing the silencing sequence is expressed 
at all after integration in the genome, because the small amount of EGFP-fluorescence 
arising shortly after transduction could as well originate from non-integrated viral RNA. Gene 
expression from non-integrated lentiviral RNA is well analyzed in integrase-defective lentiviral 
vector systems (Nightingale et al., 2006). In summary, this suggests that heterochromatic 
silencing of the reporter could occur even in the first twelve hours after transduction or 
immediately after proviral integration. Consequently, epigenetic retrotransposon-defense 
mechanisms might require the rapid silencing of newly integrated retrotransposon copies 
before they can give rise to further retroviral transcripts and retrotransposition events.  
3.4 The GAG region of IAP-Ez retrotransposons contains a 160 bp sequence 
(GAG2.22) that silences strong constitutive promoters in mouse ES cells, but 
does not recruit a DNA-binding factor in DNA pull-downs in vitro. 
In previous studies it was shown that the UTR region of mouse IAP retrotransposons 
silences neighboring promoters in lentiviral reporter assays (Rowe et al., 2010). I tried to 
verify this finding by checking whether my lentiviral vector system can detect silencing 
activities of these IAP retrotransposon sequences. Indeed, I could not only detect a silencing 
activity of the UTR sequence, but also found a novel, stronger silencing activity inside the 
GAG sequence of the IAP element (Figure 2.8). This sequence element could be narrowed 
down to a size of 160 bp, which are sufficient for silencing of strong constitutively active 
promoters like the PGK and the EF1α promoter (Figure 2.9).  
Interestingly, removing larger parts of the 160 bp GAG2.22 silencing sequence at its 5’ or 3’ 
end or removing internal sequences resulted in a severe reduction of silencing activity 
(experiments performed by Katharina Schmidt - data not shown) (Schmidt, 2014). Presuming 
that the DNA sequence of the GAG2.22 sequence is recognized by DNA-binding proteins to 
facilitate transcriptional repression, the DNA-binding site is either unusually long or it is 
bound by multiple DNA-binding factors that cooperate in transcriptional repression. Due to 
the intrinsic symmetry of the DNA double strand, many sequence-specific DNA-binding 
factors bind to palindromic sequences. Searching for palindromic sequences inside the 
GAG2.22 sequence identifies only few, very short palindromes (http://www.alagu-molbio.net/) 
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(Figure 3.1A). However, assuming that a dimer of DNA-binding proteins might also recognize 
binding sites on the sense and antisense strand that are more divergent, I aligned the 
GAG2.22 sequence with its reverse complement sequence using the YASS alignment 
software and the LALIGN algorithm (Huang and Miller, 1991; Noe and Kucherov, 2005). 
Interestingly, the GAG2.22 sequence contains two independent partially palindromic 
sequences (Figure 3.1B). These hypothetical transcription factor binding sites are separated 
by a spacer of 53 bp and consequently cover a region from nucleotide 9 to 142 of GAG2.22 
(Figure 3.1B and C). It might therefore be possible that two independent transcription factors 
recognize and target the GAG2.22 sequence for silencing (Figure 3.1C). If this binding model 
was true, why should evolution select for two recognition motifs in such a short sequence? 
The use of two repressor binding sites probably generates a more robust system, because 
mutations of the GAG2.22 sequence would not easily result in a failure of repression. 
Consistently, we have found that silencing is strongly decreased but not lost when the 
GAG2.22 sequence is shortened at the 5’ and the 3’ end (experiments performed by 
Katharina Schmidt - data not shown) (Schmidt, 2014). In addition, the use of two repressor 
binding sites might also guarantee a higher specificity of binding for the silencing machinery. 
This might avoid “off-target” effects at other regions of the genome that could be disastrous 
for the organism. 
We tried to identify DNA-binding factors that are recruited to GAG2.22 using DNA pull-down 
experiments followed by SILAC mass spectrometry in collaboration with Dr. Falk Butter 
(Figure 2.25). Even though binding of Zfp809 and its associated protein Trim28 to its known 
DNA-binding site could easily be detected, we were not able to identify a specific binding of a 
repressive GAG2.22-binding protein (Figure 2.25). A protein that was found to be enriched at 
the GAG2.22 sequence compared to a point mutant sequence was Ubtf (Figure 2.25), a very 
abundant protein involved in rRNA transcription. Depletion of Ubtf did not lead to a relief of 
GAG-silencing, suggesting that it might bind to the GAG2.22 sequence but is not involved in 
transcriptional repression (Figure 2.25). The failure of identifying specific hits by DNA pull-
down experiments could be either explained in the way that the GAG2.22-recognizing protein 
cannot be identified with the used approach or by the fact that the GAG2.22 sequence is 
recognized by a much more complex mechanism. Indeed, if two independent GAG2.22-
binding proteins are important for GAG2.22 recognition, these proteins will interact and result 
in a complex rearrangement of the DNA like looping or compaction. The formation of such a 
higher order repressor complex might be highly unfavorable in vitro and might not occur on 
immobilized linear DNA. The existence of such a repressor complex at the GAG2.22 
sequence could also explain that the GAG2.22 sequence is slightly depleted of histones and 
histone modifications in ChIP-sequencing data (Figure 2.16A and data not shown). Future 
experiments using GAG2.22-sequences mutated in the proposed repressor-binding 
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sequences will test the proposed binding-model. Concatemers of the isolated individual 
binding-sites in DNA pull-downs might also generate a higher affinity for the isolation of the 
individual transcription factors.  
 
Figure 3.1 Analysis of the GAG2.22 sequence and a hypothetical binding model of 
GAG2.22 recognition   
A) A search for palindromes (highlighted in capital letters) inside the GAG2.22 sequence 
does not reveal long palindromic sequences. B) Alignment plots of the forward and 
reverse complement strand of GAG2.22 (in 5’ to 3’ direction) reveal two symmetric and 
partially palindromic sequences that might be potential repressor binding sites. C) A 
hypothetical binding model: Two transcription factor dimers might be involved in 
recognition of the GAG2.22 sequence to ensure that silencing specifically occurs on IAP 
elements. D) CpG dinucleotides are highlighted in yellow inside the GAG2.22 sequence. 
Hypothetical repressor binding sites are indicated in red and blue. All  sequences in this 
figure are shown in 5’ to 3’ direction.  
On the other hand, transcriptional repression of transposons in plants has been described to 
occur via complex RNA-dependent mechanisms (Law and Jacobsen, 2010). A possible 
explanation why we could not identify a binding protein for the GAG2.22 sequence might 
therefore be that the GAG2.22 sequence is only triggering epigenetic silencing when 
transcribed into RNA. Yet, the GAG2.22 sequence is upstream of the promoter sequence in 
the cloned reporter vectors and might not be transcribed at all. Conversely, most active 
promoters produce low abundant antisense transcripts that may still be sufficient for the 
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recruitment of silencing factors (Core et al., 2008; Djebali et al., 2012; Seila et al., 2008). 
However, the IAP-UTR and IAP-GAG sequence are both capable of silencing adjacent 
promoters even when they are cloned in antisense direction, which strongly argues against 
an RNA-directed mechanism (data not shown) (Rowe et al., 2010). 
An interesting observation is the high density of CpG-dinucleotides inside the GAG2.22 
sequence which are normally underrepresented in mammalian genomes due to mutagenic 
effects of CpG methylation (Figure 3.1D) (Shen et al., 1992). These CpG dinucleotides 
partially overlap with the hypothetical binding sites described above (Figure 3.1D). 
Methylation of cytosines inside CpG dinucleotides is one of the major repression 
mechanisms of endogenous retroviruses in later stages of development (reviewed in chapter 
1.2.2.) and IAP elements are heavily DNA methylated throughout development (Figure 2.17). 
Therefore, it is possible that the accumulation of CpG dinucleotides inside the GAG2.22 
sequence also has a role during the initiation of silencing and recognition of the GAG2.22 
sequence. Recently it was shown that transcription factor binding and CpG-density are 
important regulators for the establishment of a repressive chromatin state by 
DNA-methylation enzymes in mouse ES cells (Lienert et al., 2011b). Therefore, recognition 
of the GAG2.22 sequence might also involve the detection of unmethylated CpG 
dinucleotides.  
3.5. The GAG2.22 sequence silences reporter genes in a Setdb1- and Trim28-
dependent manner and autonomously recruits H3K9me3. 
Knockdown of Trim28 leads to an impairment of GAG2.22-mediated silencing (Figure 2.11). 
Trim28 has been extensively characterized as an epigenetic master regulator that is 
recruited via KRAB domain zinc finger proteins (Iyengar and Farnham, 2011). Strikingly, the 
KRAB domain zinc finger protein family shows a coevolution with endogenous retroviruses 
and contains many mouse-specific proteins (Thomas and Schneider, 2011). Consequently, it 
is very likely that mouse-specific KRAB domain zinc finger proteins are responsible for 
GAG2.22-dependent transcriptional repression in mouse ES cells. Many KRAB domain 
proteins are specifically expressed in mouse ES-cells (Corsinotti et al., 2013), and testing 
these proteins for their ability to repress GAG2.22 might be a promising approach to identify 
the mouse-IAP retrotransposon silencing factor in the future. Therefore, I grouped these 
KRAB zinc fingers for their average expression in mouse ES cells relative to their expression 
in MEFs based on a previous study (Corsinotti et al., 2013) (Figure 3.2).  
In addition to Trim28, I also found that Setdb1 is important for GAG2.22-mediated repression 
(Figure 2.9). Setdb1 and Trim28 have both been shown to be master regulators of 
endogenous IAP elements and other endogenous retroviruses in mouse ES cells (Karimi et 
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al., 2011; Matsui et al., 2010; Rowe et al., 2010). Setdb1 has been extensively characterized 
to be recruited by Trim28 in a sumoylation-dependent manner and is most likely the enzyme 
that induces H3K9me3 at Trim28 target sites (Ivanov et al., 2007) (reviewed in 1.3.2). 
Previously, it has been shown that Setdb1 requires mCAF1 (Atf7ip) to act as an H3K9me3 
methyltransferase (Schultz et al., 2002; Wang et al., 2003). Whether also Atf7ip is involved in 
Trim28/Setdb1-dependent silencing of endogenous retroviruses, could be analyzed by using 
the reporter systems established in this thesis.  
 
Figure 3.2 25 KRAB zinc finger proteins that are potential candidates for being the mouse -
IAP retrotransposon silencing factor   
KRAB zinc finger proteins were grouped for their expression in mES cells relative to their 
expression in MEFs based on published RNA-seq analyses (Corsinotti et al., 2013). The 
indicated expression units are relative RNA-seq read counts (Corsinotti  et al., 2013). For 
some of the candidate proteins, I cloned the respective cDNAs and generated stable MEF -
cell lines to see whether these cells show ectopic GAG2 -repression. However, I could not 
induce GAG-dependent silencing in MEFs by overexpressing the indicated cDNAs (data 
not shown).  
The UTR-region of IAP retrotransposons also recruits Trim28-dependent transcriptional 
silencing and DNA de novo methylation (Rowe et al., 2013a; Rowe et al., 2010). 
Consistently, I found that GAG2.22-dependent reporter silencing also involves Trim28 and 
Setdb1 (Figure 2.9), indicating that IAP element sequences might indeed have multiple 
nucleation sites for recruiting Setdb1 and Trim28. In my hands, reporter silencing mediated 
by the IAP-GAG sequence was massively stronger than IAP-UTR-mediated silencing 
(Figure 2.9). This indicates that the GAG-mediated silencing might be the predominant way 
of how IAP-Ez retrotransposons are targeted for epigenetic silencing in early mouse 
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development. Moreover, the IAP-Ez-GAG region encodes the structural capsid protein, which 
is important for the formation of retroviral particles and which shows a much higher 
evolutionary conservation than the UTR region of IAP elements (Kuff and Lueders, 1988; 
Rowe et al., 2010). One might speculate that the GAG2.22-targeting mechanism, which 
covers a large portion of a functional and coding IAP gene, robustly prevents the bypass of 
epigenetic silencing by inserting small point mutations. 
Interestingly, Suv39h and Suv4-20h enzymes are not essential for GAG2.22-mediated 
silencing (Figure 2.9). Consistently, Suv4-20h knockout ES cells don’t show a massive 
upregulation of endogenous IAP elements and Suv39h knockout cells largely maintain 
H3K9me3 methylation on IAP elements (Bulut-Karslioglu et al., 2012; Matsui et al., 2010). 
However, quantitative assays show that Suv4-20h knockout ES cells have a slight 
upregulation of endogenous IAP elements, probably because Suv4-20h contributes to 
silencing of IAP elements by non-coding-RNA (personal communication Prof. Ingrid Grummt 
– article in press). In addition, others have shown that many H3K9me3-binding proteins are 
dispensable for retrotransposon silencing (Maksakova et al., 2011). This is in accordance 
with the luciferase screening approach I have shown in this study (Figure 2.3).  
The most prominent pathway of retrotransposon-repression in later development is DNA 
methylation, although it is dispensable for silencing IAP elements at the ES-cell stage 
(extensively reviewed in chapter 1.2.2). In accordance with these previous studies, 
GAG2.22-dependent silencing is also occurring in Dnmt1 knockout and Dnmt3a/b double 
knockout cells (Figure 2.9). Although, DNA-methylation is dispensable for retroviral silencing 
in mouse ES cells and early embryonic stages, Trim28-dependent silencing has recently 
been implicated to play a vital role in the deposition and maintenance of DNA-methylation at 
endogenous retroviral sequences, imprinted loci and other genomic regions in early mouse 
development (Messerschmidt et al., 2012; Quenneville et al., 2012; Quenneville et al., 2011; 
Rowe et al., 2013a). The recruitment of Trim28 to IAP elements might therefore not only be 
important to silence IAP elements during early development but also to ensure maintenance 
and establishment of DNA-methylation, because at later stages of development 
DNA-methylation is crucial for IAP silencing when Trim28 and Setdb1 become dispensable 
for this process (see chapter 1.2.2) (Rowe et al., 2013a; Walsh et al., 1998). 
I used a recombinase-mediated cassette exchange (RMCE) system to integrate the 
GAG2.22 sequence into chromatin (Baubec et al., 2013; Lienert et al., 2011b), and I could 
find that it is sufficient to recruit the heterochromatic H3K9me3 mark (Figure 2.10). The 
GAG2.22 sequence not only induces silencing of nearby promoters but also autonomously 
recruits histone modifications to nearby chromatin. This finding is an example of how DNA-
sequences can directly determine the chromatin state and it questions the hypothesis that 
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the chromatin state is mostly inherited epigenetically and independently of the underlying 
DNA sequence. How many of these functional “chromatin-defining” sequences exist in vivo is 
unknown but could be identified by an experiment I propose in Figure 3.3. In short, the 
genome is fragmented, cloned into transfer vectors and the genomic fragments are 
reinserted into the cellular genome. If a fragment de novo recruits a histone modification, it 
will be isolated by histone modification ChIP. ChIP-PCR using universal primers amplifying 
newly inserted DNA-fragments will enrich for “epigenome regulating sequences” that can be 
deconvoluted by next generation sequencing.  Similar experiments that try to unravel the 
functionality of different DNA-sequences in a genome-wide manner have already been 
performed by others (Akhtar et al., 2013; Arnold et al., 2013). 
 
Figure 3.3 Sequencing Project for Identification of DNA-Elements that Recruit 
Modifications (SPIDER-Mod)  
This proposed experiment could identify sequences that recruit specific chromatin 
modifications. Here H3K9me3 is used as an example. First,  genomic DNA is sheared , end-
repaired and DNA fragments are cloned into a lentiviral vector library with high coverage. 
Next, the lentiviral library is prepared and stably integrated into a cell line. After 
chromatin immunoprecipitation (ChIP) of H3K9me3 -modified regions virally integrated 
DNA elements that are modified by H3K9me3 are enriched by PCR and identified using 
deep sequencing. Differences in library representation are controlled by amplifying and 
sequencing all integrated DNA sequences. For the analysis of active chromatin marks 
piggy-pac transposase systems can be used, that do  not have an intrinsic preference for 
integrating into active chromatin domains. Instead of cloning fragments that represent the 
entire genome, a subpool of DNA-fragments that is endogenously modified by H3K9me 3 
could also be used for library generation.  
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3.6. Genome-wide shRNA screens for Zfp809- and GAG2.22-dependent 
silencing in MEFs and mouse ES cells 
In this study, I performed two genome-wide shRNA-screening experiments to identify novel 
players that are involved in heterochromatic silencing (Figure 2.12 and 2.13). In the screen 
for Zfp809-dependent silencing in MEF cells Trim28 was identified as the strongest hit, which 
is the master regulator of Zfp809-dependent silencing (Figure 2.13). This indicates that the 
established screening-assay is capable of detecting functional hits.  
However, the number of potential off-target hits seems to be high in both screens, indicated 
by the fact that a substantial number of scoring shRNAs target genes that are not expressed 
(see list in appendix and Figure 2.14). This is probably due to fact that the cell-sorting step in 
the screening outline displayed a bottleneck in the screening experiment. Because only very 
limited numbers of EGFP-positive cells could be sorted, a high coverage of the shRNA library 
could not be maintained throughout the experiment (chapter 2.13). Nonetheless, the top hits 
should still be informative and it will be very interesting to validate them in the context of 
heterochromatin silencing.  
Apart from Trim28, the second strongest hit that scored with three independent shRNAs in 
the Zfp809/MEF screen was Gak (Figure 2.13). Gak is a kinase of 150 kDa that has been 
implicated into clathrin-coated vesicle uncoating and which is associated with Cyclin G and 
Cdk5 (Greener et al., 2000; Kanaoka et al., 1997). Recent studies have also revealed a 
nuclear localization of Gak and have implicated Gak in the formation of the mitotic spindle 
and the attachment of tubulin-fibers to the chromosome (Sato et al., 2009; Shimizu et al., 
2009; Tanenbaum et al., 2010). Therefore, Gak could be a novel interesting protein that is 
involved in heterochromatic silencing, maybe by influencing higher order chromosome 
structure.  
The top hit in the screen for GAG2-dependent silencing in mES-cells was Top2b. This gene 
encodes DNA topoisomerase II beta, an enzyme that is required for the topological 
organization of DNA by transiently breaking and rejoining DNA inside the nucleus. 
Interestingly, topoisomerase II beta localizes to pericentric heterochromatin in mouse cells 
and was found to be associated with Trim28 in my mass-spectrometry-based screen 
(Figure 2.24) (Cowell et al., 2011). Topoisomerase II beta has also been implicated into gene 
transcription in general and has been shown be important for the regulation of imprinted 
genes (Baranello et al., 2012; Huang et al., 2012; King et al., 2013; Vos et al., 2011). In 
addition to Top2b, I could also identify Top2a as an interactor of Trim28 in mouse ES cells 
and as hit in the GAG2/mES cell shRNA screen (Figure 2.24). This further supports the 
hypothesis that topoisomerase II is an important player in heterochromatic gene silencing. A 
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potential model that could explain an involvement of topoisomerase II into heterochromatin 
formation could be that heterochromatin formation requires the relaxation of DNA supercoils 
generated by chromatin condensation. Alternatively, topoisomerase II might collaborate with 
chromatin remodeling enzymes to remove DNA supercoils generated by the sliding and 
deposition of nucleosomes (Varga-Weisz et al., 1997). Interestingly, I identified the SNF-2-
type ATPase chromatin remodeler Atrx as a modulator of GAG2-dependent reporter 
silencing (Figure 2.14). Analyzing Top2b function in heterochromatin formation in the context 
of Atrx might therefore be an interesting project to study in the future. 
3.7. Atrx and Daxx catalyze heterochromatic gene silencing 
Secondary screening of shRNAs enriched in the primary shRNA screen revealed that the 
SNF2-type chromatin remodeler Atrx is important for silencing of the IAP-GAG reporter 
(Figure 2.14). To verify this finding and to identify whether the Atrx-associated protein Daxx 
is also involved in this process, I generated Atrx and Daxx knockout cells using RNA-guided 
nucleases (Figure 2.15 and 2.18). Interestingly, GAG-silencing was not lost in Atrx and Daxx 
knockout cells, but was massively delayed (Figure 2.15 and 2.18), indicating that Atrx and 
Daxx are not mandatory for reporter silencing but rather accelerate heterochromatic 
silencing. But how are Daxx and Atrx targeted to chromatin?  
Daxx has already been found to be important for transcriptional repression mediated by 
sumoylated transcription factors where it is targeted by its Sumo-interaction motif (reviewed 
in chapter 1.3.4.) (Chang et al., 2005; Croxton et al., 2006; Hollenbach et al., 1999; Kim et 
al., 2003; Kuo et al., 2005; Lehembre et al., 2001; Li et al., 2000b; Lin et al., 2004; Lin et al., 
2006; Lin et al., 2003; Obradovic et al., 2004; Park et al., 2007; Shih et al., 2007; Zhao et al., 
2004). Interestingly, also the nuclear localization of Daxx to PML nuclear bodies and to 
pericentric heterochromatin seems to be dependent on its Sumo-interaction motif (Ishov et 
al., 1999; Lin et al., 2006; Shih et al., 2007). Consequently, I could show that in rescue 
experiments wild-type Daxx can restore the repressive activity of Daxx but not a Daxx mutant 
lacking its Sumo-interaction motif (Figure 2.19). This suggests that Daxx might also be 
recruited to the newly inserted GAG2.22 reporter in a Sumo-dependent manner. 
Interestingly, also Setdb1 is recruited via Sumo-dependent interactions and is associated 
with sumoylated Trim28, which has been shown to have autosumoylation activity (Ivanov et 
al., 2007). It can therefore be hypothesized that Daxx is also recruited to sumoylated Trim28. 
Alternatively, Daxx might also be targeted to sumoylated transcription factors, which might be 
sumoylated during heterochromatin formation. The transcription factor YY1, which binds the 
promoter region of IAP elements and other cellular promoters (including the human EF1α 
promoter), has recently been shown to greatly accelerate heterochromatin formation on 
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M-MLV retroviruses but not to be absolutely essential for silencing in general (Gerstein et al., 
2012; Schlesinger et al., 2013). Interestingly, YY1 also binds to IAP elements in vivo and can 
also be sumoylated (Deng et al., 2007; Schlesinger et al., 2013), underlining the possibility 
that also sumoylated YY1 might recruit Daxx to IAP sequences. Moreover, also Atrx has 
been found to be a potential Sumo-target in proteome-wide screens (Westman et al., 2010), 
suggesting that the Sumo-interaction motif of Daxx might also be important for its interaction 
with Atrx. Which sumoylated protein is actually important to recruit Daxx is unknown and will 
be hard to identify among the high number of sumoylated proteins involved in 
heterochromatin formation. Yet, there is still the possibility that Atrx is the most important 
targeting factor for Daxx.  
Atrx itself has been shown to bind unmodified H3K4 in combination with di- or trimethylated 
H3K9 with its ADD-domain (Eustermann et al., 2011; Iwase et al., 2011). In addition, Atrx has 
an Hp1-interaction motif that together with the ADD-domain recruits Atrx to heterochromatic 
regions (Eustermann et al., 2011; Iwase et al., 2011). Therefore, it is possible that Atrx and 
Daxx are recruited to chromatin independently. However, Atrx and Daxx associate on protein 
level (Xue et al., 2003), which rather supports the hypothesis that both proteins act as a 
stable Atrx/Daxx complex that uses many different protein interaction modules to be tethered 
to certain chromatin regions. Testing Daxx/Atrx double knockout cells in my reporter assay 
will further reveal whether Daxx and Atrx act in the same silencing pathway and 
consequently, whether they can act independently from each other.  
Atrx is enriched at the GAG2.22 sequence of endogenous IAP elements in vivo and is 
recruited to new insertions of the GAG2.22 sequence (Figure 2.16). Although H3K9me3 is 
present all over the analyzed regions, Atrx does not spread over the complete IAP 
retrotransposon sequence in vivo or on a reporter gene in vitro, but rather stays localized at 
the GAG2.22 sequence (Figure 2.16 and 2.10). This argues against the hypothesis that Atrx 
is recruited exclusively via its ADD-domain and its Hp1 interaction motif because one would 
rather expect a colocalization with H3K9me3. A possible explanation for this observation 
could be that the Atrx/Daxx complex has the highest affinity to proteins at the nucleation site 
of silencing (presumably Trim28). In fact, Atrx was found as a Trim28-interacting protein 
using mass-spectrometry-based screening experiments (Figure 2.24). Rescue experiments 
using Atrx mutants in Atrx deficient cells will reveal which part of the protein is responsible for 
its targeting. 
In addition, one could analyze whether the ATPase activity of the SNF2-type domain of Atrx 
is required for its repressive activity. Some ATRX-syndrome patients have mutations in the 
SNF2-type ATPase domain of Atrx (Gibbons et al., 2008), suggesting that this domain might 
be important in vivo. However, in vitro assays did not reveal any specific physiological 
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function of the ATPase domain of Atrx, yet (Xue et al., 2003). Due to its binding to certain 
repetitive DNA elements in ChIP experiments, it has been postulated that the ATPase of Atrx 
might actively dissolve G-quadruplex structures that form in G-rich DNA regions (Law et al., 
2010). However, this may be the case, but does not explain, why Atrx is required for quick 
heterochromatin formation.  
Consistent to the fact that Atrx and Daxx knockout cells are not defective in reporter 
silencing, Atrx and Daxx knockout cells don’t show an upregulation of endogenous IAP 
elements and depletion of Atrx does not result in a reduction of H3K9me3 or 
DNA-methylation at endogenous IAP elements (Figure 2.16, 2.17 and 2.23). A good, 
explanation for this finding is that Atrx and Daxx are probably not required for maintenance of 
H3K9me3 chromatin or DNA-methylation, but are rather involved in the establishment of 
heterochromatin. In line with this hypothesis, an impaired heterochromatin establishment 
during developmental transitions might also explain the reduced DNA-methylation at certain 
chromosomal regions in Atrx patients (Gibbons et al., 2000), while direct effects on already 
established DNA methylated regions cannot be observed (Figure 2.17). However, I cannot 
rule out that Atrx has a role during maintenance of heterochromatin, because loss of Atrx 
might also be compensated by an increased activity of Trim28, Setdb1 and the residual 
heterochromatin machinery. Consistently, knockdown experiments showed that Setdb1 and 
Trim28 are rate-limiting for de novo silencing of the GAG-reporter at a much higher 
concentration when Atrx is missing (Figure 2.22). In addition, Atrx knockout cells show much 
stronger derepression of endogenous IAP elements when Trim28 is depleted (Figure 2.22). 
Therefore, Atrx might facilitate a low plasticity of heterochromatin and render it much more 
resistant against influences that impair heterochromatin status. Consequently, I could show 
that reactivation of an EGFP reporter gene that is silenced by H3K9me3 is much easier upon 
Atrx knockdown (Figure 2.23). How loss of Atrx affects endogenous genes that are controlled 
by H3K9me3 will be an interesting aspect to study in the future. In fact, some imprinted 
genes have been shown to be deregulated in neuronal tissues in Atrx knockout mice, 
suggesting a potential link to the ATRX syndrome phenotype (Kernohan et al., 2010). In 
addition, low heterochromatin plasticity at telomeric regions could contribute to the higher 
frequency of telomeric recombination events observed in the alternative lengthening of 
telomeres pathway observed in many Atrx-deficient tumors (reviewed in 1.3.3).  
Daxx was also found to incorporate histone H3.3 at telomeres and other regions (Drane et 
al., 2010; Elsasser et al., 2012; Goldberg et al., 2010; Lewis et al., 2010; Liu et al., 2012). 
Even though H3.3-binding seems to be one of the main functions of Daxx, Daxx mutants that 
are deficient in H3.3-binding can still silence the IAP reporter gene (Figure 2.19 and 2.20). 
This suggests that H3.3-binding and H3.3 itself don’t have a functional role in Daxx-mediated  
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Figure 3.4 A silencing model for IAP retrotransposons   
A) Silencing of newly integrated IAP retrotransposons might start with the recognition of 
the GAG2.22 sequence (and possibly other IAP regions) by a mouse IAP retrotransposon 
silencing inducing protein. This sequence-specific factor might then recruit Trim28, 
potentially via a KRAB domain. Sumoylation of Trim28 could be a binding-platform for 
Setdb1 and maybe the Daxx/Atrx complex. However, Atrx could also be recruited via 
binding of its ADD domain to H3K9me3, which has been catalyzed by Setdb1. 
Alternatively, Atrx could also bind Hp1 or Trim2 8. After establishment of the H3K9me3-
domain, additional factors like Dnmts and Suv4-20h are recruited to set additional 
chromatin marks. These marks are most likely dispensable for heterochromatic silencing 
in mouse ES cells.  Additional heterochromatin players (l ike HDACs, Atf7IP and the NURD 
complex) might also be involved in this pathway but are not shown here. B) A simplified 
illustration that shows how loss of Atrx leads to increased heterochromatin plasticity that 
allows activating factors to intrude into heterochromatin.  
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repression of IAP sequences. Consequently, H3.3-deficient cells can also silence IAP 
reporter genes similarly to wild type cells (Figure 2.21). Consistently, H3.3 incorporation is 
not changed at Atrx target loci when Atrx is depleted, indicating that the main function of Atrx 
outside telomeres is not to incorporate H3.3 (Law et al., 2010). It will be a very interesting 
topic in future research to investigate if H3.3 independent functions of Atrx and Daxx are also 
important in telomere biology.  
3.8. Improvements in studying genetic interactions of heterochromatic 
silencing 
Due to recent advancements in genome-editing by RNA-dependent nucleases, genome-wide 
screening-studies using genome-wide depletion screenings with gRNA/CRISPR libraries 
have become possible (Koike-Yusa et al., 2013; Shalem et al., 2014; Wang et al., 2014b). 
Repeating my genome-wide screening assays with these assays could reduce the amount of 
potential off-target hits substantially. In addition, one could circumvent the bottleneck of 
FACS-sorting in the established screening protocols by using an antibiotic resistance marker 
to monitor reporter gene expression (Figure 3.5). Pilot experiments using the Zeocin™ 
resistance gene, already showed the feasibility of antibiotic-based selection in such 
experiments (Figure 3.5). The use of Zeocin™ for these assays is specifically important, 
because it has a small therapeutic index. This means that cells expressing the zeoR 
resistance gene below a certain level can be counterselected by increasing Zeocin™ 
concentration (Nakatake et al., 2013). In this way, the antibiotic selection allows the 
adjustment of a certain expression threshold. In addition, the heterochromatin reporter can 
be challenged by a precise concentration of doxycyclin that only results in reporter 
expression if heterochromatin is impaired. This approach could be a simple and powerful 
screening platform for the identification of factors involved in heterochromatin maintenance.  
Additionally, one could further exploit this approach to establish genetic screens for synthetic 
lethality. As an example, one could compare Atrx-deficient cells with wild type cells under 
very low doxycyclin induction to identify factors that are only required once Atrx is depleted. 
In this way, redundant pathways can be uncovered and a broad landscape of genetic 
interactions at mouse heterochromatin can be unraveled. Ultimately, the identified genetic 
interactions can then be validated in biochemical approaches in the context of other 
heterochromatic domains like pericentric or telomeric heterochromatin. Another way of 
validating these functional screens could be the use of mass-spectrometry-based interaction 
studies as performed in Figure 2.24. The combination of these approaches can give rise to a 
more specific understanding about which proteins are associated to heterochromatin and 
which proteins have functional roles at this domain. 
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Figure 3.5 Improved screening systems to identify genetic interactions at heterochromatin  
A) A screening outline based on CRISPR/Cas9-mediated gene disruption. The screening 
cell line carries a heterochromatinized, silenced reporter gene that can be challenged with 
doxycyclin. Expression of the transgene only works  when heterochromatin is impaired by 
the depletion of heterochromatin factors (see  Figure 2.23). Reporter cells are depleted for 
individual genes by transduction with a lentiviral guide -RNA library. Addition of 
doxycyclin leads to expression of the reporter gene where heterochromatin is impaired by 
a loss of a heterochromatin factor. These cells can be selected by Zeocin™ selection and 
gRNA sequences can be identified by PCR and deep-sequencing. B) Proof-of-concept 
experiment showing that Zeocin™ selection can enrich for functional hits in a positive 
selection screen. A mixture of shRNA virus targeting Atrx or a scrambled control 
sequence was generated and mouse ES cells were transduced as described in Figure 2.12. 
Next, cells were transduced with a lentiviral GAG2.22/ZeoR -reporter and cells that bypass 
heterochromatic silencing were enriched by Zeocin™ selection. The barplot indicates the 
identified shRNA sequences of individual cell clones isolated from the experiment. The 
shRNA against Atrx was strongly enriched, even though it was strongly underrepresented 
in the initial virus mix. ShRNA sequences were identified by Sanger sequencing.  
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4. Material and methods 
4.1. Material 
4.1.1. Machines, buffers and reagents 
Used kits, reagents, buffers and machines are indicated in the respective protocols in the 
methods section.  
4.1.2. qPCR oligonucleotides  
Primer design for quantitiative PCR was carried out using the Primer3Plus web interface 
(Untergasser et al., 2007) or designed manually.  
Target internal # direction sequence (5' to 3') useage 
Midline1 exon1 
  
GS707 fw tcaagtggccgagttgcttgg RT-qPCR 
GS699 rw gctatgtgcgcagggaagcag  
Midline1 exon2 GS708 fw gctagcctgcgcccgactt RT-qPCR 
GS709 rw gcagacaccaaagccggca  
Midline1 exon3 GS1544 fw agcttccttggactttgctg RT-qPCR 
GS1545 rw ttgaagcagaggctatgtgc  
Midline1 exon5 GS702 fw gtcaatgcatcccgtcaaga RT-qPCR & allele number 
GS703 rw cttgccttctttaatctttgttc  
Midline1 exon6 GS704 fw gtgatcaggctccgcaagttagc RT-qPCR & allele number 
GS705 rw gggcgtggtcattttccttcag  
Midline1 3' exons GS494 fw cctcccaggtcctaattcccg semi-quantitative PCR 
GS495 rw tctaatcgcgggagggttgg  
M18bp1 GS358 fw ctccaaaaggccagcatcacg semi-quantitative PCR 
GS359 rw ttgccggaggtaggctgttcc  
Gapdh GS276.1 fw tcaagaaggtggtgaagcag RT-qPCR 
GS276.2 rw gttgaagtcgcaggagacaa  
Actin GS278.1 fw ggtcatcactattggcaacg RT-qPCR 
GS278.2 rw tccatacccaagaaggaagg  
Atrx GS2493 fw gagcttgacgtgaaacgaagag RT-qPCR 
GS2494 rw ttgttgctgttgctgctgag  
Daxx GS2522 fw gaacagttgcaggaagatcagg RT-qPCR 
GS2523 rw aaagtctgaaggcgatgtgg  
Trim28 GS1909 fw cggaaatgtgagcgtgttctc RT-qPCR 
GS1910 rw cggtagccagctgatgcaa  
IAP global GS2512 fw cgggtcgcggtaataaaggt RT-qPCR/ChIP-qPCR 
GS2513 rw actctcgttccccagctgaa  
IAP GAG2.22 GS2600 fw cttcatgccaaagcgctctc ChIP-qPCR 
GS2601 rw atggcactaactcctgctgac  
EGFP GS1992 fw cgacggcaactacaagac ChIP-qPCR 
GS1993 rw tagttgtactccagcttgtgc  
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Target internal # direction sequence (5' to 3') useage 
Tia1 GS477 fw Gctcgccgccatcttggat ChIP-qPCR 
GS478 rw Ggctatggctgcggaagagc  
Polrmt GS1650 fw tcagcaaactccaatagcgcac ChIP-qPCR 
GS1651 rw ttgccgcacaacatggactt  
pLKO1 shRNA seq GS2273 fw cgagactagcctcgagc library cloning 
GS2274 rw ctgcgagggtactagtgag  
Rb1 intronic region  GS562 fw gctgagcattctgctgcatcg allele copy number 
GS563 rw aagccgggagaaacagcctct  
Tspan32_2 GS890 fw gccatgagagaggtgaggag allele copy number 
GS891 rw ggtaggtcccaagatgtga  
Osbpl5_1 GS924 fw aaaaagccctgtccacatca allele copy number 
GS925 rw aaccaccaagagcattgtcc  
H3.3B GS2879 fw tttcaaagtgcagccatcgg RT-qPCR 
GS2880 rw tgtctttgggcatgatggtg  
Zfp71-rs1 GS2479 fw tgttcctgggtcttgctttg RT-qPCR 
GS2480 rw ttttgccacactctgtgcac  
Zfp809 GS2119 fw gcagaagcttcaagcaggag RT-qPCR 
GS2120 rw ggatgttgtccctttggaga  
GAG2.22/polyA GS3012 fw atggaatggagagcgctttg ChIP-qPCR 
GS3013 rw acagatggctggcaactagaag  
EGFP/T2A GS3014 fw tcctgctggagttcgtgac ChIP-qPCR 
GS3015 rw tcttccctctcctcccttgtac  
TRE GS3016 fw tgggaggcctatataagcagag ChIP-qPCR 
GS3017 rw aggtcaaaacagcgtggatg  
4.1.3. CRISPR guide-RNA sequences used with pX330 vector 
Target   Internal Code  guide sequence (5’to 3’)  
Atrx ORF  #2_GS2621/GS2622 gctgttgcacgcagtcaccaagtccagtag 
Atrx ORF  #1_GS2619/GS2620 cttctgtaagaaatgcatcctgcgcaacct 
Daxx ORF  #4_GS2659/GS2660 agtacaatgatgctgtcatcgg 
Daxx ORF  #1_GS2653/GS2654 tcaagtacaatgatgctgtcat 
H3f3b ORF  #3_GS2827/GS2828 gcgcgcttttccgagccgcct 
H3f3b ORF  #4_GS2829/GS2830 gcggaaaagcgcgccctctac 
H3f3a upstream intron #1_GS2939/GS2940 gataattagtttggaagggcg 
H3f3a downstream int. #2_GS2945/GS2946 gtatgtccgtgtaatttaac 
4.1.4. Northern blot probes 
probe    generation     size 
X-chromosomal midline1  PCR on female mouse cDNA   790 bp  
     Primer: 5’-tggactttgctgatgaccccg-3’  
     Primer: 5’-ttcaacatgttgacaagtttgg-3’  
pseudoautosomal midline1 PCR on male Suv4-20h dko cDNA   1292 bp  
    Primer: 5’- gtcaatgcatcccgtcaaga-3’  
     Primer: 5’- gtccctcaaggtcgctgctccg-3’  
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M18bp1    EcoRV-fragments of M18bp1 plasmid (#433) 806 and 940 bp 
    and gel purification of fragments 
4.1.5. DNA sequences used for DNA pull-down experiments 
Zfp809-binding site  
5’-ttaatttgggggctcgtccgggatcgggagacc-3’ 
Zfp809-binding site mutant  
5’-ttaatttggggggagctccgggatcgggagacc-3’ 
GAG2.22 + 40 bp  
5’cgtaaatacggaaccaatgctaattttaccttggtgcagttagacaggctcgccggcatggcactaactcctgctgactggcaaacgattgtaaaagccgctct
ccctagtatgggcaaatatatggaatggagagcgctttggcatgaagctgcacaagcgcaggcccgagcaaacgcagctgctttgactccagagcagagag
attggacttttga-3’ 
Spectinomycin  
5’gttggcgtcatcgagcgccatctcgaaccgacgttgctggccgtacatttgtacggctccgcagtggatggcggcctgaagccacacagtgatattgatttgctg
gttacggtgaccgtaaggcttgatgaaacaacgcggcgagctttgatcaacgaccttttggaaacttcggcttcccctggagagagcgagattctccgcgctgta-
3’ 
GAG2.22 
5’cgtaaatacggaaccaatgctaattttaccttggtgcagttagacaggctcgccggcatggcactaactcctgctgactggcaaacgattgtaaaagccgctct
ccctagtatgggcaaatatatggaatggagagcgctttggcatgaagctgcacaag-3’ 
GAG2.22_Mutant38 
5’cgtaaatacggaaccaatgctaattttaccttggtgcagttaggcaggctcgcccgcatggcactaactcctgctggctggcaaacgattgtaaaagccgctct
ccctagtatgggcaaatatatggaatggagagcgctttggcatgaagctgcacaag-3’ 
4.1.6. shRNA sequences used with pLKO1 vector backbone (TRC library) 
Target   internal Code  sequence (5’to 3’)  
Trim28   A   GCAGTGAGGAACCAACGTAAA 
Trim28   B   CCACCAGTCTTCAAGGTCTTT 
Trim28   C   CCGCATGTTCAAACAGTTCAA 
Trim28   D   AGACATCGTGGAGAATTATTT  
Zfp809   A   GCATTACAGAAGAACTCATAA  
Atrx   GAG8   CCCACGGATGAGAATGTAAAT 
Cops6   GAG47   TAATGGGCCATTGTAAGCTGC 
Mmp28   GAG3   GACCACTATTGGCATTTGGAT 
Tmem174  GAG45   CGCTGTGTTCTTCAGAAGTTA 
UNK   GAG40   CATCGCTTGTTCGTCATGCAT 
Lrrc24   GAG33   GACACTGTTCCTGCAAGACAA 
8430426H19Rik  GAG74   GAATGTAATCAGTGTGGTAAA 
Hoxa11   GAG54   CTGCTCCTCTAACATGTATTT  
Ubtf   A   GAGCCAGAAGGAGCACTATAA 
Zfp71-rs1  C    GCCTTCCGTTATCCATCATTA 
Zfp71-rs1  D    ACCAGATGCTTGATTTACGAA 
Setdb1   B   GCCTTGATCTTCCATGTCATT 
Scrambled control -   CAACAAGATGAAGAGCACCAA 
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4.1.7 Plasmids used and cloned in this study 
The following list contains the most important plasmids used and cloned for this study. 
Sequences, cloning strategies and vector maps are accessible in the Schotta lab plasmid 
database. 
name # origin marker use 
1L-PGK-HygTK-L1 1281 Dirk Schübeler Lab Ampicillin RMCE 
1L-poly-L1 1280 Dirk Schübeler Lab Ampicillin RMCE 
L1-Poly-1L/TetO-EGFP-T2A-Zeo-
GAG2.22-pA 
1294 this study Ampicillin RMCE 
pBS-UAS-CMV-EGFP-Zeo 510 this study Ampicillin transient transfection 
pBS-UAS-PGK-EGFP-Zeo 592 this study Ampicillin transient transfection 
pcDNA3.1 hygro +/Gal4-VP16 605 Christian Haass Lab Ampicillin luciferase assay 
pGal4-N1 589 Schotta lab Kanamycin luciferase assay 
pGal4-N1/GW 506 Schotta lab Kanamycin luciferase assay 
pGal4-N1_GW/Adnp 631 this study Kanamycin luciferase assay 
pGal4-N1_GW/Atad2 632 this study Kanamycin luciferase assay 
pGal4-N1_GW/Cbx1 552 this study Kanamycin luciferase assay 
pGal4-N1_GW/CBX3 638 this study Kanamycin luciferase assay 
pGal4-N1_GW/CBX5 635 this study Kanamycin luciferase assay 
pGal4-N1_GW/Chd2 630 this study Kanamycin luciferase assay 
pGal4-N1_GW/Dnmt3a 624 this study Kanamycin luciferase assay 
pGal4-N1_GW/Dnttip2 634 this study Kanamycin luciferase assay 
pGal4-N1_GW/M18bp1 522 this study Kanamycin luciferase assay 
pGal4-N1_GW/MPP8 633 this study Kanamycin luciferase assay 
pGal4-N1_GW/pogZ 629 this study Kanamycin luciferase assay 
pGal4-N1_GW/Prdm6 623 this study Kanamycin luciferase assay 
pGal4-N1_GW/Rbm39 622 this study Kanamycin luciferase assay 
pGal4-N1_GW/Setdb1 636 this study Kanamycin luciferase assay 
pGal4-N1_GW/Setdb2 626 this study Kanamycin luciferase assay 
pGal4-N1_GW/Suv39h1 521 this study Kanamycin luciferase assay 
pGal4-N1_GW/Suv39h2 520 this study Kanamycin luciferase assay 
pGal4-N1_GW/Suv420h1 551 this study Kanamycin luciferase assay 
pGal4-N1_GW/Suv4-20h2 519 this study Kanamycin luciferase assay 
pGal4-N1_GW/Tardbp 625 this study Kanamycin luciferase assay 
pGal4-N1_GW/TRIM28 637 this study Kanamycin luciferase assay 
pGal4-N1_GW/Utf1 628 this study Kanamycin luciferase assay 
pGal4-N1_GW/Zfp106 620 this study Kanamycin luciferase assay 
pGal4-N1_GW/Zfp622 621 this study Kanamycin luciferase assay 
pGal4-N1_GW/Zfp828 627 this study Kanamycin luciferase assay 
pGL3/5xUAS/PGK/luciferase 646 this study Ampicillin luciferase assay 
pIC-Cre 1279 Dirk Schübeler Lab Ampicillin RMCE 
pLCIN (pLenti6-E2-Crimson-IRES-neo) 974 this study Ampicillin lentiviral 
pLEIP-GW 966 this study Ampicillin lentiviral 
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name # origin marker use 
pLenti6 puro 831 this study Ampicillin lentiviral 
pLenti6-EF1a-3FLAG-IRES-PURO 
(pLFIP) 
963 this study Ampicillin lentiviral 
pLenti6-EF1a-Cre-ERT2-T2A-hyg 842 this study Ampicillin lentiviral 
pLenti6-EF1a-CRE-IRES-PURO 
 
1087 Katharina Schmidt Ampicillin lentiviral 
pLenti6-EF1a-EGFP-IRES-PURO 
(pLEIP) 
962 this study Ampicillin lentiviral 
pLenti6-EF1a-rtTA-IRES-neo 1308 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo 940 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/1xB2 948 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/1xRBS 946 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/3xB2 949 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/3xRBS 947 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG1 1011 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2 1012 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.1 1046 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.1+2 (A) 1050 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.1+2+3 (B) 1051 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2 1047 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2.1 1037 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2.2 1038 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2.3 1039 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2.4 1040 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2.5 1041 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2.6 1042 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2.7 1043 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2.8  1054 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.2+3+4 (C) 1052 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.3 1048 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG2.3+4 (D) 1053 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG3 1013 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG4 1014 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/GAG5 1015 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/IAP-5'UTR 951 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/IAP-GAG anti 952 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/IAP-LTR 950 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/POL 1016 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/UTR1 1005 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/UTR2 1006 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/UTR3 1007 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/UTR4 1008 this study Ampicillin lentiviral 
pLenti6-EFEGT-neo/UTR5 1009 this study Ampicillin lentiviral 
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name # origin marker use 
pLenti6-EFEGT-neo/UTR6 1010 this study Ampicillin lentiviral 
pLenti6-mPGK-GW-EGFP-T2A-pur 936 this study Ampicillin lentiviral 
pLenti6-mPGK-GW-FLAG-T2A-pur 938 this study Ampicillin lentiviral 
pLenti6-PGEGT-neo 941 this study Ampicillin lentiviral 
pLenti6-PGEGT-neo/1xB2 956 this study Ampicillin lentiviral 
pLenti6-PGEGT-neo/1xRBS 954 this study Ampicillin lentiviral 
pLenti6-PGEGT-neo/3xB2 957 this study Ampicillin lentiviral 
pLenti6-PGEGT-neo/3xRBS 955 this study Ampicillin lentiviral 
pLenti6-PGEGT-neo/IAP-5'UTR anti 959 this study Ampicillin lentiviral 
pLenti6-PGEGT-neo/IAP-GAG 960 this study Ampicillin lentiviral 
pLenti6-PGEGT-neo/IAP-LTR 958 this study Ampicillin lentiviral 
pLenti6-puro 831 this study Ampicillin lentiviral 
pLenti6-TR 172 Life Technologies Ampicillin lentiviral 
pLFIP/DAXX E231A 1307 this study Ampicillin lentiviral 
pLFIP/DAXX R257A 1306 this study Ampicillin lentiviral 
pLFIP/Trim28 (aa1-480) no Stop 1095 this study Ampicillin lentiviral 
pLFIP/Trim28 noStop 1094 this study Ampicillin lentiviral 
pLFIP-DAXX-deltaSIM(aa1-731) 1273 this study Ampicillin lentiviral 
pLFIP-DAXX-FL 1272 this study Ampicillin lentiviral 
pLFIP-GW 967 this study Ampicillin lentiviral 
pLIP-H3.3-HA 1274 this study Ampicillin lentiviral 
pLP-eco env 811 this study Ampicillin virus packaging 
pPIH 651 this study Ampicillin MLV retroviral 
pPIH/Slc7a1(mCAT1) 1055 this study Ampicillin MLV retroviral 
psPAX2 183 Didier Trono lab Ampicillin virus packaging 
4.1.8. Antibodies  
ChIP 
epitope  host   company product     
H3K9me3 rabbit polyclonal Active-Motif  anti-H3K9me3 (339161.39162 13509002)  
Atrx  rabbit polyclonal Santa Cruz  anti-ATRX (sc-15408 H1412) 
Western blotting or immunoprecipitation  
epitope  host   company product    dilution 
Daxx   rabbit polyclonal Santa Cruz anti-DAXX (sc7152 E1412) 1:3000 
Atrx   rabbit polyclonal Santa Cruz  anti-ATRX (sc-15408 H1412) 1:15000 
H3.3  rabbit polyclonal Millipore  anti-H3.3 (09-838)  1:1000 
HA  rat  monoclonal Roche   anti-HA (clone 3F10)  1:1000 
α-tubulin mouse monoclonal Sigma-Aldrich anti-α-Tubulin (clone B-5-1-2) 1:3000 
Trim28  rabbit polyclonal Bethyl  anti-Trim28 (A300-275A-1) 1:3000 
FLAG  mouse monoclonal Sigma-Aldrich anti-FLAG-M2-affinity-agarose 30-50 µl per IP 
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4.1.9. Cell lines used and generated in this study 
cell line type origin generation 
293T cells human embryonic kidney cells commercial  
HeLa cells human cervix carcinoma cells commercial  
wt26 feeder-independent mouse ES cells Schotta lab  
HA36 feeder-independent mouse ES cells 
for RMCE 
Dirk 
Schübeler lab 
 
B5.3 feeder-independent mouse ES cells Schotta lab  
AinV15 feeder-independent mouse ES cells commercial  
E19.8 immortalized mouse embryonic 
fibroblasts 
Schotta lab  
W9 immortalized mouse embryonic 
fibroblasts 
Schotta lab  
KO-1-07 Atrx knockout cells this study wt26 cells (CRISPR targeted with sgRNA 
mix against Atrx) 
KO-1-40 Atrx knockout cells this study wt26 cells (CRISPR targeted with sgRNA 
mix against Atrx) 
KO-1-44 Atrx knockout cells this study wt26 cells (CRISPR targeted with sgRNA 
mix against Atrx) 
KO-1-45 Atrx knockout cells this study wt26 cells (CRISPR targeted with sgRNA 
mix against Atrx) 
KO2-3 Daxx knockout cells this study wt26 cells (CRISPR targeted with sgRNA 
DAXX#4) 
KO2-7 Daxx knockout cells this study wt26 cells (CRISPR targeted with sgRNA 
DAXX#4) 
KO2-18 Daxx knockout cells this study wt26 cells (CRISPR targeted with sgRNA 
DAXX#4) 
KO2-24 Daxx knockout cells this study wt26 cells (CRISPR targeted with sgRNA 
DAXX#4) 
KO9-1 Daxx knockout cells this study HA36 cells (CRISPR targeted with 
sgRNA DAXX#1) 
KO9-3 Daxx knockout cells this study HA36 cells (CRISPR targeted with 
sgRNA DAXX#1) 
KO10-3 Atrx knockout cells this study HA36 cells (CRISPR targeted with 
sgRNA ATRX#1) 
KO11-1 H3.3B knockout cells this study wt26 cells (CRISPR targeted with 
sgRNAH3.3#3) 
KO12-4 H3.3B knockout cells this study wt26 cells (CRISPR targeted with 
sgRNAH3.3#4) 
KO20-21 H3.3 double knockout cells this study KO11-1 cells (CRISPR-targted with 
sgRNAs H3.3A#1 and #2) 
KO20-18 H3.3 double knockout cells this study KO11-1 cells (CRISPR-targted with 
sgRNAs H3.3A#1 and #2) 
KO20-24 H3.3 double knockout cells this study KO11-1 cells (CRISPR-targted with 
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sgRNAs H3.3A#1 and #2) 
KO20-20 H3.3 double knockout cells this study KO11-1 cells (CRISPR-targted with 
sgRNAs H3.3A#1 and #2) 
KO21-7 H3.3 double knockout cells this study KO12-4 cells (CRISPR-targted with 
sgRNAs H3.3A#1 and #2) 
KO21-13 H3.3 double knockout cells this study KO12-4 cells (CRISPR-targted with 
sgRNAs H3.3A#1 and #2) 
HA36_TetO-
9 
HA36 cells with TetO-EGFP-T2A-
ZeoR-GAG2.22 
this study RMCE in HA36 cells 
HA36_TetO-
8 
HA36 cells with TetO-EGFP-T2A-
ZeoR-GAG2.22 
this study RMCE in HA36 cells 
T86 inducible HA36_TETO-8 cells 
expressing rtTA 
this study lentiviral tranduction of HA36_TetO8 with 
rtTA 
T87 inducible HA36_TETO-9 cells 
expressing rtTA 
this study lentiviral tranduction of HA36_TetO9 with 
rtTA 
T37 HeLa cells expressing Slc7a1 
(mCAT1) 
this study transfection and transduction of retroviral 
Slc7a1 in HeLa 
T52 cells expressing 3xFLAG/HA-
Trim28(RBCC) 
this study wt26 cells stably transduced with Trim28-
RBCC domain 
T53 cells expressing 3xFLAG/HA-Trim28 
full length 
this study wt26 cells stably transduced with Trim28 
T55 cells expressing 3xFLAG/HA-Trim28 
full length 
this study w9 cells stably transduced with Trim28 
*Daxx rescue cell lines are not listed here and were generated freshly multiple times by 
lentiviral transduction. 
4.1.10. Bacterial strains 
For cloning purposes DH5α (Life Technologies) and Stellar (Clontech) E.coli strains were 
used. Propagation of vectors containing gateway-cassettes was performed in ccdB-resistant 
db3.1 bacteria (Life Technologies).  
4.2. Molecular biology methods 
4.2.1. Molecular cloning  
Plasmid cloning and purification was performed using standard procedures (Sambrook et al., 
2001). For traditional cloning restriction enzymes (NEB), rapid™ alkaline phosphatase 
(Roche) and T4 DNA ligase (Roche) was used. Cloning PCRs were performed using 
Phusion™ polymerase (NEB) or Q5™ polymerase (NEB) according to the manufacturers’ 
protocols. DNA was purified using commercial column purification kits (Promega, Macherey-
Nagel, Qiagen). For subcloning of cDNAs into different vectors, Gateway™ cloning (Life 
Technologies) was performed according to the manufacturer’s protocol. Many different PCR 
fragments or multiple fragments were cloned in one step by Infusion™ cloning (Clontech) 
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according to the manufacturer’s protocol or a self-made Gibson assembly™ cloning mix 
(NEB) (Gibson et al., 2010; Gibson et al., 2009; Hamilton et al., 2007). Gibson assembly mix 
was generated and aliquoted after combining 219 µl water, 100 µl 5x Gibson assembly buffer 
(450 mM Tris/Cl pH 7.5, 25 % (w/v) PEG 8000, 50 mM MgCl2, 50 mM DTT, 1 mM of each 
dNTP, 5 mM NAD), 0.2 µl T5 exonuclease (10 U/µl) (NEB), 6.25 µl Phusion polymerase 
(2 U/µl) (NEB) and 50 µl Taq Ligase (40 U/µl NEB). Aliquots of 15 µl were stored at -80°C. 
5 µl of purified DNA fragment mix was added to defrosted aliquots of Gibson assembly mix 
and cloning was performed as described elsewhere (Gibson et al., 2010; Gibson et al., 
2009).  
4.2.2. RNA purification and cDNA synthesis  
For RNA purification, cells were lysed in RLT buffer (Qiagen) supplemented with 
2-mercaptoethanol as instructed by the manufacturer and RNA was purified using RNEasy™ 
purification (Qiagen). Traces of DNA were removed by including a DNaseI (Qiagen) 
on-column digestion step as suggested by the manufacturer’s protocol. 
Between 0.5 µg and 5 µg total RNA was reverse transcribed into complementary DNA 
(cDNA) using Superscript III™ (Life Technologies) and random hexameric primers (NEB) 
according to the manufacturer’s protocol. Reactions that were not treated with reverse 
transcriptase enzyme were used as a negative control to check for DNA background.  
For strand-specific reverse transcription, a single strand-specific primer was used for reverse 
transcription. 
4.2.3. Semi-quantitative reverse transcriptase PCR 
Semi-quantitative PCR was performed by using Jumpstart™ polymerase (Sigma Aldrich) or 
Taq Polymerase (5-Prime) using primers against the respective cDNA targets according to 
the manufacturers’ protocols. PCR-Products were visualizes using agarose gel 
electrophoresis and ethidium bromide (Roth) staining.  
4.2.4. Quantitative PCR (qPCR) 
The relative amount of cDNA after reverse transcription, the copy number of different alleles 
inside genomic DNA or enrichment of DNA after chromatin immunoprecipitation was 
measured by qPCR. PCR was carried out with the Fast SYBR® Green Master Mix™ 
(Applied Biosystems) in a LightCycler480™ (Roche) according to the Fast SYBR Green 
Master Mix™-protocol. Primers were evaluated for generating a single PCR product and for 
linear amplification in a wide range of DNA template dilutions (up to 1:10000). Every PCR-
reaction was performed in a total volume of 10 µl in triplicates in a 384-well plate (Sarstedt). 
Two independent control genes (Gapdh and Actin) were used as reference genes for qRT-
PCR experiments and geometric mean of reference Ct values was used as normalization as 
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described by others (Vandesompele et al., 2002). Three independent control genes were 
used for evaluating the copy-number of the midline1 exons. For qRT-PCR of repetitive 
regions like IAP elements, negative control samples that were not treated with reverse 
transcriptase were used to control for genomic DNA background.  
Ct-values were generated by the LightCycler480-Software (Roche) using the 2
nd derivative 
max function and fold changes were calculated using the 2 –ΔΔC method.  
4.2.5. Northern Blotting 
Northern Blotting was performed using RNAse-free material, DEPC-treated water and 
RNAse-free reagents. 5-20 µg of total RNA was denatured in three volumes of RNA 
formaldehyde sample buffer (Ambion) at 65°C for 20 min and separated by a denaturing 
agarose gel (1 % agarose, 6,66 % formaldehyde) in 1x MOPS buffer (40 mM 3-(N-
morpholino) propanesulfonic acid, 10 mM sodium acetate, 1 mM EDTA, adjusted to pH 7.0 
using NaOH). RNA was blotted overnight on a positively-charged Nylon membrane (Roth) by 
capillary blot in 10x SSC (1.5M NaCl, 150 mM sodium citrate, pH 7.0). RNA was crosslinked 
to the membrane using a UV-autocrosslinker (Stratagene). The membrane was rehydrated 
and blocked for at least 30 min at 68°C using QuickHyb™ hybridization solution 
(Stratagene). 25 ng of radio-labeled DNA probes (see 4.2.6) were mixed with 25 µg salmon-
sperm DNA, denatured at 95°C for 5 min and added to QuickHyb™ hybridization solution at 
68°C for overnight hybridization with the membrane. Membranes were washed several times 
with 1xSSC 0.1 % SDS at 68°C under vigorous shaking until only low amounts of 
radioactivity could be detected at the edges of the membrane. X-ray films (Fuji) were 
exposed to the membrane in the presence of an intensifier screen for a few hours to several 
days at -80°C. Films were developed in a photo developer (Agfa).  
4.2.6. Radiolabeling of DNA 
DNA corresponding to the mRNA of interest were amplified by PCR from cDNA or isolated 
by restriction digest from plasmids containing the respective cDNA. 
50 ng of dsDNA was radiolabeled using 5 µCi alpha-32P -dCTP using the PrimeIt (II)- 
Random Prime Labeling Kit™ (Stratagene) according to the manufacturer’s protocol and 
purified using QuickSpin™ Gel Filtration Columns (Roche). Radiolabeled DNA was stored at 
-20°C for up to three weeks.  
4.2.7. DNA methylation analysis of genomic DNA 
Genomic DNA was prepared using the DNEasy Blood and Tissue Kit™ (Qiagen) and 
subjected to bisulfite conversion using the EpiTect Bisulfite Kit™ (Qiagen) according to the 
manufacturer’s protocol. Jumpstart™ Taq polymerase (Sigma Aldrich) was used to amplify 
the IAP-gag region and the Oct4 promoter sequence. PCR primers for bisulfite-converted 
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DNA were either designed using the MethPrimer tool (Li and Dahiya, 2002) or taken from 
previous studies (Rowe et al., 2013a). 
PCR products were subcloned into pBluescript-SK2+ vector (Stratagene) using InfusionHD™ 
cloning (Clontech) and analyzed by Sanger sequencing (Eurofins MWG Operon). 
Methylation analysis of sequencing data was performed using BiQ Analyzer (Bock et al., 
2005). 
4.3. Biochemical methods  
4.3.1. Preparing whole cell protein extracts 
Cells were washed once with 1xPBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2  mM 
KH2PO4) and trypsinized using 1xPBS containing 1 x Trypsin/EDTA (PAA or Sigma Aldrich). 
Cells were resuspended in growth medium and counted using a CasyCounter™ (Roche). 
Equal amounts of cells were washed with 1xPBS and were resuspended in SDS-Buffer (50 
mM Tris/Cl pH 7.5, 2 % SDS, 1x complete™ Roche Protease Inhibitor). Cell lysates were 
incubated at 98°C for 10 to 15 min on a heatblock and centrifuged for 15 min at 17000 x g at 
room temperature. Supernatants were used for western blotting. When required, protein 
concentration was measured using the Pierce™ BCA Protein Assay Kit (Thermo Scientific). 
4.3.2. Preparing nuclear cell extracts by hypotonic lysis 
Cells were washed once with 1xPBS and trypsinized using 1xPBS containing 
1 x Trypsin/EDTA (PAA or Sigma Aldrich). Cells were resuspended in 1xPBS and counted 
using a CasyCounter™ (Roche). Cells were resuspended in at least five pellet volumes of 
swelling buffer A (10 mM HEPES/KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT and 
0.5x complete protease inhibitors (Roche)). Cells were incubated for 10 min on ice, vortexed 
shorty and pelleted for 10 sec at 17.000 x g. Supernatant was discarded and nuclei were 
resuspended in around 30 µl buffer C per 1 Mio cells (20 mM HEPES/KOH pH 7.9, 
25 % (v/v) glycerol, 300 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1x complete protease 
inhibitors (Roche)). Nuclear extract was incubated for 20 min on ice and centrifuged at 
14000 x g for 15 min at 4°C. Supernatant was used for western blot or immunoprecipitation. 
If required, protein concentration was measured using the Bradford Bio-Rad protein assay 
(Bio-rad). 
4.3.3. Immunoprecipitation of Trim28 for mass spectrometry  
Cells were washed once with 1xPBS and trypsinized using 1xPBS containing 
1 x Trypsin/EDTA (PAA or Sigma Aldrich). Cells were resuspended in 1xPBS and counted 
using a CasyCounter™ (Roche). 75 Mio mouse ES cells and 12 Mio MEF cells were 
resuspended in 1 ml DMEM and separated on a Ficoll gradient (20 % Ficoll, 80 mM Tris/Cl 
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pH 7.4, 8 mM MgCl2, 8 mM CaCl2, 1.6 % NP40, 1.28 % TritonX-100, 0.1 % DMSO). Nuclei 
were isolated by centrifugation through Ficoll using the following centrifugation protocol in a 
Hereaus #75006475 rotor: 400 rpm - 30 sec, 500 rpm – 30 sec, 600 rpm – 30 sec, 700 rpm – 
30 sec, 800 rpm – 6 min.  
Nuclei were resuspended in IP Buffer (50 mM Tris/Cl pH 7.5, 0.1 % NP40, 15 % Glycerol, 
300 mM NaCl, 18 µM ZnSO4, 0.5 mM DTT, 1 x complete protease inhibitor) and disrupted 
with two short pulses (20 % power, 3 sec) of a ultrasound sonifier (Branson). 1.5 µl (375 U) 
of Benzonase™ (Merck) was added and lysates were incubated at 37°C for 15 min to digest 
nucleic acids. Lysate was cleared by centrifugation at 17000 x g for 30 min at 4°C and 
supernatant was used for immunoprecipitation. A small aliquot was saved to use as an input 
control. Immunoprecipitation was carried out with 50 µl Flag-M2 affinity agarose (Sigma 
Aldrich) for 2 h at 6°C. Beads and immunoprecipitated material were transferred into fresh 
reaction tubes, washed three times with IP buffer and eluted in 2x Roti®-Load 1 sample 
buffer (Roth) for 5 min at 95°C.  
4.3.4. Other immunoprecipitation protocols used in this study 
Daxx, Trim28 and Atrx-immunoprecipitation experiments were performed as indicated in 
4.3.3, except that Benzonase™-treated nuclear extracts were prepared by hypotonic lysis 
and buffer C (see 4.3.2) was used as an IP-buffer.  
Co-immunoprecipitation of H3.3 by FLAG-immunoprecipitated DAXX mutants was performed 
as described elsewhere (Elsasser et al., 2012), except that RNase A was used instead of 
RNase I and beads were washed three times instead of two times after immunoprecipitation.  
4.3.5. Western blotting 
Roti®-Load 1 (Roth) Laemmli sample buffer was added to protein extracts. Samples were 
incubated at 95°C for 3 min, centrifuged for 2 min at 17000 x g at room temperature and 
loaded onto precast SDS gels (SERVA) or self-made SDS gels. After separation of proteins 
by SDS-PAGE, proteins were blotted onto PVDF membranes in a wet-blotting chamber 
(Bio-Rad) at 400 mA for 1.5 h at 6°C using ice-packs.  
Membranes were blocked with 5 % skim milk (Santa Cruz or Heirler Cenovis) in 1xTBS 
(20 mM Tris/Cl, pH 7.6, 150 mM NaCl) for at least 30 min under mild agitation. Primary 
antibody incubation was performed between 1 h to 16 h in 1 % skim milk in 1xTBST 
(0.1 % Tween-20 in 1xTBS). Membranes were rinsed two times in 1xTBST and washed 
three times for 5 min in 1xTBST. Incubation with ECL-coupled secondary antibodies was 
performed for 1.5 h in 1 % skim milk in 1xTBST. Again, membranes were rinsed two times in 
1xTBST and washed three times for 5 min in 1xTBST. Chemoluminescence signals were 
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detected using Immobilon™ Western kit (Millipore) and X-ray films (Fuji) according to the 
manufacturer’s protocol. 
4.3.6. Chromatin immunoprecipitation (ChIP) 
Cells were washed once with 1xPBS and trypsinized using 1xPBS containing Trypsin/EDTA 
(PAA or Sigma Aldrich). Cells were resuspended in growth medium and counted. Twenty to 
thirty million cells were washed with 1xPBS and crosslinked in 10 ml of 1 % under mild 
agitation. For Atrx-ChIPs EGS (ethylene glycol bis[succinimidylsuccinate]) (Pierce - Thermo 
Scientific) was added to a final concentration of 2 mM to crosslink proteins for 30 min at room 
temperature before crosslinking with 1 % methanol-free formaldehyde in 1xPBS for 10 min at 
room temperature. Crosslinking was quenched by adding 2.5 M glycine to a final 
concentration of 125 mM. Crosslinked cells were washed two times with 1xPBS and cell 
pellets were either snap-frozen and stored at -80°C or directly processed. 
Cells were resuspended in 1 ml lysis buffer (10 mM Tris/Cl pH 8.0, 1 mM EDTA, 
0.5 mM EGTA, 0.25 % SDS, 0.1 % Sodium deoxycholate, 200 mM NaCl, 1x complete 
protease inhibitor) and sheared at 4°C to a chromatin size between 150 bp and 800 bp using 
focused-ultrasonification (Covaris). 10 % Triton-X100 was added to the lysates to a final 
concentration of 1 % and lysates were cleared by centrifugation at 14000 x g for 30 min at 
4°C. 
Nine volumes of IP buffer (20 mM Tris/Cl pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 1 % Triton, 
167 mM NaCl, 1x complete protease inhibitor) were added to one volume of lysate. 1 ml of 
diluted lysate was used for immunoprecipitation with 3-5 µg of antibody prebound to 
magnetic Protein G Dynabeads™ (Life Technologies) over night. After over night incubation 
beads were transferred into fresh reaction tubes and washed three times with IP buffer and 
once with 1 x STE buffer (50 mM NaCl, 10 mM Tris/Cl pH 8.0, 1 mM EDTA). 
Immunoprecipitated DNA was eluted from beads in elution buffer (50 mM Tris/Cl pH 8.0, 
50 mM NaHCO3, 1x SDS, 10 mM EDTA) at 65°C for 30 min under vigorous shaking. 
DNA-Protein crosslinks were reversed by incubating the immunoprecipitated material or input 
chromatin for 4 to 16 h at 65°C in elution buffer supplemented with 200 mM NaCl. 
Immunoprecipitated material was then diluted by the addition of one volume 1 x TE buffer 
(10 mM Tris/Cl pH8.0, 1 mM EDTA) and incubated for 30 min with 10 µg/µl RNaseA 
(Sigma Aldrich) at 37°C and 2–4 h with 20 µg/ml Proteinase K at 56°C (Bioline). DNA was 
purified using QIAquick™ PCR purification Kit (Qiagen) according to the manufacturer’s 
protocol and enrichment of specific DNA regions was analyzed by qPCR.  
114   4. Material and methods 
 
4.3.7. Silver staining of protein gels 
Protein gels were fixed with 40 % ethanol/10 % acetic acid for 2 h or overnight and washed 
three times with 30 % ethanol for 20 min. Then, protein gels were treated with 
0.02 % Na2S2O3 for 1 min and washed three times with water for 20 seconds. Protein gels 
were treated with 0.2 % AgNO3 for one hour in the dark and were washed again three times 
with water for 20 seconds. Ag+ ions bound to proteins were then reduced to elemental silver 
for 5-10 min with a reducing developing buffer (3 % Na2CO3, 0.05 % formaldehyde, 0.0004 % 
Na2S2O3). Reduction was quenched by washing the protein gels once with water and rinsing 
the gel for 5 min in 0.5 % glycine. Gels were washed once more with water for 30 min, 
photographed and stored at 4°C until the gel was cut for mass-spectrometry analysis.  
4.3.8. Sample preparation for mass-spectrometry 
To prepare samples for mass spectrometry, immunoprecipitated proteins were separated by 
gel electrophoresis and stained by silver staining. Gel lanes were cut into eight pieces 
corresponding to different ranges of molecular weights. The gel pieces were shredded into 
smaller fragments and transferred into 200 µl PCR tubes for further processing.  
Gel pieces were incubated two times with 100 µl water, two times with 100 µl 20 mM NH4CO3 
and three times with 100 µl acetonitril (10 min for every incubation step). Samples were then 
rehydrated and reduced with 50 µl 10 mM DTT/20 mM NH4CO3 for 1 h and alkylated with 
50 µl 55 mM iodoacetamide/20 mM NH4CO3 for 30 min. Gel pieces were then washed 10 min 
with 100 µl 20 mM NH4CO3 and dehydrated again by incubating them three times for 10 min 
with 100 µl acetonitril. 10-15 µl of a 25 ng/µl solution of sequencing-grade Trypsin (Promega) 
in 20 mM NH4CO3 was added and gel pieces were incubated for 30 min at 4°C. Non-
absorbed trypsin was removed and 50 µl 20 mM NH4CO3 was added before incubating the 
gel pieces over night at 37°C on a PCR-tube shaker. After overnight incubation 50 µl 50 % 
acetonitril, 0.25 % trifluoroacetic acid was added for 10 min and the supernatant containing 
trypsinized peptides was transferred into a fresh PCR tube. This extraction step was 
repeated once under the same conditions and twice using pure acetonitril. Supernatants 
containing extracted were pooled and peptides were dried in a speedvac centrifuge. Peptides 
were resolubilized in 10 µl of 0.1 % trifluoroacetic acid and stored at -20°C until final 
processing and loading on the liquid chromatography column coupled to an orbitrap mass 
spectrometer (Thermo Scientific).   
The final processing, handling of the mass spectrometer and peptide analysis using the 
Scaffold3™ software was performed by Dr. Ignasi Forné.  
4.3.9. DNA pull-down experiments and SILAC 
DNA pull-down experiments have been carried out by Dr. Falk Butter as described earlier 
(Butter et al., 2010). 
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4.4. Cell biology methods 
4.4.1. Cell culture of mES cells and MEF cells 
Cell lines were cultured at 37°C, 5 % CO2 under standard procedures as described earlier 
(Dambacher et al., 2012). 
4.4.2. Transfection of mouse ES cells, MEF cells and HeLa cells 
Mouse embryonic stem cell lines were transfected with Jetprime™ (Polyplus) in a 2:1 ratio of 
transfection reagent vs. plasmid according to the manufacturer’s protocol. MEF cell lines 
were transfected using Jetprime™ (Polyplus), Lipofectamine2000™ (Life Technologies) or 
MirusLT-1™ (Mirus) according to the manufacturer’s protocol. HeLa cell lines were 
transfected using FugeneHD™(Roche) using the manufacturer’s protocol.  
4.4.3. Transfection of HEK293T cells and lentivirus production 
HEK293T cells were transfected using the calcium phosphate transfection method for 
producing lentivirus. HEK293T cells were never grown longer than fifteen passages and kept 
in MEF medium containing 500 µg/ml G418 (PAA). Cells were always maintained 
subconfluent until being used for virus production. Five million HEK293T cells were seeded 
onto 10 cm dishes in growth medium without G418. On the next day the medium was 
replaced with fresh growth medium without G418 one hour before transfection. For 
transfection, a mix of 24 µg plasmid DNA consisting of 8 µg lentiviral transfer vector, 8 µg 
psPAX2 and 8 µg pLP-eco-env was mixed with 120 µl of 2.5 M CaCl2 and adjusted to 
1200 µl with sterile water. Occasionally, the amount of lentiviral transfer vector was increased 
proportionally to its size when very large lentiviral transfer vectors (>10 kb) were used to 
ensure an equimolar ratio between packaging plasmids. Then, 1200 µl 2xHBS solution 
(HEPES 50 mM, NaCl 280 mM, Na2HPO4 1.5 mM, adjusted to pH 7.05 with NaOH) was 
added slowly and dropwise to the mix while vortexing it gently on a vortexer (Scientific 
Industries). The transfection mix was added immediately to the cells. Four to eight hours 
after transfection the medium which contained precipitates of calcium phosphate and DNA 
was removed, cells were washed with 1xPBS and fresh growth medium without G418 was 
added. Virus supernatant was harvested 48 h after transfection. Viral supernatants were 
harvested a second time 72 h after transduction when a maximum amount of lentiviral 
particles was required. Viral supernatants were centrifuged at 3000 x g for 5 min at room 
temperature to pellet cells and cellular debris before the supernatant was decanted, 
aliquoted, snap frozen in liquid nitrogen and stored at -80°C until further use.  
For genome-wide shRNA screening, viral supernatants of GAG2-EGFP reporter virus and 
EGFP control virus were concentrated by polyethylenglycol precipitation. One volume of 
precipitation-solution (42.5 % (w/v) polyethylenglycol 8000, 1.33 M NaCl) was mixed with 
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three volumes of viral supernatant and incubated 30 min to overnight at 4°C. Virus was 
pelleted by centrifugation at 1,500 x g for 45 minutes at 4°C. The pellet was gently 
resuspended in 1/100th of the original volume of the supernatant in DMEM (Sigma Aldrich) 
and virus was stored at -80°C.  
4.4.4. Lentiviral transduction  
Mouse ES cells were seeded on gelatinized 6-well or 12-well dishes in ES medium 
containing 8 µg/ml polybrene™ (Hexadimethrinbromid H9268 – Sigma Aldrich) and viral 
supernatant was added to the cells. 6-well or 12-well plates were spun in a prewarmed 
centrifuge at 1000 x g for 1 h at 34°C to enhance viral transduction. After centrifugation the 
medium was carefully replaced by ES medium. Cells were either assayed by FACS or split 
two days after transduction. When required, selection antibiotics were added 48 h after 
transduction to generate stable cell lines. The concentrations used were experimentally 
determined for every individual cell line. 
Concentrations used:  180 – 360 µg/ml G418 (PAA) 
 0.4 – 2 µg/ml puromycin (Sigma Aldrich)  
150 µg/ml hygromycin B (PAA) 
MEF and HeLa cells were transduced accordingly except for minor differences. MEF and 
HeLa cells were seeded one day before transduction on standard 6-well or 12-well dishes 
and different concentrations of selection antibiotics were used.  
Concentrations used:  300 µg/ml hygromycin B (PAA)  
1.2 – 2.5 µg/ml puromycin (Sigma Aldrich). 
Virus titers of EGFP reporter lentivirus were compared by titrating viral supernatants. For 
this, different amounts of viral supernatant were used to transduce 100.000 T37 HeLa cells 
and the percentage of EGFP-positive was determined two days later with a Canto™ FACS 
counter (Becton Dickinson). The percentage of EGFP-positive cells was tried to be kept 
below 15 % to ensure a linear relationship between the amount of used virus and virus 
transduction. The number of infectious particles per volume was calculated with the following 
formula:  n x r / v = transduction particles / ml                   
n = cell number at time of transduction, r = percentage of green cells 48 h post transduction, 
v = volume of viral supernatant used for transduction 
4.4.5. Lentiviral knockdown experiments 
Lentiviral shRNA sequences were taken from the TRC library (Moffat et al., 2006) or 
designed according to the TRC library guidelines (http://www.broadinstitute.org/rnai/public/). 
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Cloning of shRNA sequences into the lentiviral pLKO1 vector was performed as described 
earlier (Dambacher et al., 2012). 
Cell lines were selected with puromycin 48 h after transduction. Knockdown cell lines were 
used for reporter assays starting at day four to six days after shRNA transduction. 
Knockdown was evaluated by qRT-PCR or western blotting at day four to six after shRNA 
transduction. 
4.4.6. Genome-wide lentiviral shRNA screen and secondary screen 
The two genome-wide shRNA screening has been performed as described in section 2.12. 
W9 MEFs and wt26 mouse ES cells were used for the two different screens, because they 
performed best in terms of transduction capability and signal to noise ratio.  
The amount of required shRNA lentivirus was predetermined by transducing both cell lines 
with a known concentration of pLKO1-Ubi-EGFP-puro transduction particles (Sigma Aldrich), 
followed by puromycin selection. 
For the MEF/Zfp809 screen W9 cells were seeded on ten 15 cm dishes one day before 
transduction (1.8 Mio W9 cells /15 cm dish). Cells were transduced in 10 ml of growth 
medium containing 8 µg/ml polybrene™ with pooled Lentiplex™ shRNA viruses (Sigma 
Aldrich) with a multiplicity of infection < 0.3. Medium was changed the next day. 48 h after 
transduction transduced cells were selected with 1.2 µg/ml puromycin and split 1:2. 
Puromycin selection was continued until the end of the experiment. Four days after 
transduction cells were pooled and split on thirty 6-well plates (200.000 cells / well). On the 
next day cells were transduced with 1xZfp809-bs-EGFP reporter-lentivirus and EGFP control 
virus at an MOI of 1 and split onto thirty 15 cm dishes. Cells were maintained on thirty 15 cm 
dishes and after additional eight days EGFP-positive cells were sorted using a MoFlo cell 
sorter (Becton Dickinson) and genomic DNA was isolated using DNEasy Blood and Tissue 
Kit™ (Qiagen). Sequencing of stably integrated shRNA sequences was performed by the 
shRNA sequencing core facility at Partners Healthcare center (MA, USA).  
The mES/GAG screen was performed with wt26 feeder-independent mouse ES cells growing 
on gelatinized tissue culture plates. Apart from using different EGFP reporter constructs the 
screening experiment was identical to the MEF/Zfp809 screen, except that cells were 
transduced directly after seeding and different time points were used for transduction, 
selection and sorting (see Figure 2.12). In addition, 0.4 µg/ml puromycin was used instead of 
1.2 µg/ml puromycin to select stably transduced cells. 
After preparation of genomic DNA, a small amount of DNA was used to PCR-amplify shRNA 
sequences that were enriched in the EGFP-positive cell fraction. PCR was performed using 
Q5 polymerase according to the manufacturer’s protocol using pLKO1-specific primer 
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sequences (5’-cgagactagcctcgagc-3’ and 5’-ctgcgagggtactagtgag-3’ - PCR protocol: 98°C 1 
min, 32x [98°C for 20 sec, 63°C for 20 sec, 72°C for 23 sec], 72°C for 5 min). PCR products 
were gel-purified and cloned into pLKO1 using InfusionHD™ (Clontech). 75 individual 
lentiviral shRNA vectors were isolated. This small candidate library prepared out of the 
primary screen was used for a secondary screen.  
For secondary screening 293T cells were seeded on a 96-well plate. After one day 293T 
cells were co-transfected with lentiviral packaging plasmids and the individual shRNA 
transfer vectors using Jetprime™ (Polyplus). Two days after transfection viral supernatants 
were used to transduce wt26 cells seeded on a 96-well plate in the presence of 8 µg/ml 
polybrene™. Two days after transduction wt26 cells were selected with puromycin for stable 
integration of the shRNA-cassette. After another two days knockdown cell lines were 
separated onto two 96-well plates and were either transduced with a GAG2-EGFP reporter 
virus or an EGFP control virus. Silencing capability was calculated by normalizing the 
number of EGFP-positive cells from the GAG2-EGFP reporter virus to the EGFP control 
virus. ShRNA vectors resulting in a strong derepression of GAG2-silencing were sequenced 
using Sanger sequencing.   
4.4.7. Luciferase Assay 
For luciferase experiments MEF cells were seeded on a 96-well plate one day before 
transfection. 150 ng pGL3-5xUAS-firefly plasmid, 7.5 ng Gal4-fusion plasmid and 7.5 ng 
renilla plasmid were transfected into MEF cells using Lipofectamin2000 (Life Technologies) 
according to the manufacturer’s protocol and luciferase activity was monitored using the 
Dual-Luciferase® Reporter Assay System™ (Promega). Luciferase experiments were 
performed in triplicates.  
4.4.8. FACS counting and FACS sorting 
The number of EGFP-positive cells was measured using a Canto™ FACS counter (Becton 
Dickinson) normally two days after lentiviral reporter transduction or transfection of EGFP 
plasmids. Cells were washed once with 1xPBS and trypsinized using 1xPBS containing 
Trypsin/EDTA (PAA or Sigma Aldrich). Cells were resuspended, stored on wet ice and 
immediately used for FACS analysis. 
For genome-wide shRNA screening, cells were stored in growth medium on ice until being 
sorted using a MoFlo™ FACS sorter (Becton Dickinson). Cell sorting was performed by Dr. 
Joachim W. Ellwart at Helmholtz Zentrum Munich. 
4.4.9. Measurement of DNA-content by PI-FACS  
Cells were washed once with 1xPBS, trypsinized using 1xPBS containing Trypsin/EDTA 
(PAA or Sigma Aldrich), resuspended in growth medium and counted using a Casy 
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Counter™ (Roche). An equal number of cells of every cell line was washed twice in 1xPBS 
and resuspended in 1xPBS. -20°C cold methanol was added slowly to the cell suspension 
under very gentle vortexing until reaching a final concentration of 70 % methanol (v/v). Cells 
were fixed for 1 h at 4°C or over night at -20°C. After fixation, cells were washed once with 
1xPBS and were resuspended in PI staining buffer (40 µg/ml propidium iodide, 3.8 mM 
sodium citrate in 1xPBS, 10 µg/ml RNase A). After incubation for 1 h at 37°C, cells were 
analyzed using a Canto™ FACS counter (Becton Dickinson) using the PE-channel in linear 
mode. Data analysis was performed using FlowJo™ software (TreeStar).   
4.4.10. Generating knockout cells using CRISPR/Cas9 
Knockout of genes in mouse ES cells was performed by RNA-guided Cas9 nucleases using 
the pX330 plasmid (Cong et al., 2013; Hsu et al., 2013). Guide RNA sequences were 
manually identified close to PAM sequences (5’-NGG-3’) in the genome or designed using an 
online bioinformatic webinterface (http://crispr.mit.edu/) (Hsu et al., 2013). DNA 
oligonucleotides corresponding to the guide RNA sequence were annealed and ligated into 
Bbs1 cut pX330 plasmid as described elsewhere (Cong et al., 2013). 
300.000 mouse ES were seeded one day before transfection on 6-wells and were 
transfected using Jetprime™ (Polyplus) reagent.   
Transfection protocol: 200 µl Jetprime™ buffer, 3.1 µg of pX330 plasmid, 0.3 µg of a plasmid 
with puromycin resistance (pLenti6-EF1a-FLAG IRES PURO) and 6.6 µl Jetprime™ reagent 
were mixed and vortexed shortly. After incubation for 15 min at room temperature the 
transfection mix was added to the cells and the medium was changed after 8 to 16 h.  
Two days after transfection highly transfected cells were selected with 1.5 µg/ml puromycin 
for 16 to 24 h. Cell were then washed with medium without puromycin and cell cultivation 
was continued without puromycin. This short selection step significantly enriches for cells 
carrying mutations (Wang et al., 2013).  
Transfected cells were seeded sparsely to allow picking of individual colonies. Clonal cell 
lines were analyzed by western blotting or by PCR and Sanger sequencing.  
4.4.11. Recombinase-mediated cassette exchange (RMCE) and inducible expression 
HA36 mouse ES cells that carry a selection cassette allowing positive and negative selection 
were provided by Prof. Dr. Dirk Schübeler (FMI Basel) and have been described elsewhere 
(Baubec et al., 2013; Lienert et al., 2011b). Recombinase-mediated cassette exchange was 
performed as described earlier (Baubec et al., 2013; Lienert et al., 2011b), except for minor 
changes in the protocol.  
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HA36 cells were maintained in 150 µg/ml hygromycinB (PAA) until transfection and 
transfected using Jetprime™ transfection reagent (Polyplus). 
Transfection protocol: 500 µl Jetprime™ buffer, 8 µg of L1-poly-1L/TetO-EGFP-T2A-Zeo-
GAG2.22-pA, 1.5 µg of pIC-Cre, 0.5 µg pCAG-Cre and 20 µl Jetprime™ reagent were mixed 
and vortexed shortly. After incubation for 15 min at room temperature the transfection mix 
was added to the cells and the medium was changed after additional 16 h. 70 h after 
transfection 3 µM Ganciclovir (Invivogen) was added to the medium for the next six days in 
order to select for recombined cell clones. Clonal cell lines were tested for successful 
integration of the reporter by PCR. Inducible expression of the EGFP reporter was tested by 
doxycyclin treatment and FACS analysis after transducing the cells with a lentivirus 
containing a reverse tet-transactivator (plasmid # 1308).  
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5. Abbreviations  
aa amino acids 
Atf7ip Activating transcription factor 7-interacting protein 1 (different name for mAM, Mcaf1) 
Atrx   Alpha thalassemia/mental retardation syndrome X-linked 
bp base pair 
BS binding site 
Cas9 CRISPR-associated endonuclease 9 
Cbx chromobox protein homolog (a family of proteins)  
cDNA complementary DNA 
ChIP chromatin immunoprecipitation 
CMV/LTR cytomegalovirus/long terminal repeat hybrid promoter (a DNA sequence element of 
lentiviral vectors)  
Co-IP   co-immunoprecipitation 
CpG a dinucleotide of cytosine and guanine (a substrate for DNA methylation) 
CRISPR clustered regularly interspaced short palindromic repeats 
Daxx   Death domain-associated protein protein 6 
dko double knockout  
DNA deoxyribonucleic acid 
eco M-MLV env ecotropic envelope protein of the Moloney-Murine-Leukemia-Virus 
EGFP   enhanced green fluorescent protein (a recombinant protein )  
EGFP+   enhanced green fluorescent protein positive  
FACS   fluorescence-activated cell sorting/counting 
FITC channel Fluorescein isothiocyanate channel (FACS channel detecting green fluorescence) 
G418   Geneticin ( a selection antibiotic) 
GAG   group-specific antigen 
GAG2.22 sequence element of the group specific antigen coding region of IAP-Ez 
retrotransposons that is capable of recruiting heterochromatic repression in mES cells 
Gal4-DBD DNA-binding domain of the Gal4 transcription factor 
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gRNA guide RNA 
H3.3 histone H3.3  
H3f3a and H3f3b mouse genes encoding the histone H3.3 protein 
H3K27ac acetylation of Lysine 27 of Histone H3 
H3K4me1 mono-methylation of Lysine 4 of Histone H3 
H3K9me1,2 or 3 Histone 3 Lysine 9 monomethylation, dimethylation or trimethylation 
H4K20me1,2 or 3  Histone 4 Lysine 20 monomethylation, dimethylation or trimethylation 
HA   hemagglutinin (a polypeptide tag) 
hEF1α   human elongation factor 1 alpha promoter 
HEK293T human embryonic kidney cell line 293 transformed with the large-T-antigen of SV40 
virus   
HeLa a human cervix carcinoma cell line 
Hp1 heterochromatin protein 1 (in mammals three genes encode for Hp1 proteins – Cbx1, 
Cbx3 and Cbx5)  
HygR-HSV-TK a recombinant selection marker generated by the fusion of the hygromycin resistance 
gene and the thyimidin kinase of Herpes Simplex Virus allowing positive and negative 
antibiotic selection 
IAP   Internal A-type Particle (a mouse LTR retrotransposons subclass) 
IAP-E   Internal A-type Particle containing an envelope gene 
IP   immunoprecipitation 
IRES internal ribosomal entry site 
Kap1   KRAB-associated protein 1 (alternative name for Trim28) 
ko knockout  
LC-MS/MS   liquid chromatography coupled to tandem mass spectrometry 
LTR long terminal repeat (a big subclass of retrotransposons) or  
regulatory sequence element actually flanking the retrotransposon sequence 
M18bp1 Mis18-binding protein 1  
mAM murine Atf7a associated modulator (different name for Atf7ip, Mcaf1) 
Mcaf1 MBD1-containing chromatin-associated factor 1 (different name for mAM, Atf7ip) 
MEF   mouse embryonic fibroblasts 
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mES cells  mouse embryonic stem cells 
M-MLV   Moloney-Mouse Leukemia Virus (a mouse retrovirus) 
MOI multiplicity of infection (value that accounts for the ratio of transduction particles 
relative to the number of cells) 
mPGK mouse phosphoglycerate kinase  
mRNA messenger-RNA 
neoR neomycin resistance gene (gene encoding an enzyme conferring resistance to 
neomycin or its derivates like G418) 
Oct-4 octamer-binding transcription factor 4 (Pou5f1) 
ORF open reading frame 
PAM protospacer adjacent motif  
PCR polymerase chain reaction 
PE channel Phycoerythrin channel (FACS channel detecting yellow fluorescence) 
PI propidium-iodide 
PML promyelocytic leukemia (a protein that can form distinct nuclear aggregates called 
“PML nuclear bodies”) 
Pol   polymerase 
Polrmt mitochondrial DNA-directed RNA polymerase 
Pro   protease 
qPCR quantitative PCR 
RBCC domain   N-terminal RING finger/B-box/coiled coil (a protein domain of Trim28) 
Rev Regulator of Expression of Virion Proteins (an HIV-1 protein) 
RGN RNA-guided nucleases 
RMCE recombinase-mediated cassette exchange 
RNA ribonucleic acid 
RRE    rev-response element (a DNA sequence element of lentiviral vectors) 
 
cPPT   central polypurine tract (a DNA sequence element of lentiviral vectors) 
RT reverse transcriptase 
RT-qPCR reverse transcriptase quantitative PCR 
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rtTA reverse tet-transactivator (a recombinant protein used for the generation of inducible 
promoters) 
Scr scrambled  
 
sgRNA small-guide RNA 
shRNA short hairpin RNA  
shRNA-seq short hairpin RNA- sequencing 
SILAC  stable isotope labeling by amino acids in cell culture 
SIM Sumo-interaction motif 
SINΔU3 LTR self-inactivating long terminal repeat promoter lacking the U3 sequence (a DNA 
sequence element of lentiviral vectors) 
SV40ori   origin of replication of the SV40 virus 
TAC   thesis advisory committee 
T2A 2a-type self-cleavage peptide of the Thosea asigna virus  
Tat Trans-Activator of Transcription (an HIV-1 protein) 
Tia1 T-cell-restricted intracellular antigen-1 
Tif1b   Transcription intermediary factor 1-beta (alternative name for Trim28) 
TRE Tet response element: Tet operator sequences upstream of a minimal cytomegalovirus 
promoter (an inducible promoter sequence) 
Trim28   Tripartite motif containing 28 (also known as Kap1, Tif1β) 
UAS upstream activating sequence (binding site of Gal4) 
Uniprot-ID  identification code of a protein in the uniprot database 
UTR   untranslated region 
zeoR resistance gene conferring resistance to Zeocin™ 
Zfp809 Zinc finger Protein 809  
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Genes targeted by two to four independently scoring shRNAs in the 
1xZfp809/MEF shRNA screen (genes targeted by 1 shRNA are available upon 
request) 
Sequences encoded by the shRNA code can be obtained at www.sigmaaldrich.com 
(genes are sorted by the number of scoring shRNAs and in alphabetical order) 
shRNA code targeted gene # of scoring shRNAs 
TRCN0000071364 Trim28 3 
TRCN0000071366 Trim28 3 
TRCN0000071363 Trim28 3 
TRCN0000027605 Gak 3 
TRCN0000027663 Gak 3 
TRCN0000027649 Gak 3 
TRCN0000070170 Asna1 2 
TRCN0000070172 Asna1 2 
TRCN0000174364 Atl2 2 
TRCN0000174949 Atl2 2 
TRCN0000070086 Atp5g3 2 
TRCN0000070083 Atp5g3 2 
TRCN0000100102 BC053393 2 
TRCN0000100100 BC053393 2 
TRCN0000081436 Bpnt1 2 
TRCN0000081433 Bpnt1 2 
TRCN0000030679 Capn9 2 
TRCN0000030681 Capn9 2 
TRCN0000069880 Catsper1 2 
TRCN0000069879 Catsper1 2 
TRCN0000200374 Ccdc53 2 
TRCN0000176446 Ccdc53 2 
TRCN0000124012 Coq2 2 
TRCN0000124010 Coq2 2 
TRCN0000120845 Csn3 2 
TRCN0000120842 Csn3 2 
TRCN0000068246 Cxcl11 2 
TRCN0000068245 Cxcl11 2 
TRCN0000028750 Cxcr4 2 
TRCN0000028678 Cxcr4 2 
TRCN0000176612 Fam72a 2 
TRCN0000178544 Fam72a 2 
TRCN0000119660 Fgb 2 
TRCN0000119658 Fgb 2 
TRCN0000067181 Fgf18 2 
TRCN0000067179 Fgf18 2 
TRCN0000065926 Icam1 2 
TRCN0000065924 Icam1 2 
TRCN0000112345 Itm2a 2 
TRCN0000112348 Itm2a 2 
TRCN0000076642 Lpo 2 
TRCN0000076640 Lpo 2 
TRCN0000194167 Mios 2 
128   8. Appendix 
 
shRNA code targeted gene # of scoring shRNAs 
TRCN0000175108 Mios 2 
TRCN0000125029 Mlec 2 
TRCN0000125030 Mlec 2 
TRCN0000124857 Mrgpra8 2 
TRCN0000124855 Mrgpra8 2 
TRCN0000075816 Oas2 2 
TRCN0000075817 Oas2 2 
TRCN0000111781 Pcif1 2 
TRCN0000111784 Pcif1 2 
TRCN0000091414 Plek2 2 
TRCN0000091417 Plek2 2 
TRCN0000078752 Rsph1 2 
TRCN0000078751 Rsph1 2 
TRCN0000120986 Rufy3 2 
TRCN0000120982 Rufy3 2 
TRCN0000123596 Safb2 2 
TRCN0000123598 Safb2 2 
TRCN0000070316 Slc14a2 2 
TRCN0000070314 Slc14a2 2 
TRCN0000080166 Smoc2 2 
TRCN0000080163 Smoc2 2 
TRCN0000110485 St6galnac1 2 
TRCN0000110487 St6galnac1 2 
TRCN0000119932 Tceanc 2 
TRCN0000119935 Tceanc 2 
TRCN0000102619 Tial1 2 
TRCN0000102615 Tial1 2 
TRCN0000124538 Tm7sf2 2 
TRCN0000124537 Tm7sf2 2 
TRCN0000108812 Tpm4 2 
TRCN0000108813 Tpm4 2 
TRCN0000124572 Vangl2 2 
TRCN0000124570 Vangl2 2 
TRCN0000084307 Zfp131 2 
TRCN0000084303 Zfp131 2 
TRCN0000084687 Zfp646 2 
TRCN0000084686 Zfp646 2 
TRCN0000096114 Zfp668 2 
TRCN0000096115 Zfp668 2 
TRCN0000088677   2 
TRCN0000120396   2 
TRCN0000023983   2 
TRCN0000120394   2 
TRCN0000023980   2 
TRCN0000174122   2 
TRCN0000088676   2 
TRCN0000067570   2 
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Genes targeted by two to four independently scoring shRNAs in the 
GAG2/mES-cell shRNA screens (genes targeted by 1 shRNA are available upon 
request) 
Sequences encoded by the shRNA code can be obtained at www.sigmaaldrich.com  
(genes are sorted by the number of scoring shRNAs and in alphabetical order) 
shRNA code targeted gene # of scoring shRNAs 
TRCN0000070989 Top2b 4 
TRCN0000070992 Top2b 4 
TRCN0000070991 Top2b 4 
TRCN0000070990 Top2b 4 
TRCN0000091125 Actrt2 3 
TRCN0000091126 Actrt2 3 
TRCN0000091127 Actrt2 3 
TRCN0000108577 Dach2 3 
TRCN0000108576 Dach2 3 
TRCN0000108575 Dach2 3 
TRCN0000070846 Hoxb3 3 
TRCN0000070844 Hoxb3 3 
TRCN0000070843 Hoxb3 3 
TRCN0000106089 Rundc3b 3 
TRCN0000106087 Rundc3b 3 
TRCN0000106088 Rundc3b 3 
TRCN0000086331 Zbtb20 3 
TRCN0000086328 Zbtb20 3 
TRCN0000086329 Zbtb20 3 
TRCN0000189745 1110012L19Rik 2 
TRCN0000201569 1110012L19Rik 2 
TRCN0000034371 A430107D22Rik 2 
TRCN0000034373 A430107D22Rik 2 
TRCN0000113480 Abcf3 2 
TRCN0000113482 Abcf3 2 
TRCN0000110442 Abo 2 
TRCN0000110444 Abo 2 
TRCN0000124737 Acbd3 2 
TRCN0000124736 Acbd3 2 
TRCN0000113267 Acot5 2 
TRCN0000113268 Acot5 2 
TRCN0000085625 Aff1 2 
TRCN0000085623 Aff1 2 
TRCN0000095170 AI854703 2 
TRCN0000095173 AI854703 2 
TRCN0000090848 Ank2 2 
TRCN0000090852 Ank2 2 
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shRNA code targeted gene # of scoring shRNAs 
TRCN0000082088 Ankrd6 2 
TRCN0000082090 Ankrd6 2 
TRCN0000113120 Ap4s1 2 
TRCN0000113124 Ap4s1 2 
TRCN0000100371 Arf1 2 
TRCN0000100373 Arf1 2 
TRCN0000100776 Arfgap3 2 
TRCN0000100779 Arfgap3 2 
TRCN0000110025 Arhgef7 2 
TRCN0000110027 Arhgef7 2 
TRCN0000124730 Asah2 2 
TRCN0000124731 Asah2 2 
TRCN0000086218 Asb8 2 
TRCN0000086219 Asb8 2 
TRCN0000110635 Aspm 2 
TRCN0000110636 Aspm 2 
TRCN0000112870 Atp1b2 2 
TRCN0000112872 Atp1b2 2 
TRCN0000197685 Bend3 2 
TRCN0000197391 Bend3 2 
TRCN0000096898 Bzw1 2 
TRCN0000096895 Bzw1 2 
TRCN0000103598 Caskin2 2 
TRCN0000103597 Caskin2 2 
TRCN0000071051 Cbx5 2 
TRCN0000071050 Cbx5 2 
TRCN0000112846 Chac2 2 
TRCN0000112847 Chac2 2 
TRCN0000089301 Cklf 2 
TRCN0000089300 Cklf 2 
TRCN0000068673 Cnga2 2 
TRCN0000068674 Cnga2 2 
TRCN0000089943 Col24a1 2 
TRCN0000089944 Col24a1 2 
TRCN0000125698 Coro7 2 
TRCN0000125696 Coro7 2 
TRCN0000032880 Cpb2 2 
TRCN0000032881 Cpb2 2 
TRCN0000110597 Cpt1a 2 
TRCN0000110599 Cpt1a 2 
TRCN0000109565 Creld2 2 
TRCN0000109568 Creld2 2 
TRCN0000106327 Crispld1 2 
TRCN0000106325 Crispld1 2 
TRCN0000080152 Cst8 2 
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shRNA code targeted gene # of scoring shRNAs 
TRCN0000080148 Cst8 2 
TRCN0000032651 Ctsg 2 
TRCN0000032650 Ctsg 2 
TRCN0000108776 Diap3 2 
TRCN0000108775 Diap3 2 
TRCN0000024848 Dlg3 2 
TRCN0000024844 Dlg3 2 
TRCN0000008543 Dnajc1 2 
TRCN0000008541 Dnajc1 2 
TRCN0000120976 Dnajc17 2 
TRCN0000120974 Dnajc17 2 
TRCN0000115464 Dnajc9 2 
TRCN0000115462 Dnajc9 2 
TRCN0000190448 Dos 2 
TRCN0000189591 Dos 2 
TRCN0000105874 Efs 2 
TRCN0000105870 Efs 2 
TRCN0000031369 Egfbp2 2 
TRCN0000031372 Egfbp2 2 
TRCN0000201234 Eif4e2 2 
TRCN0000190491 Eif4e2 2 
TRCN0000009806 Eif4g2 2 
TRCN0000009810 Eif4g2 2 
TRCN0000181801 Fam123b 2 
TRCN0000198974 Fam123b 2 
TRCN0000076322 Farsb 2 
TRCN0000076318 Farsb 2 
TRCN0000191859 Fermt2 2 
TRCN0000191858 Fermt2 2 
TRCN0000100110 Gab1 2 
TRCN0000100111 Gab1 2 
TRCN0000041476 Gapdhs 2 
TRCN0000041477 Gapdhs 2 
TRCN0000194469 Gp1ba 2 
TRCN0000175201 Gp1ba 2 
TRCN0000102902 Grid2 2 
TRCN0000102900 Grid2 2 
TRCN0000092857 Hist2h3c1 2 
TRCN0000092853 Hist2h3c1 2 
TRCN0000085718 Homez 2 
TRCN0000085721 Homez 2 
TRCN0000066856 Il17d 2 
TRCN0000066854 Il17d 2 
TRCN0000124699 Inadl 2 
TRCN0000124700 Inadl 2 
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shRNA code targeted gene # of scoring shRNAs 
TRCN0000023475 Jak3 2 
TRCN0000023477 Jak3 2 
TRCN0000125024 Kcnc2 2 
TRCN0000125026 Kcnc2 2 
TRCN0000069278 Kcnj14 2 
TRCN0000069280 Kcnj14 2 
TRCN0000068796 Kctd4 2 
TRCN0000068797 Kctd4 2 
TRCN0000032583 Kif24 2 
TRCN0000032582 Kif24 2 
TRCN0000032297 Klk10 2 
TRCN0000032294 Klk10 2 
TRCN0000080263 Kng1 2 
TRCN0000080266 Kng1 2 
TRCN0000089735 Krt79 2 
TRCN0000089737 Krt79 2 
TRCN0000098438 Krtap9-1 2 
TRCN0000098436 Krtap9-1 2 
TRCN0000105615 Lcn9 2 
TRCN0000105619 Lcn9 2 
TRCN0000097226 Lpxn 2 
TRCN0000097227 Lpxn 2 
TRCN0000106459 Lrrc66 2 
TRCN0000106455 Lrrc66 2 
TRCN0000087550 Lxn 2 
TRCN0000087551 Lxn 2 
TRCN0000042656 Mcf2 2 
TRCN0000174066 Mcf2 2 
TRCN0000124920 Mlxip 2 
TRCN0000124919 Mlxip 2 
TRCN0000102521 Mrpl12 2 
TRCN0000102520 Mrpl12 2 
TRCN0000084582 Mxd1 2 
TRCN0000084581 Mxd1 2 
TRCN0000089824 Myo18b 2 
TRCN0000089825 Myo18b 2 
TRCN0000039343 Myst4 2 
TRCN0000039341 Myst4 2 
TRCN0000012021 Nceh1 2 
TRCN0000012018 Nceh1 2 
TRCN0000173546 Ncoa6 2 
TRCN0000173430 Ncoa6 2 
TRCN0000097694 Ndst4 2 
TRCN0000097691 Ndst4 2 
TRCN0000113665 Negr1 2 
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shRNA code targeted gene # of scoring shRNAs 
TRCN0000113667 Negr1 2 
TRCN0000119701 Nlrp14 2 
TRCN0000119697 Nlrp14 2 
TRCN0000188932 Olfr202 2 
TRCN0000185356 Olfr202 2 
TRCN0000202878 Olfr849 2 
TRCN0000202754 Olfr849 2 
TRCN0000174685 Orc5l 2 
TRCN0000175246 Orc5l 2 
TRCN0000125497 Ormdl2 2 
TRCN0000125495 Ormdl2 2 
TRCN0000085366 Ovol1 2 
TRCN0000085367 Ovol1 2 
TRCN0000193830 Parn 2 
TRCN0000173297 Parn 2 
TRCN0000112665 Parva 2 
TRCN0000112668 Parva 2 
TRCN0000111771 Pdia6 2 
TRCN0000111772 Pdia6 2 
TRCN0000197570 Piwil4 2 
TRCN0000198921 Piwil4 2 
TRCN0000098776 Pla2g12a 2 
TRCN0000098775 Pla2g12a 2 
TRCN0000097292 Pla2g4c 2 
TRCN0000097289 Pla2g4c 2 
TRCN0000027596 Plk3 2 
TRCN0000027594 Plk3 2 
TRCN0000198533 Pof1b 2 
TRCN0000197655 Pof1b 2 
TRCN0000101207 Ppil4 2 
TRCN0000101205 Ppil4 2 
TRCN0000012626 Ppp2r1a 2 
TRCN0000012623 Ppp2r1a 2 
TRCN0000089083 Prg4 2 
TRCN0000089084 Prg4 2 
TRCN0000088570 Prkcdbp 2 
TRCN0000088572 Prkcdbp 2 
TRCN0000032537 Prss23 2 
TRCN0000032534 Prss23 2 
TRCN0000032159 Psma5 2 
TRCN0000032163 Psma5 2 
TRCN0000054532 Psmb5 2 
TRCN0000031790 Psmb5 2 
TRCN0000120273 Psmc3ip 2 
TRCN0000120274 Psmc3ip 2 
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shRNA code targeted gene # of scoring shRNAs 
TRCN0000071253 Pttg1 2 
TRCN0000071254 Pttg1 2 
TRCN0000040757 Rmnd5a 2 
TRCN0000040755 Rmnd5a 2 
TRCN0000041188 Rnf5 2 
TRCN0000041189 Rnf5 2 
TRCN0000039431 Rnf8 2 
TRCN0000039432 Rnf8 2 
TRCN0000096450 Rsl1 2 
TRCN0000096451 Rsl1 2 
TRCN0000119367 Rtn1 2 
TRCN0000119371 Rtn1 2 
TRCN0000121384 Sash1 2 
TRCN0000121385 Sash1 2 
TRCN0000032466 Scpep1 2 
TRCN0000032468 Scpep1 2 
TRCN0000119389 Serinc1 2 
TRCN0000119387 Serinc1 2 
TRCN0000105563 Sfxn3 2 
TRCN0000105561 Sfxn3 2 
TRCN0000098355 Sgcz 2 
TRCN0000098358 Sgcz 2 
TRCN0000094527 Siglece 2 
TRCN0000094526 Siglece 2 
TRCN0000068085 Siglech 2 
TRCN0000068087 Siglech 2 
TRCN0000112081 Skiv2l 2 
TRCN0000112084 Skiv2l 2 
TRCN0000176761 Slain1 2 
TRCN0000198389 Slain1 2 
TRCN0000079319 Slc15a2 2 
TRCN0000079320 Slc15a2 2 
TRCN0000069017 Slc35a5 2 
TRCN0000069014 Slc35a5 2 
TRCN0000109151 Snrpa1 2 
TRCN0000109154 Snrpa1 2 
TRCN0000080182 Sparcl1 2 
TRCN0000080178 Sparcl1 2 
TRCN0000079971 Spock1 2 
TRCN0000079970 Spock1 2 
TRCN0000103288 Sptlc3 2 
TRCN0000103285 Sptlc3 2 
TRCN0000085871 Srxn1 2 
TRCN0000085868 Srxn1 2 
TRCN0000110384 St8sia2 2 
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shRNA code targeted gene # of scoring shRNAs 
TRCN0000110382 St8sia2 2 
TRCN0000079998 Stfa3 2 
TRCN0000079999 Stfa3 2 
TRCN0000115527 Stmn4 2 
TRCN0000115530 Stmn4 2 
TRCN0000108876 Syne1 2 
TRCN0000108878 Syne1 2 
TRCN0000054843 Tank 2 
TRCN0000054844 Tank 2 
TRCN0000106072 Tbc1d2b 2 
TRCN0000106073 Tbc1d2b 2 
TRCN0000114127 Tcl1b5 2 
TRCN0000114129 Tcl1b5 2 
TRCN0000085951 Tead3 2 
TRCN0000085950 Tead3 2 
TRCN0000089893 Tekt3 2 
TRCN0000089894 Tekt3 2 
TRCN0000071302 Terf1 2 
TRCN0000071299 Terf1 2 
TRCN0000119341 Tmem165 2 
TRCN0000119338 Tmem165 2 
TRCN0000124294 Tmem54 2 
TRCN0000124298 Tmem54 2 
TRCN0000177998 Tmem85 2 
TRCN0000178319 Tmem85 2 
TRCN0000101965 Tnpo3 2 
TRCN0000101968 Tnpo3 2 
TRCN0000081817 Tox3 2 
TRCN0000081815 Tox3 2 
TRCN0000098646 Ttll13 2 
TRCN0000098647 Ttll13 2 
TRCN0000040914 Ube2v2 2 
TRCN0000040915 Ube2v2 2 
TRCN0000092675 Ubqln4 2 
TRCN0000092676 Ubqln4 2 
TRCN0000030819 Usp33 2 
TRCN0000030821 Usp33 2 
TRCN0000030739 Usp4 2 
TRCN0000030742 Usp4 2 
TRCN0000104975 Vmn2r-ps105 2 
TRCN0000104976 Vmn2r-ps105 2 
TRCN0000183172 Wipf1 2 
TRCN0000195856 Wipf1 2 
TRCN0000081652 Zfp14 2 
TRCN0000081651 Zfp14 2 
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shRNA code targeted gene # of scoring shRNAs 
TRCN0000096581 Zfp688 2 
TRCN0000096582 Zfp688 2 
TRCN0000088182   2 
TRCN0000088181   2 
TRCN0000087404   2 
TRCN0000087406   2 
 
Top enriched proteins in DNA pull-down by Dr. Falk Butter (Spectionmycin vs. 
GAG2.22) 
Gene Names Uniprot Ratio 
for 
Ratio 
rev 
Tcfap2d Q91ZK0  22,1 
Gm1103;Zbtb2;mKIAA1483 Q3V1Q5;Q3V3W4;Q505G7;Q69ZI2 0,0 19,0 
Tcfap2c;Tfap2c; Q61312;A2APA8;Q3ULB3;Q3URU7;Q99L72 0,0 18,5 
Cnbp;Cnbp1;Znf9;mCG_130858 P53996-3;P53996;Q3ULK8;P53996-2;Q3U935;P53996-1;Q5QJQ9;Q3U5V2 0,0 17,5 
Zbtb25;Zfp50 Q6NV93;Q9CSB1 0,1 17,1 
Ap2tf;Tcfap2a;Tfap2a;mCG_5075;AP
-2 
P34056-3;P34056;Q8BPN4;P34056-4;P34056-1;P34056-2;Q3UL09;Q6LCW3 0,0 13,9 
Zfp296;mCG_4870 Q4FZI6;Q9D7X0;Q9EPM0 0,0 13,3 
Zic5;Opr Q7TQ40;Q9CVS3;Q9EQW1 0,0 13,0 
Zasc1;Zfp639;Znf639 Q99KZ6;Q80UZ3 0,1 12,8 
Sfrs2;Pr264;Sfrs10;mCG_6836;RP23
-468A19.7-001;IREBF2 
Q8C671;Q62093;A2AA29;Q99MY4;Q99MY5;Q06477 0,1 9,7 
L3mbtl3;Mbt1 Q8BLB7-1;Q8BLB7;Q8BLB7-2;Q8BMN8 0,1 9,4 
  0,1 9,3 
Msh6;Gtmbp Q61061;Q6GTK8;Q8C2N9;Q9CRH0;P54276 0,1 8,5 
Lin28;Lin28a;Tex17 Q8K3Y3  7,6 
Ncl;Nuc P09405;Q3TGR3;Q3TL52;Q3TT41;Q8CD23;Q8CE30;Q9CT46 0,1 7,0 
Mta1 Q8K4B0;Q2KHS8 0,1 7,0 
Mta1l1;Mta2 Q9R190;Q3TZP3;Q3UDZ8 0,1 6,9 
  0,1 6,5 
Rbap46;Rbbp7;RP23-436I3.1-
002;RP23-436I3.1-003 
Q60973;Q3UJI2;Q3UX53;Q8C5H3;A2AFI9;A2AFJ1 0,1 6,4 
RP23-199A2.1-001;Vezf1;RP23-
199A2.1-002 
Q5SXC4;Q9Z162;Q5SXC3 0,1 5,7 
Pura P42669;Q8C6E9 0,2 5,6 
Ezf;Gklf;Klf4;Zie;RP23-322L22.2-003 Q60793;B7ZCH2 0,1 5,6 
Ctcf Q61164;Q05CK6;Q3USR8;Q3UYZ8;Q3UZH8 0,2 5,4 
Purb O35295;Q3UTJ8;Q8BQK8 0,1 5,3 
Mtf2;Pcl2;mPcl2 Q02395-1;Q02395;Q05C61;Q02395-2;Q924U2 0,2 5,2 
Klf2;Lklf B2RS60;Q3V293;Q9JLV7;Q60843 0,1 5,2 
mCG_12245;Rbbp4;RP23-391E6.3-
001;Rbap48 
A2A875;Q60972 0,2 4,7 
Gatad2b;mKIAA1150 Q8VHR5-1;Q8VHR5;A1L3S7;Q69ZQ5;Q6PAH8;Q8VHR5-2 0,1 4,5 
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Gene Names Uniprot Ratio 
for 
Ratio 
rev 
Gatad2a Q8CHY6 0,1 4,3 
Dppa4 Q8CCG4;Q9CWG7 0,3 4,2 
Atf2;mCG_19373; P16951-1;P16951;A2AQF2;P70299;Q8BN75;Q8CGB4;P16951-
2;Q640L6;Q8BQY2;Q3UKS5;P16951-3;Q543G2;Q68FE3;Q8CBR9;A2AQF0 
0,2 4,2 
Sfrs3;Srp20;X16;mCG_21131 P84104-1;P84104;B2KF41;Q9D6W4;P84104-2;Q3U781;A2A4X6  4,1 
Chd4;mKIAA4075 Q5DTP7;Q6PDQ2;Q8BM83;Q3U582;Q3UFM8;Q3ULG0;Q3V265;Q6IQY9;Q99JM0;
Q9CTT2 
0,2 4,0 
Ddx36;Dhx36;Kiaa1488;Mlel1 Q8VHK9;A0JLR3;B2RQS6 0,1 4,0 
Hmgts;Tfam P40630-1;P40630;Q3TSW9;P40630-2;P97907 0,4 3,9 
Zic2 Q62520;Q8BQC1  3,8 
Hdac1;RP23-209C6.7-001 O09106;Q58E49 0,2 3,8 
Hdac2;Yy1bp P70288;Q3TMT1;Q3URA2;Q3UXH8;Q8BQ10 0,2 3,8 
Eed Q921E6-2;Q921E6;Q921E6-1;Q921E6-3 0,4 3,7 
Atf7;mCG_17588 Q3TZR9;Q3US59;Q8R0S1;Q3U2X8 0,1 3,7 
Bteb2;Iklf;Klf5 Q9Z0Z7;Q923C0 0,1 3,6 
D11Ertd530e;Kiaa0160;Suz12 Q80U70;Q3URR6;Q3UX45;Q5XG68 0,3 3,6 
Zbed6 Q3UMD3;Q8C1U4;Q8CBM9 0,2 3,4 
Mta3;mKIAA1266 A4FTZ3;Q3UII8;Q3UKM9;Q6ZPV1;Q924K8-2;Q924K8;Q3U3A7;Q924K8-1;Q3TY62 0,2 3,4 
Enx2;Ezh1 P70351-2;P70351;P70351-1 0,2 3,2 
Enx1h;Ezh2;mKIAA4065;mCG_2028 Q61188-1;Q61188;Q3TZH6;Q571L5;Q99L74;Q61188-2;Q3U575;Q8C2I5;Q6AXH7 0,3 3,1 
ENSMUSG00000053178;Gm9897;m
CG_113542;Mterf 
B9EJ57;Q05C75;Q8CHZ9 0,5 3,0 
Zfp71-rs1;Zfp738 Q8BY64;Q91W94;B8JJX9;B8JJY0;Q60915;Q4QQP3;Q7M6X0;Q8BLX6;B8JJX8;Q8
BSG2 
0,3 2,9 
Ing5 Q9D8Y8-1;Q9D8Y8;Q9D8Y8-2;Q9D8Y8-3  2,8 
Myst4 Q8BRB7-1;Q8BRB7;Q3UH94;Q501M5;Q8BRB7-2 0,4 2,8 
Hrs;Sfrs5;mCG_7614 O35326;Q9D8S5;Q5U448;Q640L9 0,3 2,8 
Rbm28 Q8CGC6;Q8R2W6 0,4 2,7 
Zfx;RP23-269L6.2-001;Zfa;RP23-
269L6.2-003 
P17012;B1ASD1;Q3UM56;Q3URA1;Q99NJ4;B1ASD2;B7ZN32;P23607;Q8CDV8 0,7 2,7 
Dppa2;Phsecrg1;mCG_127782 Q9CWH0;B2RQ54 0,5 2,6 
Blm O88700 0,3 2,6 
Zfp281 Q3U063;Q3V3S9;Q4FK52;Q99LI5 0,3 2,6 
Cxxc5 Q91WA4 0,2 2,5 
Moz;Myst3 Q8BZ21;A0PJC5;Q3UFW4;Q3UPM9;Q3V1G6;Q8C6L0 0,3 2,5 
C80731;Zfp568 Q3UPK4;Q0VGV0;Q3TLJ8  2,5 
Top enriched proteins in DNA pull-down by Dr. Falk Butter (GAG2.22 vs. point 
mutant) 
 Gene Names Uniprot Ratio 
for 
Ratio 
rev 
Ubtf A2AWT5;P25976;A2AWT7;A2AWT6;P25976-2 
 
2,55 
 
0,32 
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Proteomics interaction list of Trim28 (experiment performed with Ignasi Forné) 
Peptides were identified with Scaffold3™ - Not enriched peptides and peptides 
corresponding to splicing and ribosomal proteins have been removed from the list and are 
available upon request.  
Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
ABT1_MOUSE 31 kDa 2 3 7 5 
ADT1_MOUSE 33 kDa 2 5 4 5 
ADT2_MOUSE 33 kDa 9 14 18 11 
AAAS_MOUSE 59 kDa 0 2 2 2 
ATPB_MOUSE 56 kDa 0 3 1 1 
ATAD2_MOUSE 118 kDa 0 4 1 12 
DHX9_MOUSE 149 kDa 20 29 28 27 
BOREA_MOUSE 32 kDa 2 4 5 3 
BRD2_MOUSE 88 kDa 1 4 5 6 
CBX1_MOUSE 21 kDa 2 5 8 7 
CBX3_MOUSE 21 kDa 7 9 10 8 
CBX5_MOUSE 22 kDa 3 12 10 12 
CHD1_MOUSE 196 kDa 13 26 17 26 
H2AY_MOUSE 40 kDa 1 6 12 10 
H2AW_MOUSE 40 kDa 0 1 1 6 
CUL4B_MOUSE ? 1 4 2 3 
QCR2_MOUSE 48 kDa 2 4 3 5 
CY1_MOUSE 35 kDa 1 4 3 4 
DNJA2_MOUSE 46 kDa 0 3 4 1 
RPN2_MOUSE 69 kDa 0 2 1 2 
RING2_MOUSE 38 kDa 0 2 1 2 
EF1A1_MOUSE 50 kDa 6 7 7 8 
EF1G_MOUSE 50 kDa 1 7 7 9 
SP16H_MOUSE 120 kDa 2 6 13 3 
FXR1_MOUSE 76 kDa 0 1 1 9 
GNAI2_MOUSE 40 kDa 8 10 13 15 
GNAI3_MOUSE 41 kDa 1 6 3 4 
GNAS1_MOUSE (+1) 122 kDa 0 2 1 8 
GBLP_MOUSE 35 kDa 0 2 3 10 
GNL3_MOUSE 61 kDa 0 3 7 1 
HDGR2_MOUSE 74 kDa 3 4 10 5 
SAP18_MOUSE 18 kDa 10 12 17 11 
H2A1F_MOUSE 14 kDa 3 4 5 6 
H2B1C_MOUSE (+1) 14 kDa 10 11 12 11 
H33_MOUSE 15 kDa 8 11 10 9 
H4_MOUSE 11 kDa 12 13 13 13 
EHMT2_MOUSE 138 kDa 1 3 3 2 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
M2OM_MOUSE 34 kDa 0 2 2 2 
NAT10_MOUSE 115 kDa 15 22 21 17 
NDUA9_MOUSE 43 kDa 0 2 2 3 
NOC4L_MOUSE 59 kDa 3 7 8 4 
NOL12_MOUSE 25 kDa 0 1 3 1 
DDX21_MOUSE 94 kDa 29 36 41 36 
UBF1_MOUSE 90 kDa 8 12 22 30 
PPHLN_MOUSE 44 kDa 0 2 1 1 
DDX49_MOUSE 54 kDa 0 1 4 1 
PML_MOUSE 98 kDa 10 16 15 13 
YES_MOUSE 61 kDa 0 1 2 1 
K0020_MOUSE 73 kDa 10 13 19 13 
CTR9_MOUSE 133 kDa 0 1 1 14 
RRP12_MOUSE 143 kDa 3 15 17 7 
RUVB2_MOUSE 51 kDa 2 9 13 3 
S30BP_MOUSE 34 kDa 3 8 9 4 
SMC1A_MOUSE 143 kDa 1 7 6 4 
SSF1_MOUSE 53 kDa 0 1 7 1 
SMCA5_MOUSE 122 kDa 37 40 43 41 
THOC2_MOUSE ? 0 2 2 2 
SPT6H_MOUSE 199 kDa 2 9 24 4 
TIF1A_MOUSE 117 kDa 1 28 30 22 
TIF1B_MOUSE 89 kDa 19 56 62 57 
TBA1B_MOUSE 50 kDa 6 11 9 10 
BAZ1B_MOUSE 171 kDa 17 26 34 49 
WDR18_MOUSE 47 kDa 2 9 3 5 
WDR61_MOUSE 34 kDa 0 1 4 10 
ZCH18_MOUSE 106 kDa 6 10 19 11 
ZFP1_MOUSE 47 kDa 0 5 2 1 
ZNF12_MOUSE ? 0 3 2 3 
ZN120_MOUSE 51 kDa 0 7 6 5 
ZFP2_MOUSE 53 kDa 0 2 4 2 
ZN235_MOUSE 73 kDa 1 4 3 3 
ZFP57_MOUSE 48 kDa 0 23 19 11 
1433T_MOUSE 28 kDa 0 2 1 0 
ACL6A_MOUSE 47 kDa 2 6 4 1 
AROS_MOUSE 16 kDa 1 2 2 1 
DDX24_MOUSE 96 kDa 5 7 10 0 
BAZ2A_MOUSE 210 kDa 2 7 11 0 
CSK2B_MOUSE 25 kDa 0 3 2 0 
CEBPZ_MOUSE 120 kDa 3 6 8 3 
CENPV_MOUSE 28 kDa 3 6 6 2 
CHD4_MOUSE 218 kDa 15 20 25 5 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
STAG1_MOUSE 145 kDa 0 5 2 0 
COR2B_MOUSE 55 kDa 0 1 2 0 
CTBP2_MOUSE 49 kDa 0 4 7 0 
CDK11_MOUSE ? 14 15 31 13 
DNMT1_MOUSE 183 kDa 3 7 11 3 
MCM2_MOUSE 102 kDa 3 4 6 1 
MCM4_MOUSE 97 kDa 3 5 12 3 
TOP2A_MOUSE 173 kDa 20 22 30 14 
RPB1_MOUSE 217 kDa 0 2 20 0 
RPB2_MOUSE 134 kDa 0 1 7 0 
RPAB3_MOUSE 17 kDa 0 1 2 0 
RAD21_MOUSE 72 kDa 0 1 2 0 
UHRF1_MOUSE 88 kDa 8 15 21 2 
ELAV1_MOUSE 36 kDa 1 7 4 0 
ENY2_MOUSE 12 kDa 2 3 4 1 
ESF1_MOUSE 98 kDa 1 2 3 0 
GRWD1_MOUSE 49 kDa 0 3 3 0 
GRTP1_MOUSE 41 kDa 0 3 2 0 
HSP7C_MOUSE 71 kDa 22 23 26 22 
MYST4_MOUSE 209 kDa 0 2 3 0 
RBBP4_MOUSE 48 kDa 3 5 6 2 
EZH2_MOUSE 85 kDa 1 3 3 0 
IMA2_MOUSE 58 kDa 5 6 7 2 
IMDH2_MOUSE 56 kDa 0 6 3 0 
ILF2_MOUSE 43 kDa 0 4 2 0 
LRWD1_MOUSE 72 kDa 3 5 4 0 
LITD1_MOUSE 88 kDa 22 37 39 0 
TDH_MOUSE 41 kDa 0 4 1 0 
KDM5B_MOUSE 176 kDa 6 16 11 0 
MATR3_MOUSE 95 kDa 19 24 29 16 
MTCH2_MOUSE 33 kDa 5 7 7 0 
TOM40_MOUSE 38 kDa 0 5 3 0 
MK67I_MOUSE 36 kDa 3 6 6 2 
MBB1A_MOUSE 152 kDa 45 54 58 39 
NDUAA_MOUSE 41 kDa 1 2 2 1 
NDUA4_MOUSE 9 kDa 0 2 1 0 
NU133_MOUSE 129 kDa 11 19 12 2 
NU155_MOUSE 155 kDa 9 15 12 7 
NU214_MOUSE 213 kDa 3 7 4 0 
NR0B1_MOUSE 53 kDa 0 4 3 0 
NPA1P_MOUSE 255 kDa 6 19 30 5 
NOL8_MOUSE 129 kDa 5 8 9 2 
NUCL_MOUSE 77 kDa 11 15 14 1 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
NU188_MOUSE 197 kDa 3 6 4 1 
ORC1_MOUSE 95 kDa 1 6 9 0 
ORC2_MOUSE 66 kDa 2 5 4 0 
ORC4_MOUSE 50 kDa 2 5 5 1 
ORC5_MOUSE 50 kDa 1 5 3 0 
PAPD5_MOUSE 70 kDa 0 1 3 0 
PCID2_MOUSE 46 kDa 4 10 5 4 
PHF11_MOUSE ? 2 22 16 0 
MPCP_MOUSE 40 kDa 6 9 10 1 
PINX1_MOUSE 37 kDa 0 1 2 0 
EED_MOUSE 50 kDa 0 4 7 0 
DDX47_MOUSE 51 kDa 0 1 2 0 
RBM19_MOUSE 106 kDa 2 4 5 2 
ELYS_MOUSE ? 8 16 16 4 
FA60A_MOUSE 25 kDa 1 3 2 0 
JARD2_MOUSE 137 kDa 1 8 6 0 
MAK16_MOUSE 35 kDa 0 3 3 0 
REST_MOUSE 118 kDa 0 3 1 0 
RFC2_MOUSE 39 kDa 1 3 3 1 
RRP7A_MOUSE 32 kDa 7 12 12 7 
RBM7_MOUSE 30 kDa 0 2 5 0 
PNO1_MOUSE 27 kDa 2 7 7 2 
RRP15_MOUSE 31 kDa 0 2 2 0 
SAFB2_MOUSE 112 kDa 1 6 2 0 
AURKB_MOUSE 39 kDa 5 6 7 1 
PP1G_MOUSE 37 kDa 5 7 6 2 
SFXN1_MOUSE 36 kDa 0 2 2 0 
PDS5B_MOUSE 164 kDa 2 6 7 1 
UTP20_MOUSE 318 kDa 20 34 41 8 
SON_MOUSE 261 kDa 0 1 2 0 
ERR2_MOUSE 48 kDa 0 2 1 0 
SMC3_MOUSE 142 kDa 0 2 2 0 
SMRC1_MOUSE 123 kDa 3 7 6 1 
RIF1_MOUSE 266 kDa 5 11 11 2 
TERF1_MOUSE 48 kDa 0 2 1 0 
ZO2_MOUSE 131 kDa 0 2 1 0 
SMCA4_MOUSE ? 10 12 13 10 
TRI39_MOUSE 56 kDa 0 7 2 0 
TBB5_MOUSE 50 kDa 6 17 17 6 
CC063_MOUSE 181 kDa 0 4 5 0 
UTF1_MOUSE 36 kDa 0 4 3 0 
VDAC1_MOUSE 32 kDa 0 1 2 0 
VDAC2_MOUSE 32 kDa 4 9 9 2 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
VDAC3_MOUSE 31 kDa 4 8 5 4 
WDR83_MOUSE ? 0 1 5 0 
WDR82_MOUSE 35 kDa 0 3 1 0 
ZMYM4_MOUSE 172 kDa 1 3 3 0 
ARPC2_MOUSE 34 kDa 2 3 2 10 
ADNP_MOUSE 92 kDa 3 4 1 6 
CLH_MOUSE 192 kDa 7 12 6 24 
OST48_MOUSE 49 kDa 0 2 0 1 
DPYD_MOUSE-R ? 0 1 0 2 
NEDD4_MOUSE 103 kDa 2 3 1 6 
EIF3F_MOUSE 38 kDa 0 1 0 2 
FINC_MOUSE 272 kDa 1 3 0 19 
GPC4_MOUSE 63 kDa 0 1 0 4 
AT1A1_MOUSE 113 kDa 0 2 0 1 
TCPZ_MOUSE 58 kDa 0 3 0 1 
ATRX_MOUSE 279 kDa 13 20 11 35 
TMOD3_MOUSE 40 kDa 23 24 18 24 
CX056_MOUSE 26 kDa 0 1 0 2 
USP9X_MOUSE-R ? 0 1 0 2 
VIME_MOUSE 54 kDa 2 5 0 23 
ZFP60_MOUSE 82 kDa 0 4 0 1 
ZFP90_MOUSE 72 kDa 0 1 0 7 
TRI27_MOUSE 59 kDa 0 4 0 1 
MCM3A_MOUSE 217 kDa 2 3 2 1 
ASSY_MOUSE 47 kDa 0 3 0 0 
ATPA_MOUSE 60 kDa 5 6 4 0 
ATPG_MOUSE 33 kDa 1 2 1 1 
CSK21_MOUSE 45 kDa 11 14 10 7 
CENPQ_MOUSE 31 kDa 0 2 0 0 
C1QBP_MOUSE 31 kDa 0 2 0 0 
CDK1_MOUSE ? 3 5 3 0 
CYTSA_MOUSE 124 kDa 0 15 0 0 
ZDBF2_MOUSE 274 kDa 0 2 0 0 
MSH6_MOUSE 151 kDa 1 2 1 0 
MCM6_MOUSE 93 kDa 10 13 10 5 
TRI33_MOUSE 124 kDa 0 2 0 0 
EFTU_MOUSE 50 kDa 0 4 0 0 
EDC4_MOUSE 152 kDa 1 2 1 0 
FRIL1_MOUSE 21 kDa 1 2 1 0 
G3P_MOUSE 36 kDa 7 8 6 4 
HXK2_MOUSE 103 kDa 1 4 1 1 
H2A2A_MOUSE 14 kDa 9 11 9 8 
ING4_MOUSE 29 kDa 1 2 1 0 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
ING5_MOUSE 28 kDa 5 6 4 2 
ODB2_MOUSE 53 kDa 0 10 0 0 
MBD3_MOUSE 32 kDa 3 5 3 1 
MK01_MOUSE 41 kDa 0 2 0 0 
NID2_MOUSE 154 kDa 0 2 0 0 
NU107_MOUSE 107 kDa 10 12 10 4 
NU160_MOUSE 158 kDa 27 30 25 23 
NVL_MOUSE 94 kDa 3 5 3 0 
NOC3L_MOUSE 93 kDa 1 2 0 0 
NUP37_MOUSE 37 kDa 5 7 5 5 
NUP43_MOUSE 42 kDa 4 6 2 2 
NUP53_MOUSE 35 kDa 1 2 1 0 
PCNA_MOUSE 29 kDa 3 4 3 1 
ANM1_MOUSE 42 kDa 7 12 3 1 
P5CR2_MOUSE 34 kDa 1 2 1 0 
GDIB_MOUSE 51 kDa 0 2 0 0 
RFC3_MOUSE 41 kDa 2 3 2 1 
RFC4_MOUSE 40 kDa 0 3 0 0 
RBM14_MOUSE 69 kDa 1 2 1 0 
STK38_MOUSE 54 kDa 4 7 2 1 
SPTA2_MOUSE 285 kDa 14 19 4 2 
SPIN1_MOUSE 30 kDa 2 3 2 0 
SUN1_MOUSE ? 1 2 0 0 
SMRCD_MOUSE 116 kDa 0 2 0 0 
TYSY_MOUSE 35 kDa 5 6 5 1 
UBP7_MOUSE 128 kDa 0 2 0 0 
CI114_MOUSE 43 kDa 11 15 10 2 
K1797_MOUSE 199 kDa 1 2 0 1 
WDR5_MOUSE 37 kDa 1 3 1 1 
ZF106_MOUSE 209 kDa 0 3 0 0 
ZN250_MOUSE 60 kDa 0 4 0 0 
ZFP59_MOUSE 73 kDa 0 4 0 0 
ZFP62_MOUSE 105 kDa 1 3 1 1 
ZN667_MOUSE 70 kDa 0 2 0 0 
PRS4_MOUSE 49 kDa 0 0 1 4 
PRS7_MOUSE 49 kDa 1 1 2 4 
RT16_MOUSE 15 kDa 0 0 1 3 
RT31_MOUSE 44 kDa 1 1 3 4 
RM23_MOUSE 17 kDa 0 0 3 1 
RM03_MOUSE 39 kDa 0 0 3 1 
RS15_MOUSE 17 kDa 3 2 4 8 
RS17_MOUSE 16 kDa 3 3 4 7 
RS25_MOUSE 14 kDa 3 3 4 6 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
RS8_MOUSE 24 kDa 5 5 9 11 
RL13_MOUSE 24 kDa 6 5 8 11 
RL18A_MOUSE 21 kDa 3 0 4 7 
RL36A_MOUSE 12 kDa 7 6 8 8 
IF4A3_MOUSE 47 kDa 23 21 37 26 
IGH1M_MOUSE (+1) 43 kDa 19 17 20 20 
GCAA_MOUSE (+1) 36 kDa 0 0 1 4 
INT1_MOUSE 245 kDa 0 0 1 2 
KRR1_MOUSE 44 kDa 2 2 3 3 
NCBP1_MOUSE 92 kDa 0 0 3 1 
PININ_MOUSE 82 kDa 20 9 38 27 
DDX41_MOUSE 70 kDa 4 0 9 11 
RNPS1_MOUSE 34 kDa 2 2 7 6 
SRSF9_MOUSE ? 1 1 7 3 
THOC1_MOUSE 75 kDa 0 0 1 2 
TRA2B_MOUSE 34 kDa 11 10 19 12 
UTP6_MOUSE 70 kDa 8 8 19 10 
RM37_MOUSE 48 kDa 2 2 3 2 
RM44_MOUSE 38 kDa 0 0 3 0 
RL14_MOUSE 24 kDa 2 1 3 1 
RL19_MOUSE 23 kDa 2 2 4 2 
RL32_MOUSE 16 kDa 2 2 3 2 
RL38_MOUSE 8 kDa 2 2 3 2 
DDX51_MOUSE 70 kDa 4 2 8 0 
DDX54_MOUSE 98 kDa 1 1 2 0 
CIR1_MOUSE ? 0 0 2 0 
CRNL1_MOUSE 83 kDa 8 2 17 3 
NHP2_MOUSE 17 kDa 1 1 2 1 
HNRPL_MOUSE 64 kDa 5 5 8 5 
HNRPM_MOUSE 78 kDa 14 4 18 9 
LV1A_MOUSE (+1) 12 kDa 1 1 3 1 
K1C14_MOUSE 53 kDa 3 1 5 3 
K22O_MOUSE 63 kDa 1 1 2 1 
NOP14_MOUSE 99 kDa 6 6 8 3 
NOP56_MOUSE 64 kDa 27 20 28 18 
NOP58_MOUSE 60 kDa 18 10 20 10 
NO66_MOUSE 68 kDa 2 1 3 0 
PESC_MOUSE 68 kDa 5 3 7 4 
PR40A_MOUSE 108 kDa 4 4 5 4 
PRP6_MOUSE 107 kDa 10 10 12 10 
ISY1_MOUSE 33 kDa 4 1 8 2 
SLU7_MOUSE 68 kDa 0 0 2 0 
SPF27_MOUSE 26 kDa 0 0 2 0 
DDX5_MOUSE 69 kDa 7 6 8 2 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
DDX56_MOUSE 61 kDa 4 2 6 3 
CWC15_MOUSE 27 kDa 2 2 8 1 
SDA1_MOUSE 80 kDa 1 0 2 0 
VIR_MOUSE 201 kDa 5 4 6 3 
RRP1B_MOUSE 81 kDa 7 5 13 2 
RBM39_MOUSE 59 kDa 4 4 5 0 
RBM8A_MOUSE 20 kDa 3 1 6 3 
SRRM1_MOUSE 107 kDa 0 0 2 0 
SRRM2_MOUSE 295 kDa 27 16 40 11 
SRSF1_MOUSE ? 10 9 18 9 
SRSF2_MOUSE ? 3 2 5 3 
SRSF4_MOUSE ? 2 2 4 2 
SRSF7_MOUSE ? 8 7 12 6 
SMD2_MOUSE 14 kDa 1 1 2 0 
SNW1_MOUSE 61 kDa 5 1 11 0 
SK2L2_MOUSE 118 kDa 1 1 6 0 
RU17_MOUSE 52 kDa 6 4 12 5 
PSMD2_MOUSE 100 kDa 1 1 1 9 
RS12_MOUSE 15 kDa 2 2 2 4 
RS24_MOUSE 15 kDa 1 1 1 2 
RS29_MOUSE 7 kDa 2 1 2 4 
RLA2_MOUSE 12 kDa 0 0 0 2 
RL11_MOUSE 20 kDa 5 5 5 9 
RL13A_MOUSE 23 kDa 0 0 0 2 
RL18_MOUSE 22 kDa 1 1 1 2 
RL21_MOUSE 19 kDa 3 3 3 5 
RL23_MOUSE 15 kDa 3 3 3 4 
RL27A_MOUSE 17 kDa 3 3 2 5 
RL34_MOUSE 13 kDa 0 0 0 2 
RL37A_MOUSE 10 kDa 4 3 4 7 
RL8_MOUSE 28 kDa 6 6 6 11 
IGKC_MOUSE 12 kDa 17 17 17 18 
KV2A7_MOUSE 12 kDa 8 8 8 9 
KV3AA_MOUSE (+1) 12 kDa 1 1 1 2 
KV3AJ_MOUSE 12 kDa 3 3 3 4 
KV5AB_MOUSE (+2) 12 kDa 2 1 1 3 
K1C17_MOUSE 48 kDa 10 6 6 12 
K2C6A_MOUSE 59 kDa 10 7 10 13 
SRSF5_MOUSE ? 2 2 2 3 
GRP78_MOUSE 72 kDa 3 1 4 12 
ACINU_MOUSE 151 kDa 23 13 38 24 
DDX50_MOUSE 82 kDa 0 0 1 6 
MCM7_MOUSE 81 kDa 6 2 15 9 
HNRPU_MOUSE ? 24 24 33 26 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
IMA4_MOUSE 58 kDa 0 0 1 2 
LMNA_MOUSE 74 kDa 5 1 6 48 
NIPBL_MOUSE 315 kDa 1 0 3 3 
NOL9_MOUSE 81 kDa 3 3 6 9 
CDC73_MOUSE 61 kDa 0 0 1 10 
PTCD3_MOUSE 78 kDa 1 0 6 5 
PELP1_MOUSE 118 kDa 7 6 10 8 
LAS1L_MOUSE ? 7 7 11 13 
SENP3_MOUSE 64 kDa 4 3 7 5 
SET1B_MOUSE-R ? 0 0 2 1 
WDR65_MOUSE ? 0 0 2 1 
DDX18_MOUSE 74 kDa 4 2 6 4 
CSK22_MOUSE 41 kDa 5 5 6 2 
CIR1A_MOUSE 77 kDa 4 3 6 0 
CCDC9_MOUSE 61 kDa 0 0 6 0 
CCNL1_MOUSE 60 kDa 2 2 10 2 
CCNL2_MOUSE 58 kDa 1 1 4 0 
DOCK6_MOUSE 233 kDa 1 1 3 0 
TDIF2_MOUSE 84 kDa 14 12 15 10 
DPPA2_MOUSE 34 kDa 3 3 4 0 
DPPA4_MOUSE 33 kDa 3 2 4 0 
RPB3_MOUSE 31 kDa 0 0 3 0 
RPB9_MOUSE 15 kDa 0 0 2 0 
DMD_MOUSE 426 kDa 1 0 2 1 
RBP2_MOUSE 341 kDa 19 18 22 7 
FANCI_MOUSE 149 kDa 0 0 2 0 
GPTC8_MOUSE 165 kDa 0 0 2 0 
H13_MOUSE 22 kDa 3 2 6 3 
H15_MOUSE 23 kDa 0 0 2 0 
H2AX_MOUSE 15 kDa 3 2 4 3 
IP3KA_MOUSE 51 kDa 0 0 2 0 
LMNB1_MOUSE 67 kDa 23 23 30 11 
HELLS_MOUSE 95 kDa 11 6 15 0 
MEN1_MOUSE 67 kDa 1 1 2 0 
MFAP1_MOUSE 52 kDa 2 1 3 2 
MINT_MOUSE 399 kDa 0 0 2 0 
NAA40_MOUSE ? 2 2 3 0 
NGDN_MOUSE 36 kDa 3 2 5 3 
NUP93_MOUSE 93 kDa 12 3 17 12 
NXF1_MOUSE 70 kDa 1 1 4 1 
NOL6_MOUSE 129 kDa 23 23 25 18 
NUP85_MOUSE 75 kDa 14 6 19 13 
ORC3_MOUSE 82 kDa 3 0 8 0 
PPIG_MOUSE 88 kDa 7 5 16 7 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
PWP1_MOUSE 56 kDa 7 2 8 1 
DDX10_MOUSE 101 kDa 18 16 23 8 
DDX27_MOUSE 86 kDa 0 0 2 0 
DDX52_MOUSE 67 kDa 4 1 5 0 
IWS1_MOUSE 85 kDa 4 2 7 2 
MGNR_MOUSE (+1) 17 kDa 8 6 14 7 
CN021_MOUSE 70 kDa 5 2 6 2 
RBM34_MOUSE 41 kDa 0 0 2 0 
RUVB1_MOUSE 50 kDa 6 5 7 6 
SAS10_MOUSE 53 kDa 2 1 4 1 
SPT5H_MOUSE 121 kDa 0 0 2 0 
TCOF_MOUSE 135 kDa 4 3 5 0 
WDR43_MOUSE 75 kDa 9 6 13 5 
WDR76_MOUSE 69 kDa 0 0 2 0 
ZCH10_MOUSE 19 kDa 1 1 3 1 
ACTA_MOUSE 42 kDa 17 17 16 31 
ARP2_MOUSE 45 kDa 4 4 0 9 
ARC1B_MOUSE 41 kDa 2 0 0 3 
ARPC4_MOUSE 20 kDa 3 2 3 4 
ARP3_MOUSE 47 kDa 3 2 1 13 
AKAP9_MOUSE-R ? 1 0 1 2 
ANXA1_MOUSE 39 kDa 0 0 0 4 
ANXA2_MOUSE 39 kDa 0 0 0 9 
ATAD3_MOUSE 67 kDa 1 0 0 4 
PGBM_MOUSE 398 kDa 0 0 0 4 
BCLF1_MOUSE 106 kDa 26 10 19 46 
ACTBL_MOUSE 42 kDa 1 0 1 2 
PGFRB_MOUSE 123 kDa 0 0 0 2 
PGS1_MOUSE 42 kDa 0 0 0 5 
BAZ1A_MOUSE 178 kDa 1 1 1 5 
CRTAP_MOUSE 46 kDa 0 0 0 6 
CAV1_MOUSE 21 kDa 0 0 0 4 
CHM4B_MOUSE 25 kDa 0 0 0 2 
CHCH3_MOUSE 26 kDa 2 1 2 3 
F120A_MOUSE 122 kDa 0 0 0 4 
CUL4A_MOUSE 88 kDa 0 0 0 2 
DDB1_MOUSE 127 kDa 2 0 0 9 
MCM5_MOUSE 82 kDa 11 2 10 16 
TOP2B_MOUSE 182 kDa 1 0 1 5 
RPN1_MOUSE 69 kDa 1 0 0 3 
ERH_MOUSE 12 kDa 7 7 6 8 
ERLN1_MOUSE (+1) 39 kDa 1 1 1 2 
EIF3C_MOUSE 106 kDa 0 0 0 5 
EIF3I_MOUSE 36 kDa 0 0 0 2 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
EIF3L_MOUSE 67 kDa 0 0 0 2 
SSRP1_MOUSE 81 kDa 3 0 3 7 
FBLN2_MOUSE 132 kDa 0 0 0 3 
FLNA_MOUSE 281 kDa 1 0 0 7 
FMR1_MOUSE 69 kDa 0 0 0 26 
FXR2_MOUSE 74 kDa 0 0 0 7 
LEG1_MOUSE 15 kDa 0 0 0 2 
GELS_MOUSE 86 kDa 5 0 0 22 
GNA1_MOUSE 21 kDa 0 0 0 2 
GUF1_MOUSE 72 kDa 1 1 1 2 
GNAO_MOUSE 40 kDa 0 0 0 2 
HP1B3_MOUSE 61 kDa 0 0 0 5 
HDAC2_MOUSE 55 kDa 0 0 0 2 
SUV91_MOUSE 48 kDa 0 0 0 3 
IF2B2_MOUSE 66 kDa 1 1 0 7 
ITIH3_MOUSE 99 kDa 0 0 0 2 
IFM3_MOUSE ? 0 0 0 2 
K1211_MOUSE-R ? 1 1 1 2 
LARP4_MOUSE 80 kDa 0 0 0 2 
NFIP1_MOUSE 25 kDa 0 0 0 3 
NCOA5_MOUSE 65 kDa 0 0 0 2 
PALLD_MOUSE-R ? 1 1 1 2 
PHIP_MOUSE 207 kDa 0 0 0 15 
PGAM5_MOUSE 32 kDa 9 6 8 10 
PLEC_MOUSE ? 2 1 0 66 
PTRF_MOUSE 44 kDa 0 0 0 11 
PLOD3_MOUSE 85 kDa 1 0 1 20 
LRP1_MOUSE 505 kDa 0 0 0 2 
P4HA1_MOUSE 61 kDa 0 0 0 2 
KPCA_MOUSE 77 kDa 0 0 0 3 
S61A1_MOUSE 52 kDa 0 0 0 5 
ODPA_MOUSE 43 kDa 0 0 0 3 
ODPB_MOUSE 39 kDa 0 0 0 2 
RP9_MOUSE 25 kDa 0 0 0 4 
WDR12_MOUSE 47 kDa 0 0 0 2 
PAF1_MOUSE 61 kDa 2 0 2 10 
LEO1_MOUSE 76 kDa 0 0 0 6 
SQSTM_MOUSE 48 kDa 0 0 0 2 
SDPR_MOUSE 47 kDa 0 0 0 7 
GTR1_MOUSE 54 kDa 1 0 0 3 
SMHD1_MOUSE 226 kDa 0 0 0 3 
SUN2_MOUSE ? 1 0 1 21 
TEX10_MOUSE ? 6 2 5 7 
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Accession Number Molecular 
Weight 
Peptides in Mock Peptides (Trim28-
RBCC) 
Peptides Trim28 FL 
mESC 
Peptides FL (MEF 
cells) 
TSP1_MOUSE 130 kDa 0 0 0 3 
TR150_MOUSE 108 kDa 37 19 29 47 
TTHY_MOUSE 16 kDa 3 1 2 4 
JAK1_MOUSE 133 kDa 0 0 0 5 
ZN326_MOUSE 65 kDa 0 0 0 10 
ZRAB2_MOUSE 37 kDa 0 0 0 2 
 
Used IAP-GAG sequences that are not listed in the methods section (in 5’ to 3’ 
direction) 
gag (used and cloned in antisense)  
tgaatttcccttgctgtccttcagaggattcccacgtcaaggcaacggagcttatagtgggacatgattgatatcctaggccctgtaatgaatgagatgactctgtggtgggccatgctttg
ggccaccaatgtgtagagattatacttttatctgctccggtatcaaggatgccttcaaactcttttccattaatcttaaggcggagcttaggtctatcatttaaagatacaaccaaataggca
gaatcatttcctgaggagcccattttctttatctcaggtcctgcagatttctccctggtattatcagggaggagcagcagctgagctatcctatctcctttactaatagaaaaaacgcccttag
ggcttgagcacaggacctgtatttcaggggaatgttgacaatccataactccagggtggactactaagccctgcaaggtgagtgaaccccggccgagaataaggcccatggttccc
aggggcaaggatggtataggctccactggcaccggctgaatactcatttgaggcattaataggaagtcggaggcggcacgcaggtccacccttgtgggtcttcctgggtcgcctctct
gactgcttcttgggtcctgacaaaccggttcccatatctttgagggccctgggaccgagggcccgatgacccgttttttggcacataaagctgattgactatcaggtgggggaaggact
ctgccctttatatccctcacagagcgacactggtcagctctatgataacccttgccacacttagagcaaagagtgagagtccctccctgtttatctggagctctgcaatctttcttaaaatgc
ccaggctttccgcaattaaaacatgtcctctgatcatttctgctcatggagcggttctgagattggaggatggcggccgctaagcctgcattggtgagaggtcccccaagctctcgacag
accctgagccagtcttgtaagcctttgttctttcttggagctatggccgctcggcactcctttgtggcttgctcatagatgagctgttctatcagaggcgcagcttgctctgactctccaaaaat
acgctctgctgcctctgtcattctggccacaaaatctgagaaggattcctgaggtccctggattatctttgttaactgcccagtggtttcacctgctcgggagagcgccttccaggccctaat
agccgtggaagaaatctgggcataagctccccaatggtagtttgtctgatcagcagaataagctccctgacccgttaacaagtcaaaagtccaatctctctgctctggagtcaaagca
gctgcgtttgctcgggcctgcgcttgtgcagcttcatgccaaagcgctctccattccatatatttgcccatactagggagagcggcttttacaatcgtttgccagtcagcaggagttagtgc
catgccggcgagcctgtctaactgcaccaaggtaaaattagcattggttccgtatttacggaccgactcggcaatttctttaatctgtacgtattctaccggagcgtggacacgcccacc
ctcggctccttcaaagactggaaatgcctgttgtattttcctttgttcctctctgggaatgaatgagtctgcacattgcctctctgcgcattgtctctctgcgcagggctgaccactacgcaggg
cggggactccgcatagggcggaccttgaagccgactgccctgaggccaatcagcaaactggccttcgccagccgcttttggcttccttaactgattagctagcactttacctggctggt
acccttttttctcataatgagctgcttcttcctcccagtctgtttcttcagaggagaattcatcatctgattcagagctaccaagagctggctccccgagcccatctagcgatgagcacaggc
tccttttcctagagacctccgctaattgatctttcttcttttccctttttcctcttttt 
gag2 
aaggaaaatacaacaggcatttccagtctttgaaggagccgagggtgggcgtgtccacgctccggtagaatacgtacagattaaagaaattgccgagtcggtccgtaaatacgga
accaatgctaattttaccttggtgcagttagacaggctcgccggcatggcactaactcctgctgactggcaaacgattgtaaaagccgctctccctagtatgggcaaatatatggaatg
gagagcgctttggcatgaagctgcacaagcgcaggcccgagcaaacgcagctgctttgactccagagcagagagattggacttttgacttgttaacgggtcagggagcttattctgct
gatcagacaaactaccattggggagcttatgcccagatttcttccacggctattagggcct 
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